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Abstract
The aim of this project was to create a high-level expression system for halophilic 
dihydrolipoamide dehydrogenase (DHLipDH), and use this system to express 
site-directed mutants to investigate structural features important in conferring 
halophilicity.
Attempts were made to express the enzyme in Escherichia coli. Although 
large quantities of a glutathione-S-transferase-DHLipDH fusion product were 
obtained, it was found difficult to purify and cleave the DHLipDH fragment from 
the rest of the fusion. Homologous expression was finally achieved using a 
shuttle vector, capable of replicating in both Haloferax volcanii and E. coli. The 
recombinant enzyme was purified to near homogeneity by a combination of 
hydroxylapatite and Cu2+-chelate chromatography. Crystallisation trials using the 
purified product have identified conditions around which further optimisation 
should yield crystals suitable for X-ray diffraction.
Using a molecular model, a putative K+-binding site was identified at the 
dimer interface of the enzyme, consisting of four coordinated glutamate residues. 
This site is apparently absent from the enzyme from non-halophilic sources, so 
was deemed a suitable target of site-directed mutagenesis. The site was 
perturbed and mutant proteins expressed in a strain of H. volcanii lacking 
DHLipDH activity, developed in collaboration with Dr. M. Dyall-Smith (University 
of Melbourne, Australia). Characterisation of these mutants have identified 
significant changes in the halophilic stability of the enzyme, and a role for the site 
in stabilising the protein in elevated salt conditions is discussed.
Additionally, the region upstream of the DHLipDH gene in the genome 
has been sequenced and coding regions for components homologous to those 
from pyruvate dehydrogenase multienzyme complexes (PDHC) identified. These 
complexes have never previously been found in the Archaea. The E2 
component appears to have undergone an internal duplication event that would 
perturb formation of an active complex, possibly explaining the lack of activity of a 
PDHC in this organism.
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1. Introduction
1.1 General phenotypes of the Archaea
The Archaea (previously known as archaebacteria) encompass three main 
phenotypes, namely thermophilic, halophilic and methanogenic (reviewed by 
Woese & Olsen, 1986; Fewson, 1986; Woese, 1987; Danson et a/., 1992). The 
thermophiles are sulphur-dependent organisms found in thermophilic 
environments (55->110°C), such as submarine vents and hot springs, and many 
can reduce or oxidise sulphur to produce energy. Some are also acidophiles, 
growing at acidities as low as pH 0. The methanogens are obligate anaerobes, 
reducing carbon dioxide to methane (Jones et al., 1987). They are found in a 
wide variety of habitats, such as in cattle rumen, sewage-treatment plants and 
anaerobic sediments. The halophiles require high concentrations (up to 5 M) of 
sodium chloride for growth and survival. Some are also highly alkaliphilic. Their 
internal environment has a high concentration of potassium chloride, isotonic with 
the exterior. Recently, a psychrophilic archaeon has been isolated and this may 
represent a fourth main phenotype (Preston et al., 1996).
The Archaea display a diverse range of morphological forms: irregular 
disks, cocci or straight or curved rods. They vary in size from 0.2 pm to 10 pm in 
diameter.
1.1.1 Physiology
Archaea possess some distinctive biochemical pathways involved with central 
metabolism (Danson, 1993). Some halophilic Archaea have been shown to 
catabolise glucose and galactose via a modified Entner-Doudoroff pathway 
(Tomlinson et al., 1974). Glucose is oxidised to gluconate by an NAD+-
1
dependent dehydrogenase and is then converted to 2-keto-3-deoxygluconate. 
This is phosphorylated with ATP to form 2-keto-3-deoxy-6-phosphogluconate, 
which then undergoes aldol cleavage to produce pyruvate and glyceraldehyde 3- 
phosphate. Thermoacidophilic Archaea catabolise glucose through a further 
modification of this pathway, in which no phosphorylated intermediates are used 
to produce the first molecule of pyruvate (Figure 1.1).
Archaea have some other biochemical features that phenotypically 
distinguish them from other organisms. They lack muramic acid-containing 
peptidoglycan in their cell envelopes (Kushner et al., 1964; Brown & Cho, 1970) 
and their membrane lipids are composed of ether-linked isoprenyl 
phosphoglycerides (Tornabene & Langworthy, 1979). Archaea generally lack 
sensitivity to many antibiotics concerned with cell wall and protein synthesis 
(Woese et a/., 1978; Bonelo etal.t 1984).
1.2 Archaeal phylogeny
Phytogeny is the evolutionary history of a taxonomic group, such as a species or 
a group of related organisms. Historically, taxonomic classifications were based 
on the fossil record, visible traits and, more recently, the results of biochemical 
investigations of the organisms. Such classification schemes were more data 
retrieval systems, conveying information such as structure, physiology and 
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Figure 1.1: Pathways of glucose catabolism in halophilic and 
thermoacidophilic Archaea. The modified Entner-Doudoroff pathways of 
halophiles ( — ►) and the non-phosphorylated Entner-Doudoroff pathway 
of Sulfolobus soifataricus and Thermoplasma acldophilum 
[ - - -►) are shown alongside the classical Entner-Doudoroff pathway of 
eubacteria ( — ►). Conversion of glyceraldehyde into pyruvate via 
glycerate has been demonstrated only in T. acidophilum (Danson, 1993).
The use of non-comparable properties to create phylogenetic relationships is 
fraught with difficulties. Comparison of genetic sequences has, for this reason, 
been found to be a more reliable and useful method for such analyses. 
Ribosomal RNA (rRNA) sequences have proved to be a suitable subject for such
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studies. They are found in all living organisms, are readily isolated and evolve 
only slowly with time, enabling the relatedness of distant species to be 
determined. The first rigorous analysis of the 16S and 18S rRNA of a wide range 
of organisms (Woese & Fox, 1977; Woese et al., 1978) clustered the organisms 
into three primary kingdoms or “urkingdoms” with the proposed names; the 
eubacteria, the eukaryotes and the archaebacteria. This replaced the dichotomy 
between prokaryotes and eukaryotes that was previously accepted. It appeared 
that the archaebacteria were no more related to typical bacteria than the bacteria 
were related to the eukaryotes. It was later proposed that a new taxon be 
introduced above the level of kingdom called a “domain”, with all life comprising 
three domains: the Bacteria, the Archaea and the Eucarya, each containing at 
least two kingdoms (Woese et al., 1990). The term “archaebacteria” was 
abandoned due to its suggestion of a specific relationship between the Archaea 
and the Bacteria.
The archaeal domain comprises two kingdoms. The first of these, the 
Euryarchaeota, is a phenotypically-diverse group containing the methanogens, 
the extreme halophiles, sulphate-reducers and some thermophiles. The other 
archaeal kingdom, the Crenarchaeota, is a more homogenous grouping of 
thermophilic phenotypes, comprising acidophilic and sulphur-dependent 
thermophiles.
1.2.1 Creation of phylogenetic trees from molecular data
Phylogenetic trees can be produced from sequence data of molecular species, 
such as rRNA, by a number of methods (for a review see Beanland and Howe,
1992). Any of these procedures can produce incorrect trees because they all 
involve assumptions and approximations. The general procedure of all the 
methods involves creating a sequence alignment to generate data for
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phylogenetic inference. Following the phylogenetic inference steps, such as 
parsimony, maximum likelihood or evolutionary parsimony (method of invariants) 
the tree is tested to see how strongly it is favoured over others.
During the sequence alignment step it must be confirmed that the 
sequences are homologous, that is whether they have a degree of similarity 
greater than would be expected by chance or convergence. Many alignments 
are not suitable for direct use by inference programs as gaps can lead to 
grouping artefacts.
Parsimony is one of the most popular inference methods due to its 
relative simplicity and ease of interpretation. The theory is that simple 
explanations should be favoured over complex ones. In other words, a 
parsimonious tree is the tree that requires the least evolutionary changes to 
explain the data.
Maximum likelihood methods use sophisticated statistical models, taking 
into account factors such as unequal rates of nucleotide substitution in different 
lineages, site-specific rate variability and the distribution of variable sites. These 
methods are gaining favour due to their overtly statistical nature and the fact that 
many of them are less restrictive in the assumptions they follow than other 
techniques.
1.2.2 Rooting the universal phylogenetic tree
A phylogenetic tree derived from a comparison of a single molecular species 
from a range of organisms is generally unrooted, because the universal ancestor 
cannot be determined. A sequence-based tree relating a restricted group of 
organisms can be rooted by establishing at which point it is closer to an outgroup, 
but for a tree relating all organisms there can be no such outgroup (Doolittle & 
Brown, 1994). In order to root the phylogenetic tree derived from 16S rRNA
(Woese et al., 1990; Wheelis et al., 1992) the Dayhoff strategy was used - a 
comparison of the amino acid sequences of pairs of paralogous proteins, 
assumed to have arisen by duplication events, whose common ancestor 
predates the most recent universal ancestor. The proteins used were the a and 
p subunits of ATPases and the translation elongation factors EF-1a (Tu) and EF- 
2 (G), each of which shows extensive sequence homology across members of 
the three domains (Gogarten et al., 1989, Iwabe et al., 1989). By inferring a 
composite phylogenetic tree from such comparisons the root can be positioned 
where the two genes are thought to have diverged. The root on the rRNA tree 
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Figure 1.2: Rooted universal phylogenetic tree derived from 16S and 18S 
rRNA sequence comparisons using distance matrix and maximum 
parsimony algorithms (reproduced from Wheelis etal., 1992). Rooting of 
the tree was achieved by using data from duplicated genes encoding the a 
and (3 subunits of ATPases and elongation factors EF-1a and EF-2 (Iwabe 
etal., 1989)
The validity of rooting the tree in such a manner is not universally acclaimed, 
however. Using a similar procedure with glutamate dehydrogenase genes as
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was used by Iwabe et al. (1989), it was found to be impossible to root the tree 
conclusively (Benachenhou-Lahfa, Forterre & Labedan, 1993; Forterre et a/.,
1993). With this discrepancy in mind, and the fact that the currently-accepted 
position of the root is based on just two pairs of sequences, doubts must remain 
as to the accuracy of the placing.
The major conclusions from Woese’s tree are that the Archaea are a 
monophyletic evolutionary group that lie on the Eukaryl lineage. The shortest 
branches of the tree are to the hyperthermophilic Archaea, suggesting that they 
are the most primitive.
1.2.3 Opposition to the universai tree
Not every member of the evolutionary community was prepared to embrace 
Woese’s universal phylogenetic tree. Objections ranged from both philosophical 
debate about the purpose of phylogenetic categorisation to questioning the 
statistical validity of the methods employed.
Mayr (1990) argues that basing a classification solely on differences in 
rRNA sequences ignores the apparently enormous evolutionary step from the 
prokaryotes to the eukaryotes. The general organisation of Archaea and 
Bacteria, with regard to lack of a nucleus, chromosomes and organelles, is far 
removed from that of the Eucarya. Mayr would prefer a system based on two 
domains: the eukaryotes and the prokaryotes.
Margulis and Guerrero question the assumption that molecules of a single 
member of a species yield information typical of that species (Margulis & 
Guerrero, 1991; Margulis, 1996). Greater concern is shown when the chosen 
sequence varies between different tissues of an organism, or at different stages 
in its life cycle. Their modification of Whittaker’s original “five kingdoms” scheme 
is based on molecular biological results as well as more traditional taxonomic
methods. In their scheme, they have two superkingdoms - the Procaryotae and 
the Eucaryotae. The prokaryotic domain contains just one kingdom, the Monera, 
which includes all the eubacteria and Archaea. The eukaryotes are divided into 
three higher kingdoms; Animalia, Fungi and Plantae. The last kingdom is the 
Protoctista, containing all living things with a nucleus that do not display animal, 
plant or fungal qualities.
Lake (1988, 1989) has argued that the methods employed in the 
construction of Woese’s phylogenetic tree are prone to errors when rates of 
nucleotide substitution are greatly unequal in juxtaposed branches, and when 
mutations are frequent. He suggested use of the evolutionary parsimony 
algorithm as being the least sensitive to unequal rate effects. Using this 
algorithm he obtained a tree with a different branching pattern (Figure 1.3), 
suggesting two superkingdoms, with the methanogens and halophiles grouping 
with the eubacteria and the sulphur-dependent thermoacidophiles grouping with 
the eukaryotes. In this proposal, therefore, Archaea are polyphyletic.
This view has been rejected by Olsen and Woese (1993) on the grounds 
of the alignment used and the fact that methods other than evolutionary 
parsimony give different results. In addition, the same method using 23S rRNA 
also gives a different grouping to Lake (Gouy & Li, 1989).
1.2.4 The consensus view
It is now commonly accepted that life on Earth can be divided into three domains, 
although the position of the root of the tree is not without controversy. Since the 
original suggestion of the archaeal tree, more supporting evidence has become 
available. The resolution of the tree has been enhanced by the complete 
sequencing of many 16S rRNAs and trees created using other molecular 
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Figure 1.3: Lake’s rooted tree, constructed using the evolutionary 
parsimony algorithm (reproduced from Lake, 1989)
1.3 The halophilic Archaea
1.3.1 Ecology, taxonomy and phenotypes
The Halobacteriaciae comprise six genera: Haloarcula, Halobacterium,
Halococcus, Haloferax, Natronobacterium and Natronococcus (for a review see 
Rodriguez-Valera, 1988). They are found in hypersaline environments such as 
salt lakes and salterns (where sea water is evaporated to produce salt) and even 
in highly-alkaline soda lakes (natronobacteria). In such habitats they are easily 
identifiable by their red colour, mainly caused by their carotenoid pigments. The 
halobacteria can only grow in salt solutions above 15% (w/v) and most require 20
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- 25% (w/v) for good growth (sea water is ~3.5% salt). Such hypersaline 
environments are inhibitory to growth and survival of most other forms of life.
The halobacteria are all either strict aerobes or facultative anaerobes. 
They are chemoorganotrophic and grow on complex media, while some species 
of Halobacteria can utilise solar energy through their production of 
bacteriorhodopsin. Generation times are considerably longer than most bacteria, 
with cells dividing every 3-4 hours in the case of Haloferax volcanii to 8-12 hours 
for species of Halobacterium. The osmotic pressure of the external environment 
is balanced by isotonic accumulation of K+ ions (Kushner, 1988). This is 
maintained against a large concentration gradient.
In general, the halophilic Archaea do not have a rigid cell wall (with the 
exception of the halococci). The cell boundary consists of a single layer of 
glycoprotein, called the S-layer. This S-layer is held together by divalent cations 
and can be completely stripped from the cells by treatment with EDTA. This 
property is utilised in the preparation of competent cells for transformation. Many 
of the halobacteria have a rod-shaped morphology, although some take on 
square or triangular forms. Haloferax species commonly have thin cup-shaped 
cells. Due to the lack of a cell wall most halobacteria are Gram-negative, while 
the halococci are Gram-positive.
Halobacteria are insensitive to antibiotics usually used in bacterial 
selection procedures. They are, however, sensitive to mevinolin, an inhibitor of 
3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase - a key enzyme in the 
biosynthesis of isoprenoids and cholesterol. They also have sensitivity to 
novobiocin, which inhibits DNA gyrase by blocking binding of ATP. Plasmids 
containing resistant genes to each of these antibiotics are available and their 
development has enabled transformant selection.
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1.3.2 Haloferax volcanii
Haloferax volcanii was first isolated from the Dead Sea in 1975 (Mullakhanbhai & 
Larsen, 1975). It requires at least 1 M NaCI for growth, with cells lysing upon 
dilution of the culture medium with water. Optimum growth conditions are NaCI 
concentrations between 1.7 and 2.5 M at 30 to 40°C. These salt conditions 
categorise H. volcanii as a moderately-extreme halophile. The organism has a 
high requirement for Mg2+, with an optimum concentration of 0.2 M, higher than 
many other halophiles.
The use of H. volcanii for molecular biological studies has the advantage 
over that of many halophiles in that its genome is relatively stable. Many 
halophiles have a large number of mobile insertion sequences that lead to 
genetic instability, making it necessary to avoid repetitive sub-culturing.
Transformation techniques have been developed for H. volcanii 
(Charlebois et al., 1987) and a number of shuttle vectors are now available that 
will replicate in both E. coli and H. volcanii (Lam & Doolittle, 1989; Holmes et al., 
1991; Holmes etal., 1994). These developments have established the organism 
as perhaps the species of choice for genetic-level studies of halophilic Archaea.
1.4 Enzymes in high salt environments
The effects of high concentrations of certain salts on protein stability are related 
to modifications of the solvent properties of the aqueous solution by the salt (Von 
Hippel & Schleich, 1969). The internal environment of the extremely halophilic 
Archaea is close to a saturating concentration of KCI, requiring the proteins of 
these organisms to be themselves halophilic. They are usually only stable in 
solvents of very high salt concentration (Eisenberg & Wachtel, 1987). Under
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these conditions, most proteins from non-halophilic organisms are likely to 
precipitate or unfold, depending on the salt.
The folding of a protein is determined by the interaction of the amino acid 
side-chains with water (Dill, 1990; Zaks, 1992). In order to minimise the 
entropically unfavourable solvation of hydrophobic residues, these are forced into 
the hydrophobic interior of the molecule. In contrast, charged and polar amino 
acids occupy the surface area, resulting in a tightly-bound hydration layer. The 
surface-energy of the protein-water interface, caused by the hydrogen-bonding 
nature of the solvent, results in the molecule folding to minimise its surface area. 
Addition of solutes, such as salts, to the bulk solvent disturb the hydrogen- 
bonding nature of the water and hence the surface energy, resulting in a change 
of conformation of the protein.
Increases in surface tension resulting from increasing salt concentration 
induce proteins to further minimise their surface area and they may aggregate, 
resulting in salt-precipitation. Since the surfaces of proteins are charged, 
however, they are able to attract hydrated salt ions, counter-balancing the 
exclusion of the salt. Effect of salt on protein conformation, therefore, is a 
balance of these two effects (Timasheff, 1992).
1.4.1 Structural features important for halotolerance
Halophilic proteins generally have a high proportion of acidic amino acids, with an 
excess of acidic over basic residues of about 17%. In addition, they also have a 
lower hydrophobic amino acid content (Reistad, 1970; Lanyi, 1974).
A large proportion of the work investigating stability of halophilic proteins 
has been conducted on malate dehydrogenase from Halobacterium marismortui 
(Mevarech, Eisenberg & Neumann, 1977; Mevarech & Neumann, 1977; Pundak 
& Eisenberg, 1981; Pundak et a/., 1981; Reich et al., 1982; Zaccai, Wachtel &
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Eisenberg, 1986; Zaccai, Bunick & Eisenberg, 1986; Zaccai et a/., 1989; Hecht et 
al., 1989; Bonnets et a/., 1993) but other work suggests that the main findings 
are relevant to other halophilic proteins (Guinet et al., 1988). The X-ray 
crystallographic structure of H. marismortui malate dehydrogenase has been 
resolved to 3.2A (Dym et al., 1995). The structure is seen to be stabilised by 
arginine, glutamate and aspartate salt bridges, both interior and exterior to the 
monomer subunits and there are increased negative charges over the surface 
when compared to non-halophilic homologues.
Proteins are not able to compete with a highly concentrated salt solution 
for water molecules through normal hydration interactions of their amino acid 
residues. Halophilic proteins, however, seem to have evolved a folded structure 
that can coordinate hydrated salt ions on the surface, at a higher local 
concentration than in the bulk solvent. Generally, they are rich in the acidic 
residues glutamate and aspartate. A recent model of H. volcanii dihydrofolate 
reductase (Bohm & Jaenicke, 1994) has an asymmetrical charge distribution 
over the surface of the protein, with positive charges around the active site and 
negative charges on the opposite side of the molecule. The negative charges 
form clusters that are shielded at high salt concentrations but are repulsed at 
lower concentrations. This repulsion leads to the destabilisation of the protein in 
the absence of salt.
1.4.2 Alternative mechanisms for existence in high salt
In contrast to the halophilic Archaea, halotolerant Bacteria and methanogenic 
Archaea accumulate high concentrations of organic osmolytes to balance the 
osmotic pressure of the external environment (Severin et al., 1992; Lai et al., 
1991). These compounds, now commonly known as “compatible solutes” 
(Brown, 1976) must fulfil their function while remaining physiologically inert.
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A wide range of compatible solutes are involved in osmotic adaptation 
and include sugars, polyols, amino acids and derivatives of them, 
tetrahydropyrimidines, betaines and ectoines (a class of cyclic amino acids). In 
times of need, some compatible solutes can be synthesised de novo, but in 
preference, they are generally accumulated from the culture medium.
Some bacteria that are not usually halotolerant can be induced to limited 
tolerance by osmotic stress conditioning (Ishida et al., 1994). Some strains of E. 
coli, when exposed to a moderate osmotic stress (~0.5 M NaCI for instance) for a 
short time, in the order of 30 minutes, are subsequently able to grow in a medium 
containing up to 1.2 M NaCI. Inhibition of this acquired osmotolerance can be 
achieved by treatment of the cells with chloramphenicol or rifampicin, suggesting 
that synthesis of new protein or RNA may be important.
1.5 Dihydrolipoamide dehydrogenase (DHLipDH)
Dihydrolipoamide dehydrogenase (EC 1.8.1.4) catalyses the NAD+-dependent 
oxidation of dihydrolipoamide (Williams, 1976) through a catalytic mechanism 
involving the alternate oxidation and reduction of an intrachain disulphide bond 
and a base on the enzyme (Figure 1.4). It has a tightly, but non-covalently, 
bound FAD cofactor that participates in the transfer of electrons from 
dihydrolipoamide to NAD+.
The enzyme exists as a dimer, with the active site comprising residues 
from both subunits. Stopped-flow spectroscopy has revealed that the enzyme 
follows a ping-pong mechanism, which can be divided into two half-reactions, i) 
reduction of the oxidised enzyme to the reduced form, and ii) the transfer of 
electrons from the reduced form to the nicotinamide cofactor (Figure 1.5) 
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Figure 1.4: NAD+-dependent oxidation of dihydrolipoamide catalysed by 
dihydrolipoamide dehydrogenase (Danson, 1988).
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Figure 1.5: Mechanism of DHLipDH. Key: E = oxidised enzyme, EH2 = 2- 
electron-reduced enzyme, lip(SH)2NH2 = dihydrolipoamide, lipS2NH2 = 
lipoamide.
1.5.1 2-Oxo acid dehydrogenase multienzyme complexes
In all eukaryotes and most eubacteria DHLipDH is an integral component of the 
pyruvate, 2-oxoglutarate, and branched-chain 2-oxoacid dehydrogenase 
multienzyme complexes (Perham, 1991; Mattevi, de Kok & Perham, 1992) 
(Figure 1.6), as well as the glycine cleavage system (Kikuchi & Hiraga, 1982).
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These multienzyme complexes consist of three components, a 2-oxoacid 
dehydrogenase (E1), a dihydrolipoamide transacylase (E2) and a 
dihydrolipoamide dehydrogenase (E3). The E2 components form a structural 
core to which the E1 and E3 components are bound non-covalently. The 
pyruvate dehydrogenase (PDHC) and 2-oxoglutarate dehydrogenase (OGDHC) 
multienzyme complexes of Gram-negative bacteria and the OGDHC and 
branched-chain 2-oxo acid dehydrogenase (BCDHC) complexes of mammals 
contain 24 copies of the E2 component arranged with octahedral symmetry. In 
the PDHC of eukaryotes and Gram-positive bacteria, however, the core 
comprises 60 E2 chains arranged with icosahedral symmetry. These complexes 
have a high relative molecular mass of (5-10) x 106. The number of E1 and E3 
chains in each complex varies dependent on the symmetry and source, with for 
example, an E1 :E2:E3 ratio of 1:1:0.5 in the PDHC of E. coli.
CoASH
R-C-COOH R -C -S -L ip -S H













R-C-COOH + CoASH + NAD+ R—C—SCoA+ C02+ NADH + H+
Figure 1.6: The reaction mechanism of the 2-oxo acid dehydrogenase multi­
enzyme complexes (modified from Perham, 1991). ThDP, thiamin 
diphosphate; Lip, lipoic acid.
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The substrate is effectively channelled through the reactions by attachment to a 
lipoyl group, which is in turn attached to the E2 component. The lipoyl group is 
able to rotate freely within the complex, carrying the substrate in turn to each of 
the three separate reaction sites.
The E1 and E2 components of the complexes display specificity for the 
substrate of the overall reaction, whereas the E3 component is normally identical 
in the PDHC and 2-oxoglutarate dehydrogenase complexes, and is 
interchangeable between the two.
1.5.2 The ArchaeaI alternative
The Archaea, however, convert pyruvate and 2-oxoglutarate to acyl-CoA thio- 
esters via less complex oxidoreductases (Kerscher & Oesterhelt, 1982) that 
involve ferredoxin as the electron acceptor, rather than NAD+, and contain no 
lipoic acid (Kerscher & Oesterhelt, 1981a,b) (Figure 1.7).
Fd ox Fd red
FeS red FeS ox
R -C -C O O H
R -C -S C oA  CoASH
FeS ox FeS red
Fd oxFd red
Figure 1.7: The catalytic cycle of a 2-oxoacid : ferredoxin oxidoreductase, 
found in Archaea and anaerobic Bacteria (modified from Kerscher & 
Oesterhelt, 1982). ThDP, thiamin diphosphate, Fd, ferredoxin.
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It was, therefore, unexpected to find that halophilic, and methanogenic Archaea, 
as well as Thermoplasma sp., i.e. the Euryarchaeota, possess both a DHLipDH 
and lipoic acid (reviewed in Danson, 1993). As with the eukaryotic and 
eubacterial enzyme, DHLipDH from halophiles is specific for both NAD+ and 
dihydrolipoamide (Danson et al., 1984), but the lack of 2-oxoacid dehydrogenase 
complexes in the Archaea suggests that the enzyme may fulfil an additional role 
not previously elucidated.
1.5.3 Other possible roles of DHLipDH
There are a number of cases where DHLipDH apparently exists as an 
uncomplexed enzyme rather than as a component of a multienzyme complex.
A second DHLipDH from E. coli has been implicated in galactose and 
maltose transport (Richarme, 1985; Richarme & Heine, 1986). The enzyme is 
located at the plasma membrane where the oxidoreduction of dihydrolipoic acid 
and NAD+ stimulates the transport. This DHLipDH was shown to be distinct from 
the normal gene product involved in the multienzyme complexes, and failed to 
restore PDHC and OGDHC activities in a mutant strain lacking the DHLipDH 
from these complexes.
A DHLipDH from the trypanosomatidae, the causative agents of African 
sleeping sickness in humans and nagana in cattle, is also associated with the 
plasma membrane (Danson et al., 1987; Jackman et al., 1990; Else etal., 1993). 
The enzyme is present throughout the life-cycle of Trypanasoma brucei, including 
the bloodstream form where there is no functional citric acid cycle. In contrast to 
the case in E. coli, there is only one DHLipDH gene and no differences have 




A large number of primary sequences of DHLipDH from a wide range of
organisms has been determined (Table 1-1).
Organism Reference
Acholeplasma laidlawii Wallbrandt etal., 1992
Azotobacter vinelandii Westphal & De Kok, 1988
Bacillus stearothermophilus Hawkins et al., 1990 
Borges etal., 1990
Bacillus subtilis Hemila etal., 1990
Escherichia coli Stephens etal., 1983
Garden pea Bourguignon etal., 1992 
Turner etal., 1992
Haloferax volcanii Vettakkorumakankav & Stevenson, 1992
Human Otulakowski & Robinson, 1987 
Pons etal., 1988
Pig Otulakowski & Robinson, 1987
Pseudomonas fluorescens Benen etal., 1989
Pseudomonas putida 1 Burns etal., 1988 
Burns etal., 1989
Pseudomonas putida 2 Palmer, Hatter & Sokatch, 1991
Pseudomonas putida 3 Palmer, Madhusudhan, Hatter & Sokatch, 
1991
Saccharomyces cerevisiae Browning et al., 1988 
Ross et al., 1988
Trypanosoma brucei brucei Else etal., 1993
Table 1-1: Available DHLipDH gene sequences
In addition, the 3D crystal structures of the enzyme from Pseudomonas putida 
(Mattevi, Obmolova, Sokatch, Betzel & Hoi, 1992), Pseudomonas fluorescens 
(Mattevi et al., 1993) and Azotobacter vinelandii (Schierbeek et al., 1989; Mattevi 
etal., 1991) have been resolved.
1.5.5 DHLipDH from H. volcanii
The gene encoding DHLipDH from Haloferax volcanii has been cloned and 
sequenced (Vettakkorumakankav & Stevenson, 1992). The open reading frame 
codes for 475 residues and the sequence shows a high degree of homology with 
DHLipDH from a number of non-halophilic sources, especially around the active-
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site thiols. The gene has a high percentage of G and C nucleotides (69%) 
although such a G+C content is not uncommon in halophilic genes.
The pH profile of the enzyme shows activity over a pH range of 6-10.5. It 
has an optimum pH of 9, significantly above the optimal growth pH of 7 for the 
organism (Vettakkorumakankav et al., 1992). It has been shown by NMR 
spectroscopy that the internal pH of the halophiles Halobacterium halobium and
H. marismortui closely matches that of the external environment (Quirk & 
Campbell, 1990), which would suggest that the enzyme exists natively at a pH of 
about 7. At this pH the enzyme is approximately 50% active, based on the 
activity profile.
The participation of a redox disulphide bond in the active site of the 
enzyme was evidenced by studies using p-amino-phenyl arsenoxide, a trivalent 
organoarsenical that selectively forms covalent bonds with two spatially close 
thiols (Vettakkorumakankav et al., 1992). Rapid inactivation of the enzyme was 
observed upon exposure to the arsenical, indicating the presence of the redox 
disulphide in a position accessible to the substrate.
I.5.6 Molecular model of halophilic DHLipDH
The three-dimensional structure of DHLipDH from H. volcanii has been modelled 
on the homologous structure from Pseudomonas fluorescens, a psychrotrophic 
bacterium (Dr. R.J.M. Russell, University of Bath, unpublished) (Figure 1.8). The 
two molecules share a high degree of homology (43% identity, 65% similarity of 
residues).
Characteristic of other halophilic proteins, the surface of halophilic 
DHLipDH has a high degree of negative charge relative to non-halophilic 
homologues. Each monomer has 31 basic and 86 acidic residues, resulting in a 
net charge of -55 if all side chains were present in their conjugate forms. In
20
contrast, the P. fluorescens structure has a charge of -7 per monomer. In the 
absence of salt it is predicted that the molecular surface of the protein is 
predominantly negatively-charged, whereas at a salt concentration of 1 M NaCI 
the charge profile is comparable to non-halophilic proteins in their native 
environment. This is due to a screening of charges rather than to a change of 
conformation.
The molecular model of dihydrofolate reductase from H. volcanii (Bohm & 
Jaenicke, 1994) has a number of negatively-charged clusters on the surface, and 
a positively-charged area near the active site that is thought to facilitate 
orientation of the substrate. The model of DHLipDH, however, suggests that the 
entire surface of the protein forms a macrocluster. Around the active site the 
prevalence of acidic residues is approximately half, and that of basic residues 
approximately double, that over the surface taken as a whole. Again, this is 
probably due to the need for orientating the substrates.
Protein stability can be increased by the presence of disulphide bonds. 
Although the structure of DHLipDH from H. volcanii has an extra two cysteine 
residues compared to P. fluorescens, they do not appear to be involved in 
disulphide bond formation.
The enzyme’s active site appears to be structurally identical to that of P. 
fluorescens, and is conserved throughout the available structures. The 
sequence between the cysteines of the redox disulphide bridge (CLNYGC) is 
changed by one residue from that conserved between other organisms 
(CLNVGC). The overall shape of the molecule bears close resemblance, with 
the main significant differences being in the loop regions. The positions of the a- 
helices and p-sheets are relatively conserved.
21
Figure 1.8: Molecular model of H. volcanii DHLipDH, homology-modelled on 
the P. fluorescens DHLipDH structure.
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1.5.7 Use of halophilic DHLipDH as a model enzyme
The halophilic DHLipDH exists as a homodimer with a total relative molecular 
mass (Mr) of 119,000, determined by gel filtration (Danson et al., 1984). It 
displays considerable thermal stability, showing no detectable loss of activity after 
a 15 min incubation at 95°C, whereas other halophilic enzymes are inactivated at 
much lower temperatures (Danson et al., 1984). As with many other halophilic 
enzymes, DHLipDH is shown to be inactive when assayed in the absence of salt. 
Re-addition of 2 M NaCI to the inactive protein, however, results in complete 
restoration of activity almost immediately, even after storage for 24 h at 4°C in 
the absence of salt (Danson et al., 1986). This stability makes the enzyme a 
good candidate for studies into the structural properties of halophilic enzymes.
The discovery of DHLipDH in the Archaea means that it is present in all 
three evolutionary domains, suggesting that it may be an “ancient” enzyme that 
evolved before the divergence from the common progenote. This provides the 
opportunity to conduct phylogenetic analysis, as well as comparative 
enzymology.
1.6 The biotechnological potential of halophiles and their proteins
The Archaea are a diverse group of organisms with certain physical 
characteristics very different from most eubacterial cells. It is this sheer diversity 
that provides the huge potential of archaeal systems to biotechnological 
applications.
The proton-pumping, photosensitive membranes of certain halobacteria 
have enormous potential for use as optical switching elements in bio-electronics 
(Hong, 1986), from uses such as optical recording materials to components of 
opto-molecular computers (Moses, 1991). Bacteriorhodopsin has been isolated
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in a stable and active form, that is readily immobilised on solid substrates, or 
embedded in polymers. The photoreceptor has been extensively studied in 
molecular detail and its responses found to be extremely reproducible (Hong, 
1986).
The considerable halophilicity, and in many cases thermostability, of 
enzymes from halobacteria has great potential for industrial applications. 
Reactions in organic solvents can be favoured by the use of halophilic enzymes 
(Klibanov, 1989) and such conditions may have the advantage of altered 
substrate and enantiomeric specificities, due to their increased rigidity, as well as 
improved yields. Halobacterial enzymes are much more efficient at maintaining 
their hydration layer in low-water conditions than non-halophilic proteins. Such 
enzymes would be expected to be suitable for use in processes that require the 
presence of organic solvents and where water activity is low, such as where high 
substrate or product concentrations are employed (Hough & Danson, 1989).
Some halobacteria, such as Haloferax (Anton et al., 1988) and 
Haloarcula, produce extracellular polysaccharides. These compounds have 
been shown to have good Theological properties (high viscosity at low 
concentration), and are resistant to salt, temperature and pH extremes. 
Applications exist for such compounds, especially in the field of oil recovery.
The high molecular weight polymer, poly-p-hydroxybutyrate (PHB) can be 
used for the production of commodity plastics that are both biodegradable and 
biocompatible. At present, this polymer is harvested from Alcaligenes eutrophus 
by ICI to produce the plastic Biopol™. Haloferax mediterranei has been shown to 
accumulate high levels of PHB (Lillo & Rodriguez-Valera, 1990), with the 
advantage that starch can be used as a carbon source rather than glucose, 
which is required for A. eutrophus. Since starch is considerably cheaper than
24
glucose the cost of the process could be reduced. The fragility of halobacteria 
when exposed to low salt concentrations may also enable a simplified recovery 
process.
Fundamental research into the structural properties of halophilic enzymes 
is important for the long-term goal of engineering halophilicity into existing 
enzymes with useful catalytic properties. Although the favoured method of 
commercial enterprises for discovering new activities is to screen new 
microorganisms, there may be instances where rational engineering of existing 
non-halophilic enzymes is more appropriate. Even if this is not shown to be the 
case, one could argue that the fundamental understanding that such research 
endows is invaluable.
1.7 Project aims
Our research group at Bath has the aim of investigating the structural features 
that enable archaeal enzymes to be functionally active in extremes of 
temperature and salinity. To achieve this goal, the three-dimensional structures 
of equivalent enzymes from organisms living across the range of conditions, from 
mesophilic to the most extreme, are compared. Coupled with this is the testing of 
hypotheses and deductions with mutational studies.
The aim of this project has been to express dihydrolipoamide 
dehydrogenase from the halophilic archaeon H. volcanii at high levels, either in a 
non-halophilic host such as E. coli or in a mutant strain of H. volcanii that lacks a 
functional DHLipDH. Using the developed expression system, sufficient protein 
was to be purified to enable crystallisation trials to be undertaken, with the long­
term aim of resolving a three-dimensional crystal structure for the enzyme. Prior 
to this development, a molecular model of the structure would be used to analyse 
and design site-directed mutants, which could be then expressed in the system
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developed, to test particular features that may play a role in conferring 
halophilicity.
In addition to this, investigations were to be undertaken to probe the 
function of the enzyme in the Archaea. Comparisons of the growth 
characteristics of wild-type H. volcanii and a strain with the gene inactivated were 
to be made to try and assess the effect of the deficiency. To complement this, 
the region upstream of the DHLipDH gene was to be sequenced to enable 
database searching for homologous sequences that may provide further clues as 
to function.
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2. Materials and Methods
2.1 Materials
2
Cell culture: Yeast extract, tryptone and bacto-agar were supplied by Difco
Laboratories, Ml, USA. Bacteriological peptone was from Oxoid, UK. Ampicillin 
(sodium salt), tetracycline and novobiocin were obtained from Sigma, UK. 
Mevinolin was a gift of Merck Research Laboratories (USA).
Molecular biology: Restriction enzymes were supplied by Pharmacia,
Sweden; New England Biolabs, MA, USA or Gibco BRL Life Technologies Ltd., 
UK. Taq DNA polymerase, T4 polynucleotide kinase and T4 DNA ligase were 
from Boehringer Mannheim (Germany). Vent® DNA polymerase and mung bean 
nuclease were purchased from New England Biolabs. 1 kb ladder DNA markers 
were obtained from Gibco. Phenol : chloroform : isoamyl alcohol (25:24:1) and 
RNAse A were supplied by Sigma. Magic™ Miniprep and Altered Sites® II 
mutagenesis kits were obtained from Promega Corporation, Wl, USA. QIAprep™ 
spin columns were supplied by Qiagen, UK. Sequenase™ version 2.0 kits were 
supplied by United States Biochemical Corp., OH, USA. Geneclean® II kits were 
from Bio 101, CA, USA. IPTG and X-Gal were purchased from Calbiochem, UK. 
[a-^S] dATP Redivue was from Amersham International, UK. X-Ray film was 
purchased from Fuji Photo Film Co., Japan.
Plasmids: pKK223-3 and pGEX-KG were obtained from Pharmacia and 
pMEX8 was from Medac (Germany).
Chromatography: Hydroxylapatite Bio Gel HT was supplied by Bio-Rad 
Laboratories Ltd., UK. Glutathione agarose was from Sigma.
Enzyme assays: DL-lipoamide and oxaloacetate were from Sigma and 
coenzyme A was from Calbiochem, UK. NAD+ was from Boehringer Mannheim.
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Electrophoresis: Acrylamide Sequagel™ and Protogel™ were purchased 
from National Diagnostics (USA). TEMED, agarose (standard and low melting 
point) and ethidium bromide solution came from Sigma. Protein low molecular 
weight standards were obtained from Bio-Rad Laboratories Ltd.
Crystallisation: Crystal Screen™ reagents were supplied by Hampton 
Research, CA, USA.
Oligonucleotides were ordered from Pharmacia, Perkin Elmer or Severn 
Biotech, UK. BCA reagent A was from Pierce, IL, USA. All other reagents (SLR, 
AnalaR and Aristar grades) were purchased from BDH Ltd., UK, Sigma, UK and 
Fisons, UK.
DNA and amino acid sequence analysis were carried out using the GCG 
Sequence Analysis Software Package Version 7.0. Molecular visualisation was 
predominantly conducted using Rasmol Version 2.5 (PC) written by R. Sayle 
(Glaxo Group Research).
2.2 Strains and culture conditions
H. volcanii WFD11, a derivative of H. volcanii DS2 cured of the endogenous 
plasmid pHV2 (Charlebois et al., 1987) (obtained from Dr. M. Dyall-Smith, 
University of Melbourne, Australia) and strains derived from it were grown in 18% 
(w/v) salt water modified growth medium (MGM), consisting of 14.4% (w/v) NaCI,
I .8% (w/v) MgCI2.6H20, 2 .1% (w/v) MgS04.7H20, 0.42% (w/v) KCI, 0.5% (w/v) 
peptone, 0.1% (w/v) yeast extract, pH 7.2, at 37°C with shaking at 200 rpm. 
Minimal medium was used for growth experiments and consisted of the same 
salts as modified growth medium with 0.5% (v/v) glycerol, 0.05% (w/v) succinate, 
10 mM NH4CI,1 mM K2HP04 buffer, 20 mM Tris-HCI (pH 7.5), and 0.1% (v/v) 
trace elements solution. Trace elements solution consisted of 0.36 mg/ml 
MnCI2.4H20, 0.44 mg/ml ZnS04.7H20, 3.3 mg/ml FeS04.7H20 and 0.05% (w/v)
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CuS04.5H20. Where required the medium was solidified by addition of 1.5% 
(w/v) agar. Frozen stocks were maintained at -20°C and -70°C in the same 
medium containing 30% (v/v) glycerol.
Antibiotic resistance plasmids were maintained or selected for in solid and 
liquid media by addition of 0.3 pg novobiocin/ml or 4 pg mevinolin/ml.
E. coli strains TG1 (supE, hsdAS, thi, A(!ac-proAB) F’[traD36 proAB lacF 
lacZAM15], DH5a (supE44, AlacU169, (080 lacZAM15), hsdR17, recA1, endA1, 
gyrA96, thi-1, relA1)\ JM105 (thi', rpsL, endA, sbcB15, hspR4, A(lac-proAB), [F  
traD36 proAB lacFZAMIS])’, JM109 (endA1, recA1, gyrA96, thi, hsdR17 (rk~, 
mk+), relA1, supE44, X-, A(lac-proAB), [F\ traD36, proAB, lacfZAMI5]); BMH 71- 
18 mutS (thi, supE, A(lac-proAB) [mutS::Tn10][F’, proAB, lacPZAMIS]) and 
ES1301 mutS (lacZ53, mvtS201::Tn5, thyA36, rha-5, metB1, deoC, IN(rmD- 
rmE)) and strains derived from them, were grown in LB broth (1% (w/v) tryptone, 
0.5% (w/v) yeast extract and 1% (w/v) NaCI) at 37°C with shaking at 200 rpm. F  
strains were maintained on minimal M-9 plates (0.6% (w/v) Na2HP04> 0.3% (w/v) 
KH2P04, 0.05% (w/v) NaCI, 0.1% (w/v) NH4CI, 0.2% (w/v) glucose, 2 mM MgS04, 
100 pM CaCI2, pH 7.4) supplemented with 1 mM thiamine-HCI. JRG1342 
(A(aroP-lpd), DE74, metB1, met-105, azi, pox, pps-1, tsx-87?, ton?, relA1, rpsL, 
recA1) (Guest et al.t 1985) was grown in LB broth supplemented with 1% (w/v) 
glucose. Where required the medium was solidified by addition of 1.5% (w/v) 
agar. Frozen stocks were maintained at -20°C and -70°C in the same medium 
containing 30% (v/v) glycerol.
Antibiotic resistance plasmids were maintained or selected for in solid and 
liquid media by addition of 100 pg ampicillin/ml or 12.5 pg tetracycline/ml (solid 
media) or 10 pg tetracycline/ml (liquid culture).
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2.3 Biochemical Techniques
2.3.1 Preparation of cell extracts
E. coli cells were harvested by centrifugation at 10,800 x g in a Sorvall GSA rotor 
for 25 min at 4°C. The cells were then resuspended in 10 mM Tris-HCI (pH 8.0), 
1 mM EDTA containing 1 mM PMSF at a density of 0.2 g/ml and lysed by 
sonication on ice in an MSE 150 W Ultrasonic Disintegrator Mk2 using a 9.5 mm 
end diameter titanium probe. Three 30 s bursts were used with a 90 s cooling 
time between each. Cell debris was removed by centrifugation at 15,600 x g for 
30 min at 4°C in a Sorvall SS34 rotor.
For small volumes, cells were harvested at full speed in a microcentrifuge 
for 2 min in 1.5 ml Eppendorf tubes, and resuspended in a reduced volume. The 
samples were sonicated using a 3 mm end diameter exponential probe. Three 
10 s blasts were used with approximately 1 min cooling time between each. Cell 
debris was removed by further centrifugation at full speed for 10 min.
H. volcanii extracts were prepared in a similar manner with the exception 
that cells were resuspended in 2 M KCI, 10 mM Tris-HCI (pH 8.0), 1 mM EDTA 
prior to sonication.
2.3.2 DHLipDH enzyme assay
Catalytic activity was assayed spectrophotometrically at 30 or 37°C using a 
Perkin Elmer Lambda Bio or Lambda 11 spectrophotometer. The reaction 
reduces NAD+ to NADH, which has an absorbtion maximum at 340 nm and a 
molar extinction coefficient of 6,200 I mof1 cm'1. Initial rates were calculated 
using the Perkin Elmer Computer Spectroscopy Software (PECSS) version 4.31 
supplied with the instrument.
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Unless otherwise stated, assays were carried out in 2 M KCI, 10 mM Tris- 
HCI (pH 8.0), 1 mM EDTA, 1 mM NAD+ and 0.4 mM dihydrolipoamide, in a final 
volume of 1 ml. 1 unit of enzyme activity is defined as the amount required to 
produce 1 pmol of product per min.
2.3.3 Preparation of dihydrolipoamide
DL-dihydrolipoamide was prepared by the reduction of DL-lipoamide with NaBH4 
(Reed et al., 1958). 800 mg DL-lipoamide was dissolved in 20 ml methanol : 
water (4:1) over ice. 800 mg NaBH4 was added in 4 ml cold distilled water, and 
the mixture stirred over ice for 2 h. The solution was acidified with 1 M HCI until 
effervescence stopped. The product was then extracted three times with 50 ml 
chloroform, transferred to a round-bottomed flask and rotary evaporated to 
dryness. The resulting crystals were dissolved in 40 ml toluene with gentle 
warming. 16 ml hexane was added and the precipitate collected by vacuum 
filtration, followed by drying in a desiccator.
Purity was determined spectrophotometrically by titration with 5,5-dithio 
bis-2-nitrobenzoate (DTNB). 0.2 mM DTNB was reacted with 0.05 mM 
dihydrolipoamide (0.1 mM thiol groups) in a volume of 1 ml TE8 buffer. For 100% 
purity the expected absorbance at 412 nm was 1.36 (Em=13,600 I mot"1 cm"1). 
Preparations were shown to be over 98% pure.
2.3.4 Citrate synthase assay
Activity was assayed spectrophotometrically at 30°C in a Perkin Elmer Lambda 
Bio or Lambda 11 spectrophotometer by the method of Srere et al. (1963). Free 
coenzyme A reacts with DTNB, releasing thionitrobenzoate. This has an 
absorbtion maximum at 412 nm and a molar extinction coefficient of 13,600
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I mol'1 cm'1. Initial rates were calculated using the PECSS software supplied with 
the machine.
Assays were carried out in 2 M KCI, 20 mM Tris-HCI (pH 8.0), 2 mM 
EDTA, 0.2 mM oxaloacetate, 0.4 mM acetyl CoA and 0.1 mM DTNB, in a final 
volume of 1 ml.
2.3.5 Acetylation of coenzyme A
Coenzyme A was acetylated by dissolving 10 mg in 1 ml Milli-Q water, cooling on 
ice and adding 0.2 ml 1 M KHC03, followed by 0.1 ml 1 M acetic anhydride 
freshly-diluted with Milli-Q water. After incubation on ice for 10 min, acetylation 
was checked by addition of 20 pi to 1 ml of assay buffer containing 100 pM 
DTNB. A yellow colour indicated incomplete acetylation and more acetic 
anhydride was added as well as more KHCO3 to maintain the pH. The final 
concentration of acetyl-CoA was ~7.5 mM.
2.3.6 SDS polyacrylamide gel electrophoresis (SDS-PAGE)
Samples were boiled for 5 min in loading buffer (63 mM Tris, pH 6.8, 2% (w/v) 
SDS, 10% (w/v) sucrose, 5% (v/v) p-mercaptoethanol, 0.02% (w/v) bromophenol 
blue). They were then loaded onto a 10% acrylamide gel. The resolving gel 
consisted of 4 ml Protogel™ (30% (w/v) acrylamide, 0.8% (w/v) N N’-methylene 
bisacrylamide stock solution), 3 ml buffer (1.5M Tris-HCI, pH 8.9, 0.4% (w/v) 
SDS), 5 ml dH20, 50 pi 10% (w/v) ammonium persulphate and 12.5pl TEMED. 
The stacking gel consisted of 0.9 ml Protogel™, 2.4 ml buffer (487 mM Tris-HCI, 
pH 6.8, 0.4% (w/v) SDS), 3.6 ml dH20, 50pl 10% (w/v) ammonium persulphate 
and 10pl TEMED.
Gels were run in 52 mM Tris-HCI, 0.1% (w/v) SDS, 0.4% (w/v) glycine on 
an Atto Corp. Mini-Atto system at 10 mA until samples entered the resolving gel
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and then at 20 mA. The samples were stained for 30 min in Coomassie stain 
(0.25% (w/v) Coomassie Blue R, 45.4% (v/v) methanol, 9.2% (v/v) glacial acetic 




A 2.2 cm x 20 cm column of hydroxylapatite Bio-Gel HT was equilibrated with 50 
mM potassium phosphate buffer, pH 7.0, containing 1 M NaCI. The sample was 
applied and the column washed with equilibration buffer until all unbound solutes 
were removed. The product was eluted by the application of a phosphate 
gradient (50 mM to 500 mM, pH 7.0), in the presence of 1 M NaCI, over a volume 
of 400 ml at a flow rate of 30 ml/h.
2.3.7.2 FPLC Superdex 200 gel filtration
The column was equilibrated with 50 mM potassium phosphate buffer, pH 7.0, 
containing 1 M NaCI. The sample was loaded using a 2 ml loop and eluted at a 
flow rate of 60 ml/h. 1 ml fractions were collected after the void volume (30 ml).
2.3.7.3 Glutathione agarose affinity chromatography
The gel was prepared by swelling lyophilised glutathione agarose in water for 2 h. 
This was packed into 2 ml disposable columns, avoiding the introduction of air 
bubbles, and washed with 10 column volumes of water added in several aliquots. 
The column was then equilibrated with several column volumes of PBST buffer 
(150 mM NaCI, 16 mM Na2HP04, 4 mM NaH2P04l 1% Triton X-100, pH 7.3).
The sample was loaded in 3 ml PBST buffer supplemented with 2 mM 
EDTA, 0.1% (v/v) p-mercaptoethanol, 0.2 mM PMSF and 5 mM benzamidine.
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The column was washed with 8 ml PBST and the sample eluted with 2.5 ml 
cleavage buffer (50 mM Tris-HCI (pH 8.0), 150 mM NaCI, 2.5 mM CaCI2) 0.1% 
(v/v) p-mercaptoethanol) containing 10 mM glutathione.
The column was regenerated by washing with 5 volumes 0.1 M borate 
buffer, pH 8-9, containing 0.5 M NaCI, followed by 5 column volumes of water, 5 
column volumes of 0.1 M acetate buffer, pH 4, containing 0.5 M NaCI, followed 
by another 5 volumes of water.
Alternatively, a batch procedure was used whereby glutathione agarose 
was added directly to the sample and incubated for 30 min at 4°C. Washing and 
elution was accomplished by centrifugation at 1000 rpm for 5 min in a 
microcentrifuge, followed by removal of the supernatant. The same buffers were 
used as for the columns.
2.3.7.4 Copper chelate affinity chromatography
Copper chelate affinity chromatography was carried out using a 5 ml HiTrap 
chelating column (Pharmacia). The column was primed with 2.5 ml 0.1 M CuS04 
using a syringe, washed with 15 ml Milli-Q water and equilibrated with 35 ml 50 
mM potassium phosphate buffer, pH 7.0, containing 1 M NaCI. The sample was 
loaded and the column washed with 25 ml equilibration buffer. Proteins were 
eluted with an imidazole gradient (0 - 100 mM) in 50 mM potassium phosphate 
buffer, pH 7.0, containing 1 M NaCI, over 16 ml at a flow rate of 2 ml/min. 1 ml 
fractions were collected.
The column was regenerated by stripping the metal ions with 25 ml 
equilibration buffer supplemented with 50 mM EDTA, washed with 25 ml Milli-Q 
water and stored in 20% ethanol.
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2.3.8 TCA precipitation of proteins
Proteins were precipitated in 10% (w/v) trichloroacetic acid (TCA) for 30 min on 
ice. The precipitates were spun down at full speed in a microcentrifuge for 10 




100 pi of appropriately-diluted sample was mixed with 1 ml Bradford Reagent (0.1 
mg/ml Coomassie Brilliant Blue G-250, 10% (v/v) phosphoric acid, 5% (v/v) 
ethanol) in a cuvette. This was incubated at room temperature for approximately 
10 min. The absorbance at 590 nm was determined and the protein 
concentration interpolated from known standards. The standards used were 
bovine serum albumin over a range of concentrations from 0 to 200 pg/ml 
(Bradford, 1976).
2.3.9.2 BCA Assay
A 50 pi sample was mixed with 1 ml working reagent in a cuvette. The working 
reagent consisted of 50 parts BCA Reagent A (1% (w/v) bicinchoninic acid, 2% 
(w/v) Na2HC03.H20 , 0.16% (w/v) Na2 tartrate, 0.4% (w/v) NaOH, 0.95% (w/v) 
NaHC03, pH 11.25) to 1 part Reagent B (4% (w/v) CuS04). The cuvette was 
incubated at 37°C for 30 min and then the absorbance at 562 nm was 
determined. Protein concentration was interpolated from known standards. The 
standards used were bovine serum albumin over a range of concentrations from 
0 to 1200 pg/ml (Smith et al., 1985).
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2.3.10 Crystallisation trials
Protein crystallisation trials were performed using the hanging drop vapour 
diffusion method (McPherson, 1990). Drops contained 2 pi concentrated protein 
solution (10 mg/ml) mixed with 2 pi of the precipitant solution. These were placed 
on silanised glass cover slips and suspended over 700 pi of the precipitant 
solution in 24-well tissue culture plates. A seal was formed between the cover 
slip and the well plate by a layer of vacuum grease. The trials were incubated at 
room temperature over a period of weeks.
2.4 Molecular Biological Methods
2.4.1 Quantitation of DNA
DNA concentration and purity were determined spectrophotometrically by the 
measurements of absorbance at 260 and 280 nm. An absorbance of 1 at 260 
nm (1 cm path length) corresponds to approximately 50 pg/ml (double-stranded) 
DNA. An A260 / A280 ratio of greater than 1.8 was taken to indicate purity. 
(Sambrook et al., 1989).
2.4.2 Ethanol precipitation of DNA
Ethanol precipitation was used to concentrate a DNA sample or perform an 
exchange of solvent. Three volumes of absolute ethanol (stored at -20°C) and 
one tenth volume of 3 M sodium acetate, pH 5.2 (0.3 M final concentration) was 
added to the sample. This was incubated at -20°C for 30 min or longer and the 
DNA recovered by centrifugation at top speed in a microcentrifuge for 10 min. 
The DNA pellet was washed by adding a small volume (-400 pi in a 1.5 ml 
Eppendorf tube) of 70% (v/v) ethanol, incubating on ice for 2 min and spinning for
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2 min at top speed. The ethanol was removed, the pellet dried under vacuum 
and then resuspended in the desired volume of buffer.
2.4.3 DNA preparation methods
2.4.3.1 Preparation of H. volcanii genomic DNA
200 pi of stationary phase culture was harvested and resuspended quickly in the 
same volume of distilled water to lyse the cells. An equal volume of buffer- 
saturated phenol (pH 8.0) was added, incubated at 65°C for 10 min and the 
aqueous layer removed. The DNA was ethanol precipitated out of solution, 
washed and resuspended in 200 pi distilled water. DNA was further purified 
using Geneclean®.
2.4.3.2 Large scale (Maxi) preparations of E. coli plasmid DNA
100 ml of cells from an overnight culture were harvested by centrifugation at 
1,300 x g in a bench top centrifuge for 10 min. The cells were resuspended in 4 
ml 50 mM glucose, 25 mM Tris-HCI (pH 8.0), 10 mM EDTA and lysed with 
addition of 8 ml 0.2M NaOH, 1% SDS. After standing on ice for 10 min, 6 ml 3M 
KAc (pH 4.8) was added quickly and the mixture was left on ice for 15-30 min. 
The precipitate was removed by centrifugation. Nucleic acids were precipitated 
from the supernatant by addition of 18 ml isopropanol followed by incubation on 
ice for 30 min. The precipitate was removed by centrifugation and resuspended 
in 1 ml 10 mM Tris-HCI (pH 8.0), 1 mM EDTA. 1 ml of 6 M LiCI was added and 
the mixture was left on ice for 15 min. The precipitate was removed by 
centrifugation and DNA was isolated from the supernatant by ethanol 
precipitation. The DNA was resuspended in 100 pi 10 mM Tris-HCI (pH 8.0), 1 
mM EDTA and incubated with 0.1 mg/ml RNAse A at 37°C for 30 min. The
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RNAse was inactivated by adding 0.5% (w/v) SDS and heating to 75°C for 10 
min. An equal volume of 6 M LiCI was added and the mixture was left for 15 min 
at room temperature. The precipitate was removed and the DNA extracted from 
the supernatant by ethanol precipitation. Following centrifugation for 10 min in a 
microcentrifuge, the pellet was dissolved in 400 pi Milli-Q water. The DNA 
solution was extracted once with phenol : chloroform : isoamyl alcohol (25:24:1) 
and twice with chloroform : isoamyl alcohol (24:1). This was followed by ethanol 
precipitation and resuspension in 100 pi Milli-Q water.
2.4.3.3 Small scale (Mini) preparations of plasmid DNA - Alkaline lysis 
method
1.5 - 3 ml of an overnight culture was spun down at full speed in a 
microcentrifuge for 2 min. The medium was removed by aspiration, leaving the 
bacterial pellet as dry as possible. The cell pellet was then resuspended in 100 pi 
ice-cold miniprep lysis buffer (50 mM glucose, 10 mM EDTA, 25 mM Tris-HCI, pH 
8.0), and incubated for 5 min at room temperature. 200 pi of a freshly prepared 
solution containing 0.2 M NaOH, 1% (w/v) SDS was added and mixed by 
inversion. This was incubated on ice for 5 min. 150 pi ice-cold 3 M potassium 
acetate solution, pH 4.8, was added, mixed by inversion and incubated on ice for 
5 min. The mixture was then spun down at full speed in a microcentrifuge for 5 
min and the supernatant transferred to a fresh tube. 1 volume of phenol : 
chloroform : isoamyl alcohol (25:24:1) was added, mixed by vortexing for 1 min 
and centrifuged at full speed for 2 min. The upper, aqueous phase was 
transferred to a fresh tube and 1 volume of chloroform : isoamyl alcohol (24:1) 
added and mixed as before. The aqueous phase was again transferred to a 
fresh tube and ethanol precipitated, as previously described. The DNA pellet
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was resuspended in 50 pi Milli-Q water and 0.5 pi 10 mg/ml RNAse added and 
incubated for 5 min at room temperature.
Alternatively, Promega’s Magic™ Miniprep or Qiagen’s QIAprep™ kits 
were used in accordance with the manufacturer’s instructions.
2.4.3.4 Preparations of H. volcanii plasmid DNA
Plasmids isolated from H. volcanii were prepared using the same procedures as 
ones from E. coli with the exception that the cells were initially resuspended in 1 
M NaCI, 50 mM glucose, 25 mM Tris-HCI (pH 8.0), 10 mM EDTA.
2.4.4 Agarose gel electrophoresis
DNA fragments were routinely analysed and separated by horizontal agarose gel 
electrophoresis, using 1 % (w/v) gels. These were made by dissolving agarose in 
the desired volume of TAE buffer (40 mM Tris-acetate, 1 mM EDTA) by heating 
in a microwave oven. Ethidium bromide was added to a concentration of 0.5 
pg/ml and the hot agarose poured into a perspex gel mould, with a comb in place 
to form wells, and allowed to set either at room temperature or at 4°C. Once set, 
the comb was removed and the gel placed in an electrophoresis tank and 
covered in TAE buffer. Sample loading buffer (6x) was 40% (w/v) sucrose, 
0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol. Samples were 
electrophoresed at a constant voltage of 50 - 90 V. In cases where the DNA was 
to be excised and purified from the gel, ultra-pure low-melting point agarose was 
used. The size-separated DNA was visualised under UV transillumination.
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2.4.5 Recovery and purification of DNA from agarose gels
2.4.5.1 Sephadex recovery
A Sephadex G-50 spin-column was made by plugging the bottom of a 0.6 ml 
Eppendorf tube with a small amount of sterile silane-treated glass wool. A 
volume of Sephadex G-50 dry beads (equilibrated with TE buffer, autodaved and 
dried) was placed on top of the glass wool. The tube was spun at 3,300 x g in a 
swing-out rotor to pack the resin. The DNA was electrophoresed in 1% (w/v) low- 
melting-point agarose in TAE buffer as described. The desired band was excised 
from the gel under long wave UV light and the gel slice placed on top of the 
Sephadex beads. The tube was dosed and the gel melted in a 60°C water bath 
for 5-10 min. As the gel slice melted, it entered the Sephadex resin. A volume 
of TE8 buffer was added and incubated for a further 5 min at 60°C. The tube 
was then placed on ice for 5 min. Small holes were made in the top and bottom 
of the tube with a 21-gauge needle. The tube was placed in a 1.5 ml Eppendorf 
tube and spun at 3,000 x g in a refrigerated microcentrifuge at 4°C. The flow­
through contained approximately 80% of the total DNA. (Method modified from 
Mukhopadhyay & Roth, 1991).
2.4.5J2 Geneclean® method
The Geneclean® method uses a silica-based matrix called Glassmilk® that has a 
high affinity for DNA. The DNA was purified from agarose as detailed in the 
manufacturer’s instructions.
2.4.6 Restriction digestion of DNA
DNA was digested with the appropriate restriction endonuclease as specified in 
the manufacturer’s instructions. The DNA was incubated with the enzyme in
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buffer, supplied as a 10x concentrate with the enzyme, at 37°C (or 25°C for 
Smal). For digestion with two endonucleases, the enzymes could be used 
simultaneously if the buffer requirements were similar. If this was not the case, 
however, the enzymes were used sequentially, digesting first with the enzyme 
requiring the lowest buffer concentration. The buffer concentration was then 
adjusted to suit the second reaction and the enzyme added. Alternatively, the 
DNA was ethanol precipitated after the first incubation and resuspended in the 
second reaction buffer. Incubation times varied from 1 h to overnight.
2.4.7 Ligations
Ligation of cohesive ends was carried out using 1 unit of T4 DNA ligase (supplied 
at a concentration of 1 unit/pi) in the buffer supplied with the enzyme. A ratio of 
insert to vector of 2 - 5 to 1 was used in a total volume of 30 pi. The reaction was 
incubated overnight at 15°C or at room temperature for 3 h. 15 pi of the reaction 
mixture was used to transform competent E. coli cells, with the remainder kept at 
4°C for use if the first transformation failed.
2.4.8 Phosphorylation of oligonucleotides
100 pmol of each oligonucleotide was 5’ phosphorylated using 5 units of T4 
polynucleotide kinase (supplied at a concentration of 10 units/pl) in the buffer 
supplied with the enzyme, supplemented with 1 mM ATP. The final volume was 
25 pi. The reaction was incubated at 37°C for 30 min and the kinase then 
inactivated by incubating at 70°C for 10 min. Phosphorylated oligonucleotides 
were stored at -20°C.
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2.4.9 Removal of single-stranded overhangs
Single-stranded DNA overhangs, produced by cutting with restriction enzymes, 
were removed to produce blunt ends by incubation with mung bean nuclease. 
The DNA was suspended in reaction buffer (supplied with the enzyme) or in 
NEBuffer 1, 2 or 4 supplemented with 1 mM ZnS04 at a concentration of 0.1 
pg/pl. 1 unit of enzyme was added for each pg of DNA and the reaction was 
incubated at 30°C for 30 min. After this time, the enzyme was inactivated by 
addition of SDS to a concentration of 0.01% (w/v) and the DNA recovered by 
ethanol precipitation.
2.4.10 Site-directed mutagenesis
Site-directed mutants were produced using Promega’s Altered Sites® II in vitro 
mutagenesis system. The protocols supplied with the kit were followed with a few 
modifications. Firstly, the length of the DNA denaturation stage was increased 
from 5 min at room temperature to 20 min at 37°C, and secondly, BMH 71-18 
mutS cells were substituted for the ES1301 mutS strain supplied with the kit due 
to problems encountered in making the latter competent.
2.4.11 Polymerase chain reaction (PCR) amplification of DNA
Reactions contained approximately 100 ng target DNA, 0.1 pM of each primer, 
and 50 pM each of dATP, dGTP, dCTP and dTTP in a 100 pi final volume. For 
reactions with Vent® DNA polymerase the reaction also contained 20 mM Tris- 
HCI (pH 8.8), 10 mM KCI, 10 mM (NH4)2S04, 2 mM MgS04 and 0.1% (v/v) Triton 
X-100. For reactions with Taq DNA polymerase the reaction contained 10 mM 
Tris-HCI (pH 8.3), 50 mM KCI and 1.5 mM MgCI2. The reaction mixture was 
overlaid with 50 pi mineral oil to prevent evaporation. Reactions were incubated
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at 96°C for 5 min before addition of 1-2.5 units of Vent® DNA polymerase (exo+) 
or Taq DNA polymerase. The amplification program varied, but consisted of a 
melting step (usually 96°C for 75 s), an annealing step and an extension step of 
72°C (length determined by size of expected product, usually 1 min per kilobase). 
A final 10 min extension was run after the last cycle was complete. A 10 pi 
sample of the reaction mixture was visualised on a 1% (w/v) agarose gel.
2.4.12 DNA sequencing
DNA for sequencing was prepared using the maxiprep method previously 
described. Sequencing was performed using the dideoxy method of Sanger et 
al. (1977) using a Sequenase™ version 2.0 kit. Approximately 5 pg double­
stranded DNA was alkali-denatured by incubating in freshly prepared 200 mM 
NaOH, 0.1 mM EDTA in a volume of 25 pi, at 37°C for 20 min. The DNA was 
ethanol precipitated, with two washes in 70% (v/v) ethanol, and resuspended in 6 
pi Milli-Q water.
10 pmol of primer was added to the denatured DNA and annealed in 
reaction buffer (supplied with the Sequenase™ kit) in a total volume of 10 pi. 
Annealing was achieved by heating to 65°C for 2 min and cooling to 30°C over a 
period of 30 min in a water bath. The labelling reaction was performed as 
detailed in the manufacturer’s instructions, using 5 - 10 pCi [a-^S] dATP 
(supplied at a concentration of 1000 pCi/mmol). The extension and termination 
reactions were followed, again as specified in the instructions.
The sequencing reactions were run on 0.4 mm thick 6% polyacrylamide- 
urea gels prepared using Sequagel™ reagents. A Hybaid sequencing apparatus 
(20 x 45 cm) was used to prepare the gel, with one plate coated with silane. The 
Sequagel™ components were mixed and polymerisation started by addition of
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ammonium persulphate and TEMED, as described in the manufacturer’s 
instructions. The gel was poured and allowed to polymerise overnight, with a 
comb in position.
Gels were pre-run at 38 mA for 15 - 30 min in TBE (90 mM Tris-borate, 
2mM EDTA) buffer. The samples were heated to 80°C for 5 min and loaded 
immediately. The gel was run at 38 mA. After running, the gel was transferred to 
Whatman 3MM paper, dried at 80°C under vacuum and exposed to X-ray film for 
1-7 days. The film was developed in an Amersham Hyperprocessor.
2.4.13 Transformation of E. coli
2.4.13.1 CaCI2 method
100 ml of LB medium was inoculated with 1 ml from an overnight culture and 
incubated at 37°C until the Aeoo reached about 0.4 (after ~3 h). The cells were 
then aseptically transferred to sterile, chilled 50 ml Falcon tubes and kept on ice 
for 10 min. The cells were recovered by spinning at 3,300 x g for 10 min in a 
benchtop centrifuge and each pellet was then resuspended in 25 ml ice-cold 
CaCI2 solution (50 mM CaCI2, 10 mM Tris, pH 8) and stored on ice for 15 min. 
The cells were spun as before and the fluid decanted. Each pellet was 
resuspended in 3.5 ml ice-cold CaCI2 solution. 200 pi aliquots of cells were 
transferred to 1.5 ml Eppendorf tubes and incubated overnight at 4°C. The 
following day, the transforming DNA was added (up to 50 ng in a volume of 10 pi 
or less). The contents were mixed gently and the tubes stored on ice for 30 min. 
The tubes were then heat-shocked in a 42°C water bath for exactly 90 s and then 
immediately put on ice for 2 min. 800 pi of SOC medium (2% (w/v) bacto- 
tryptone, 0.5% (w/v) bacto-yeast extract, 0.05% (w/v) NaCI, 20 mM glucose, 2.5 
mM KCI, 10 mM MgCI2, pH 7.0) was added to each tube and the cultures
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incubated at 37°C for 1 h to allow the bacteria to recover and express ampicillin 
resistance. 200 jil of transformed cells were plated out on LB agar, containing 
100 pg ampicillin/ml. The plates were incubated overnight at 37°C and 
transformed colonies selected. (Modified from Sambrook etal., 1989)
2.4.13.2 RbCI /  CaC/2 method
20 ml of LB medium was inoculated with 200 pi of an overnight culture and grown 
at 37°C until the A600 reached 0.3 - 0.5 (approximately 2-3 h). The cells were 
then harvested by centrifugation at 3,300 x g for 10 min and resuspended in 1 ml 
ice-cold solution A (10 mM MOPS, 10 mM RbCI, pH 7.0). The volume was 
brought up to 10 ml with solution A and the cells spun as before. The 
supernatant was decanted and the cells resuspended in 1 ml ice-cold solution B 
(100 mM MOPS, 50 mM CaCI2, 10 mM RbCI, pH 6.5). The volume was brought 
up to 10 ml with solution B and the cells incubated on ice for 30 min. The cells 
were spun again and gently resuspended in 2 ml solution B. For long term 
storage, glycerol was added to a final volume of 10% (v/v), the cells snap-frozen 
on dry ice in 200 pi aliquots and stored at -70°C.
3 pi DMSO was added to each 200 pi aliquot of competent cells and DNA 
added (up to 200 ng in 15 pi). The cells were incubated on ice for 30 min and 
then heat-shocked at 42°C for 90 s. The cells were put back on ice for 2 min and 
1 ml LB medium added to each tube. Cells were allowed to recover for 1 h 
before being plated out on selectable media.
2.4.13.3 TSS method
100 ml LB media was inoculated with 1 ml overnight culture and incubated at 
37°C until the Aeoo reached about 0.4 (after ~3 h). Cells were then transferred to 
sterile 50 ml Falcon tubes, harvested at 3,300 x g in a benchtop centrifuge and
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the media decanted off. The cells were resuspended in one tenth their original 
volume (5 ml per tube) ice-cold TSS (Transformation and storage solution: LB 
medium with 10% (w/v) PEG 8000, 5% (v/v) DMSO, 50 mM MgCI2, pH 6.5). 100 
pi aliquots of cells were pipetted into cold 1.5 ml Eppendorf tubes and 
transforming DNA (up to 200 ng in 10 pi) added. The tubes were mixed gently 
and incubated at 4°C for 30 min. After this time, 900 pi LB + 20 mM glucose was 
added and the cells incubated at 37°C for 1 h to allow the cells to express 
antibiotic resistance. Transformants were then plated out on selectable media. 
(Chung, Niemela & Miller, 1989).
2.4.14 Transformation of H. volcanii
Transformations were performed using the P E G  method described by 
Charlesbois et al. (1987). Freshly inoculated cultures were grown until late log 
(A 60o of 0.8-1.0) and then harvested by centrifugation at 3,300 x g for 15 min, at 
room temperature, in a Sorvall SS34 rotor. The cells were then washed in 1/10 
volume of buffered spheroplasting solution (1 M NaCI, 27 mM KCI, 50 mM Tris- 
HCI (pH 8.2), 15% (w/v) sucrose) and resuspended in buffered spheroplasting 
solution containing 15% (w/v) glycerol. Spheroplasts formed on addition of 45 
mM EDTA (pH 8.0). Spheroplasts were added to tubes containing 1-2 pg DNA 
and an equal volume of 60% (v/v) purified PEG eoo added. The cells were 
incubated for 20-30 min at room temperature after which they were allowed to 
recover in 18% (w/v) salt water modified growth medium for a few hours. 
Selection of transformants was by plating onto 18% (w/v) salt water MGM agar 
containing 0.3 pg novobiocin/ml or 4 pg mevinolin/ml and incubating at 37°C for 
5-10 days.
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2.4.15 Purification of polyethyiene glycoi (PEG) 600
PEGeoo was purified by the method of Klebe et al. (1983), as outlined by Cline et 
al. (1989). 100 g of PEG eoo was weighed into a 1 or 2 I vacuum flask. 200 ml of 
benzene was added to dissolve the P E G  and mixed well. 200 ml of iso-octane 
was added, mixed well and the mixture put on ice for at least 1 h. The liquid 
separated into two phases. On ice, the lower phase became like a gel, and the 
top phase (solvent) was poured off and discarded. The flask was taken off the 
ice and 100 ml benzene added to dissolve the P E G  layer. 5 volumes of diethyl 
ether were added and mixed overnight using a magnetic stirrer at 4°C to 
precipitate the P E G  completely. The precipitate was filtered using a chilled 
Buchner funnel on ice and washed with 500 ml chilled diethyl ether. The P E G  
was scraped off and the residual ether removed in a vacuum desiccator for 
several hours. The final fluid was stored, tightly capped, at 4°C.
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3. Expression in E. coli
3.1 Introduction
3
In order to obtain a high level of expression of halophilic DHLipDH it was thought 
desirable to express the recombinant protein in E. coli. Using an E. coli system 
has a number of potential advantages over expression in the native organism. 
Firstly, the rate of growth of E. coli is significantly faster than that of H. volcanii 
even when the latter organism is grown optimally. Cultures of E. coli are typically 
incubated overnight whereas H. volcanii require a week to ten days to reach an 
equivalent cell density. Secondly, genetic manipulation techniques are at an 
advanced stage for E. coli compared to the halophilic Archaea, which have only 
recently seen the development of some of the methods that would be required, 
such as transformation. Thirdly, differences in the properties of an expressed 
halophilic protein and those from E. coli could be exploited in a purification 
procedure. Addition of a high-salt solution to an E. coli extract would be expected 
to precipitate many of the E. coli proteins, leaving the expressed halophilic 
enzyme in a near-native environment. In addition, the relative thermostability of 
halophilic DHLipDH could be utilised.
3.2 Amplification of gene from pNAT82 by PCR
The H. volcanii DHLipDH gene had previously been cloned into the pBluescript 
KS+ plasmid as part of a 4.3 kb genomic Mbo\ restriction fragment 
(Vettakkorumakankav & Stevenson, 1992). The resulting construct was 
designated pNAT82 (Figure 3.1).
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1.6 kb 2.7 kb
1.0 kb
4.3 kb
Figure 3.1: Partial restriction map of pNAT82 (Vettakkorumakankav & 
Stevenson, 1992). 1.6 kb of this clone has been sequenced and accounts 
for the DHLipDH-coding region.
The DHLipDH-coding region accounts for approximately 1.6 kb of this fragment, 
shown in the figure. About 40 bp upstream from the transcription initiation site is 
located a putative Box A archaeal promoter region.
E. coli TG1 cells were transformed with pNAT82 and a miniprep 
performed to produce template DNA for the PCR reaction. A series of restriction 
digests were carried out, which confirmed the identity of the plasmid (Figure 3.2). 
Digestion of pNAT82 with Psfl and Xba\ cut out the genomic insert, giving bands 
of 4.3 kb and 3.0 kb, corresponding to insert and vector respectively. Sma\ 
digestion produced bands of 2.8 kb and 4.5 kb, in agreement with the expected 
pattern. Seal digestion linearised the plasmid, giving a band of 7.3 kb. Digestion 
with Sail produced 1.0 kb and 3.6 kb fragments, as expected from the partial 
restriction map, as well as other bands indicative of Sail sites within the 2.7 kb of 
the genomic fragment that is so far unsequenced. Taken together, these results 
confirm the identity of the plasmid.
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1 2 3 4  P H  1 2 3 4
<  2.8
<  1.0
Figure 3.2: Restriction digestion of pNAT82. Key: (1) Psfl + Xba\, (2) Sa/I, 
(3) Sroal, (4) Seal, (P) Pst\X markers, (H) Hind\\\X markers
50
In order to ligate the gene into an E. coli expression vector, new restriction sites 
needed to be introduced at either end of the coding region. Two PCR primers 
were designed to bind to the regions shown in Figure 3.3. Primer KAJ-2 
contained a H/ndlll site at the 3’ end of the gene, after both the stop codon and a 
possible stem-loop structure. Primer KAJ-3 contained an EcoRI site and was 
designed to bind next to the start codon, after the putative Box A region.







1500 kaj-2 1600 
STOP Hindlll
1 g ac g g c g c g c  a g g g c g tc g g  t t c a c g a a c c  g c g tg a a g g a  a c tg c t c g a a
EcoRI 1 Box A I
5 ' / ^  '' 3 fc t g c t g g t g t g  a a t t c a a t g g  t c g t c g g
KAJ"3 | I I I I I I I I I *  | * * * *  I | | | | | | | | | | |




1501  g tg a g g a g c g  tc c g a a a a a c  g g c g a g c tg a  t t t t t t a a g c  g g tc a g g tc g
I I I I I I I
g tc c a g c
3 '
1551  g c a t c g a g t t  c c g g g c tg a a  g ag a
I I I I I M I I  I 11 * * 1 1 1* 1 1  I I I I KAJ-2 
c g ta g c tc a a  g g t t c g a a t t  c t c t
Hindlll
Figure 3.3: Binding positions of PCR primers KAJ-2 and KAJ-3 on pNAT82. 
Mismatches are represented by asterisks.
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KAJ-2 : 5’ tctcttaagcttggaactcgatgccgacctg 3’ 31-mer
KAJ-3 : 5’ ctgctggtgtgaattcaatggtcgtcgg 3’ 28-mer
One would have expected little trouble in amplifying from a plasmid using nearly 
consensus primers; however, this was not the case. Initially, a melting step of 5 
min at 94°C was used, followed by 30 cycles of melting at 94°C, annealing at 
temperatures ranging from 60°C down to 37°C, and extension at 72°C.
Concentrations of template, primers, nucleotides and Mg2+ were varied but none
yielded any product. An attempt was then made using an initial melting step of 
96°C for 5 min, followed by introduction of Taq DNA polymerase, 3 cycles melting 
at 95°C and then melting at 94°C for the remaining cycles. This cautious 
approach to raising the melting temperature was in deference to the limited 
thermostability of the enzyme. This time, a product of about 800 bp was 
obtained, while the expected product should have been about 1.5 kb.
It seemed that melting temperature was the critical factor, so a 
temperature of 96°C was used for all cycles and a product of 1.5 kb was obtained 
(Figure 3.4).
The PCR program finally used was as follows: 96°C for 5 min followed by 
addition of enzyme, then 30 cycles of 96°C for 75 s, 60°C for 90 s, 72°C for 2 
min. A final extension step of 72°C for 10 min was included. Table 3-1 
summarises the reaction conditions tried.
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Figure 3.4: PCR amplification of the DHLipDH gene from pNAT82. Key: (M) 
Pst\K (1) Primers KAJ-2 + KAJ-3, (2) KAJ-3 + universal M13 -40 primer. The 
reaction using the universal primer was performed to test whether the 
initial failure was due to poor binding of KAJ-2.
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J3S?conc' 10-1000 10-1000 1000-5000 200 1000 1000 1000 1000
Primers 2+3 2+3 2+3 2+3 2+3 3+M 3+M 2+3
Primer conc. (pM) 1 1 0.5 0.1 1 1 1 1
melting temp (°C)
94 94 94 94 96 96 96 96





Annealing temp 55 40 65 37 37 37 60 60
Extension temp 72 72 72 72 72 72 72 72
Product size (kb) - - - - -0.8 -1.6 -1.6 1.5
Table 3-1: Summary of PCR reactions to amplify DHLipDH from pNAT82. 
Template concentrations are approximate, based on expected yield from a 
miniprep. Primer M = M13 -40 universal primer.
3.3 Subcloning into the pMEX8 expression vector
The PCR-amplified gene was cut with EcoRI and H/'ndlll, gel-purified using 
Sephadex G-50 recovery, and ligated into similarly-cut and gel-purified pMEX8 
(Figure 3.5). This vector contains a tac promoter for high-level inducible 
expression, a multiple cloning site and a ribosomal termination sequence. 
Transformants are selectable by growth on ampicillin-containing media.
The gene was successfully ligated into the vector, as determined by 
restriction digestion (Figure 3.6), and E. coli TG1 cells were transformed using 
the CaCI2 method. Digestion with EcoRI and Sa/I individually linearised the 
construct, the latter cutting within the insert, producing a fragment of 5.1 kb. The 
insert could be cut out using EcoRI and Hin6\\\, producing fragments of 3.6 kb 
and 1.5 kb.
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3629 EcoRI, Aval, Xmal, Smal, (BamHI), Sail, 







Figure 3.5: The pMEX8 expression vector (Medac)




Figure 3.6: Restriction digestion of DHLipDH cloned into pMEX8. Key: (M) 
PsftX markers, (1) EcoRI linearises within the vector, (2) EcoRI + H/'ndlll cuts 
out the insert, (3) Sa/I linearises within the insert.
55
To check expression of halophilic DHLipDH, 200 ml of transformed cells were 
grown overnight in media containing 100 |ig ampicillin/ml and 1 mM IPTG. They 
were harvested and sonicated in TE8 containing 2 M KCI, as previously 
described. After removal of the cell debris by centrifugation, the supernatant was 
assayed for DHLipDH activity. No activity was detected above that of E. coli 
transformed with pMEX8 alone, used as a control. SDS-PAGE analysis of both 
soluble and insoluble fractions showed no noticeable difference between the 
extracts.
3.3.1 Expression in JRG1342 (DHLipDH - minus)
Expression in TG1 cells is problematic due to the presence of the host cell 
DHLipDH, which displays a significant degree of halotolerance (Figure 3.7). This 












Figure 3.7: Halotolerance of E. coli DHLipDH. The enzyme activity in whole­
cell extracts was assayed at various salt concentrations.
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To circumvent this problem, E. coli JRG1342 cells were obtained (Prof. J.R. 
Guest, University of Sheffield). These cells are an ace-lpd deletion strain of E. 
coli K12 that lack a functional DHLipDH and grow very slowly relative to wild type. 









Figure 3.8: Growth profile of E. coli JRG1342. The AS50 of a shaking culture 
at 37°C was measured every hour.
From inoculation, the cells reached an A550 of 0.4 after approximately 8 hours. 
This was the cell density used for transformation.
JRG1342 cells were successfully transformed with the construct, using 
the TSS method, and grown overnight in LB medium containing 100 jig 
ampicillin/ml. The following morning, IPTG was added to a final concentration of 
1 mM and the cells incubated for a further 4 h at 37°C. The cells were harvested 
and sonicated, as before, but no enzyme activity was detected. No activity was
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observed in JRG1342 cells transformed with pMEX8 alone (lacking an insert). 
SDS-PAGE analysis showed no difference between extracts.
3.3.2 Growth of JRG1342 in elevated salt concentrations
As the enzyme is folded under relatively high salt conditions in H. volcanii, it was 
thought that the internal environment of E. coli might be unsuitable for the protein 
to take up its correct conformation, and it might be susceptible to proteolytic 
digestion (or it would have been seen on SDS-PAGE gels). By growing E. coli in 
a medium containing a higher than normal level of salt, it was thought possible 
that the internal concentration might be increased and the enzyme would be 
more likely to fold correctly.
Transformed JRG1342 cells were grown in LB medium containing 0.25 - 
1.0 M NaCI + 50 mM KCI. No growth occurred in 1 M salt, but slow growth was 
found in 0.75 M (A550 of 0.3 after 36 h). The cells were treated as before, but still 
no activity was detectable. SDS-PAGE, however, showed a large band of an 
apparent molecular weight of 59 kD, the predicted size for DHLipDH, in the 
soluble fraction of cells grown in 0.75 M NaCI (Figure 3.9).
This band was assumed to be halophilic DHLipDH even though no 
activity was detected. This experiment was initially designed to lest whether the 
cells would grow in such conditions, rather than to check expression, so no 
untransformed cell controls were included. Later, when controls grown in the 
same elevated salt concentrations were tested, the same band was found in 
them and so the earlier assumption of expression seemed falsely optimistic. The 
band observed was most likely an E. coli protein that happened to be soluble in 









Figure 3.9: SDS-PAGE of extracts of transformed JRG1342 cells grown in a 
range of NaCI concentrations. After cell lysis and centrifugation, 
electrophoresis was performed on both the supernatant (soluble fraction) 
and the pelleted debris (insoluble fraction). Key: (M) Low molecular weight 
markers, (1) 0.25 M soluble fraction, (2) 0.5 M soluble, (3) 0.75 M soluble, (4) 
0.25 M insoluble fraction, (5) 0.5 M insoluble, (6) 0.75 M insoluble.
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As the gene had been amplified using Taq DNA polymerase, which is known to 
introduce mutations, on average, every 104 bases (Tindall & Kunkel, 1988), the 
possibility was considered that the construct may code for a mutated, and 
therefore possibly inactive, protein. For this reason, the gene was reamplified 
using Vent® DNA polymerase (exo+) which has a proof-reading ability and 
therefore higher fidelity than Taq DNA polymerase. The PCR conditions used 
were the same as before. The gene was successfully amplified and ligated into 
pMEX8, again determined by restriction digestion and also sequencing across 
the 5’ terminal join, but still no expression could be detected in cells transformed 
with the construct.
3.3.3 Inclusion of FAD in extracts to facilitate correct foiding
DHLipDH uses FAD as a cofactor, and therefore cell extracts were prepared, and 
the enzyme assayed, in the presence of 0.1 mM FAD, as a lack of this cofactor 
may prevent the enzyme from taking up its correct conformation. No difference, 
however, was seen between extracts containing the cofactor and those not.
3.3.4 Growth of cells at 30°C
Cells were also grown at 30°C, as a lower temperature can influence solubility of 
an expressed protein. The cells were grown for 5 days and 1PTG added to a final 
concentration of 0.5 mM 18 h prior to assay. Again, no activity was detected, but 
as previously there appeared to be no expression rather than expression of an 
insoluble product this was not too surprising.
3.4 Expression using the pGEX-KG fusion protein vector
As an alternative expression system, the pGEX-KG fusion protein system was 
tried (Figure 3.10). This vector produces a fusion of the protein under study with
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glutathione S-transferase (GST) (Smith & Johnson, 1988; Guan & Dixon, 1991). 
The fusion protein can be purified from a cell extract by affinity binding to 
glutathione agarose and elution with glutathione, after which the two proteins of 
the fusion can be separated by cleavage with thrombin. The gene to be 
expressed can be cloned in to the vector either contiguously with the coding 
region for GST, or utilising a glycine linker region between the two proteins. Use 
of the linker facilitates more effective cleavage but has the disadvantage of 
modifying the N-terminus of the expressed protein.
















EcoRI, Xba, Ncol, Sail, 
XhoT, SacI, Hindlll
Figure 3.10: The pGEX-KG fusion expression vector (Pharmacia). The gene 
can be cloned in next to the coding region for GST, either utilising the 
linker (EcoRI site) or not (BamHI site).
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3.4.1 Subcloning of DHLipDH gene into pGEX-KG
Primers were designed for amplifying DHLipDH with restriction sites for cloning 
into the vector, both with and without the linker. KAJ-2, used previously, was the 
reverse primer, binding to the 3’ end of the gene and introducing a H/ndlll site. 
KAJ-4 and KAJ-5 are forward primers that introduce a BamHI and EcoRI site 
respectively.
KAJ-4 : 5’ ggtgttggatccatggtcgtcggagacatcgc 3’ 32-mer
KAJ-5 : 5’ ggtggaattctaatggtcgtcggagacatcgc 3’ 32-mer
BamHI
5 r /— " —\ 3 'ggtgtt ggatccatgg tcgtcggaga catcgc
* A '}~4  I I I I I I * l  I * * *  I I I I  I I I I I I I I I I I I I  I I  I 
51 gaccccaaac tgctggtgtt agaataatgg tcgtcggaga catcgcaacc
Start codon
EcoRI
5 ' /— ^ '— n 3 'ggtgga attctaatgg tcgtcggaga catcgc
I I I I** 1***1 I I I I I I I I I I I I I I I I I I I I I
51 gaccccaaac tgctggtgtt agaataatgg tcgtcggaga catcgcaacc
Start codon
Figure 3.11: Binding positions of PCR primers KAJ-4 and KAJ-5 on 
pNAT82. Mismatches are represented by asterisks.
The DHLipDH gene was amplified from pNAT82 using Vent® DNA polymerase 
(exo+) as described in the Materials and Methods (Figure 3.12). Mg2+ 
concentrations in the range 2 mM - 6 mM were used to optimise the reaction, and 
the program used was as follows: 96°C for 5 min, followed by 30 cycles of 96°C 
for 75 s, 60°C for 60 s and 72°C for 90 s.
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M 1 2 3
Figure 3.12: PCR amplification of DHLipDH from pNAT82 using primers 
KAJ-2 and KAJ-4. Key: (M) PstlX markers, (1) 2 mM Mg2*, (2) 4 mM Mg2*, (3) 
6 mM Mg2*. Amplification with KAJ-2 and KAJ-5 produced products of the 
same size.
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The products from the reactions containing 2 mM Mg2+ were cut with the 
appropriate restriction enzymes, gel-purified and ligated into similarly cut and 
purified pGEX-KG vector to create pBAP5000 (with linker) and pBAP5001 
(without linker).
3.4.2 Expression of a GST-DHLipDH fusion protein
E. coli DH5a cells transformed with either pBAP5000 or pBAP5001, when 
induced with 0.2 mM IPTG for three hours, produced a soluble fusion product of 
approximately 86 kD, determined by SDS-PAGE. Control cells transformed with 
the pGEX-KG vector without insert produced a soluble product of approximately 
26 kD, corresponding to the GST part of the fusion. Addition of glutathione 
agarose removed some of the fusion protein from the solution but a large fraction 
remained soluble, as shown by SDS-PAGE analysis (Figure 3.13). Upon 
centrifugation, removal of the supernatant and elution of the product from the 
glutathione agarose with 10 mM free glutathione, a faint band (relative to the 
starting material) was visible at 86 kD, which is the size of the fusion protein. 
Addition of 4 jig thrombin to cleave the fusion left only very faint bands at 
approximately 58 kD (not visible in figure) and 26 kD.
No DHLipDH enzyme activity was detected when assayed in 2 M KCI. 
Incubation in 3 M KCI for 3-4 hours at 4°C in an attempt to induce a native 
conformation did not result in activity. No difference was seen between extracts 
of cells transformed with pBAP5000 and pBAP5001.
As the level of binding of the fusion protein to glutathione agarose was 
low, columns were used in place of the batch procedure. However, no increased 
binding was observed.
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14 ► ^ m
Figure 3.13: Expression of GST-DHLipDH fusion protein (with linker). Key: 
(M) low molecular weight markers, (1-2) control and fusion soluble 
fractions, (3-4) supernatants after glutathione agarose treatment, (5-6) 
elution from agarose, (7-8) thrombin cleaved, (9-10) after glutathione 
agarose to remove free GST. The double bands in lane 7 are due to partial 
removal of the linker region from GST.
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3.4.3 Thrombin cleavage of GST-DHLipDH
An attempt was also made to thrombin-cleave the fusion in the whole cell extract. 
This was done in the hope that any active protein released could be purified in 
ways other than affinity binding, possibly utilising the relative thermostability of 
halophilic DHLipDH. The cell-free extracts were incubated overnight with 
thrombin at room temperature. SDS-PAGE analysis of the extracts showed that 
the fusion was cleaved, releasing a 26 kD fragment (GST) but the DHLipDH was 
further cleaved into approximately 32 kD and 34 kD fragments (Figure 3.14).
A faint band at about 58 kD was present, which is the expected size for 
free DHLipDH, but only a relatively small increase in activity above control levels 
(approximately 2.5 times) was detected when assayed in 2 M KCI.
Since the DHLipDH cleaved from the fusion was undergoing further 
breakdown, a time-course for thrombin cleavage was undertaken. 4 pg thrombin 
was added to 2 ml extracts and these were incubated at room temperature for 
between 0 and 5 hours. 200pl samples were taken at appropriate time points 
and the reactions were stopped by addition of 0.2 mM PMSF and 5 mM 
benzamidine. Following overnight incubation in 4 M KCI at 4°C, the samples 
were assayed for enzyme activity and an SDS-PAGE gel run (Figure 3.15).
No significant increase in enzyme activity was detected in samples during 
the time-course, although activity in extracts from cells expressing the fusion 
proteins were approximately double those from the controls (Figure 3.16). From 
the SDS-PAGE gels, bands at 56 kD, thought to be DHLipDH, appear after 30 
minutes, and breakdown products of this appear at apparent molecular weights 
of approximately 34 kD and 32 kD after about 2 hours.
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Figure 3.14: Thrombin cleavage of GST-DHLipDH fusion protein in cell-free 
extract. Key: (M) low molecular weight markers, (1-3) control, pGEX- 
DHLipDH (with linker), pGEX-DHLipDH (without linker) before cleavage, (4- 














4 0  < 26
Figure 3.15: Thrombin-cleavage time course. Key: (M) low molecular weight markers, (1-3) pGEX control, pGEX-DHLipDH (with 
linker), pGEX-DHLipDH (without linker) at t=0, (4-6) t=30 min, (7-9) t=1 h, (10-12) t=2 h, (13-15) t=3 h, (16-18) t=4 h, (19-21) t=5 h
£1 pGEX control 
I BpGEX-DHJpDHw/Inker 
I □  pGEX-DHJpDH w/o Knkei
Time (min)
Figure 3.16: Time-course showing DHLipDH activity in extracts of cells 
transformed with pGEX-KG constructs following reaction with thrombin for 
varying periods.
The band at 56 kD was thought to be DHLipDH in a largely inactive conformation. 
Attempts were made at thermal renaturation of the protein, utilising the relative 
thermostability of the enzyme. Samples from the thrombin-cleavage time-course 
were heated to 65°C for 15 minutes in the presence of 3 M KCI and reassayed 
(Figure 3.17). Overall activities remain similar, with no significant change in 
activity observed between samples exposed to thrombin for various times and 
those not.
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E3 pGEX control 
■  pGEX-DHLipDH w / linker 
□  pGEX-DHLipDH w lo linker
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Tim e (min)
Figure 3.17: DHLipDH activity in extracts of cells transformed with pGEX- 
KG constructs after reaction with thrombin for varying periods and thermal 
renaturation.
3.4.4 Heat stability o f the fusion proteins
As one half of the fusion proteins consisted of the thermotolerant halophilic 
DHLipDH, it was thought possible that the fusions as a whole would exhibit such 
a property. If the fusion proteins were thermotolerant, a heat step could be used 
to purify them partially from the cell extracts, even though the problems with 
cleavage and affinity binding made it unlikely that the system would eventually be 
used.
100 pi of transformed cell extracts were heated to 65°C, 75°C and 85°C 
for 15 min. The samples were centrifuged at 13,000 rpm in a microcentrifuge for 
10 min and the supernatants analysed by SDS-PAGE (Figure 3.18).
The faint bands at 86 kD following 65°C incubation, compared with those 
from the unheated samples, suggest that the fusions show very limited 
thermostability. The same bands are barely present in the extracts heated to 
75°C and 85°C
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Figure 3.18: Heat stability of the pGEX-DHLipDH fusion proteins. Key: (M) 
low molecular weight markers, (1-2) pGEX-DHLipDH (with linker), pGEX- 
DHLipDH (without linker) not heated, (3-4) 65°C, (5-6) 75°C, (7-8) 85°C
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3.5 Subcloning into the pKK223-3 expression vector
Due to the ultimate lack of success with the GST fusion protein expression, a 
new alternative was tried. pKK223-3 (Brosius & Holy, 1984) is similar to pMEX8 
in that it has a tac promoter for inducible expression and selection is by ampicillin 
resistance (Figure 3.19). The reason this vector was tried, when expression in 
pMEX8 had failed, was because pKK223-3 was available in the lab and had 
been used successfully to express the citrate synthase from the thermophilic 
archaeon Pyrococcus furiosus (Muir et al., 1995). The DHLipDH gene was PCR 
amplified from pNAT82 using oligos KAJ-2 and KAJ-3, the same as for ligation 
















EcoRI, Smal, Xmal, BamHI, Sail, AccI, HincII, PstI, Hindlll
Figure 3.19: The pKK223-3 expression vector (Pharmacia)
The product was successfully ligated into the EcoRI and H/ndlll sites of pKK223- 
3, as determined by restriction digestion, to create pBAP5002. E. coli JM105
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cells were transformed with the plasmid but there was no apparent expression, 
as determined by SDS-PAGE of both the soluble and insoluble fractions of the 
cell extract and by enzyme assay.
Variation of the growth temperature (30°C or 37°C) and of induction times 
(from inoculation to 3 hours before harvest) and concentrations of IPTG failed to 
yield any expressed protein.
3.6 Use of compatible solutes
As there was a possibility that the internal environment of E. coli was unsuitable 
for expression of halophilic DHLipDH, attempts were made to increase the 
osmolarity of the cells’ cytoplasm. Previously the growth of JRG1342 in elevated 
salt concentrations was described, but only slow growth was achieved in 0.75 M 
NaCI. In an attempt to improve on this, the use of compatible solutes and 
osmotic stress conditioning of cells was investigated. Successes have been 
reported of induced halotolerance of E. coli by these methods (Jebbar et al., 
1992; Peddie etal., 1994).
3.6.1 Elevated salt and inclusion of betaine in growth media
E. coli JM105 cells were grown overnight in LB medium at 37°C. 1 ml of this 
culture was used to inoculate six 100 ml cultures containing 0.17 M, 0.5 M or 1.0 
M NaCI, in both the presence and absence of 100 |iM betaine. The cultures 
additionally contained 50 mM KCI, as this may have been taken up by the cells in 
order to reduce the osmotic pressure. These were incubated as before and 










0 2 4 6 8
Time/h
— 0.17M Nad
—e — 0.17M Nad + betaine
— 0. 5MNad
—B— 0.5 M Nad + betaine
—A— 1.0M Nad
—A— 1 OM Nad + betaine
Figure 3.20: Growth profile of E. coli under salt-induced osmotic stress, in 
the presence or absence of 100 pM betaine.
The growth profiles showed no significant enhancement of growth in saline media 
in the presence of betaine.
3.6.2 Osmotic stress conditioning
Reports have suggested that osmotic stress conditioning of cells can lead to 
heightened halotolerance (Ishida et al., 1994). E. coli JM105 cells were pre­
incubated in LB medium containing 0.5 M NaCI for 30 min at 37°C. 1 ml of this 
culture was used to inoculate flasks containing 100 ml LB + 50 mM KCI 
containing 0.17 M, 0.5 M or 1.0 M NaCI, with or without 100 pM betaine, and 
incubated as before. The Amo of the cultures was measured every 60 min. 
Again, no significant increase in halotolerance was observed between cultures 
containing betaine and those not. The rate of growth, however, was greater in 
the cultures containing 0.5 M and 1.0 M NaCI than in those without the pre­
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Figure 3.21: Growth profile of E. coli under salt-induced osmotic stress, in 
the presence or absence of 100 pM betaine, following osmotic stress 
conditioning
3.7 Discussion
3.7.1 Use o f PCR in gene cloning
PCR is a quick and effective method for producing large amounts of DNA for 
cloning, with the advantage that restriction sites can be easily introduced by 
including mismatches in the primer sequences. One should be aware, however, 
of the potential problems resulting from polymerase fidelity.
DNA polymerase fidelity has been extensively studied (reviewed by Bloch, 
1991). Taq DNA polymerase has been shown to have a base substitution error 
rate of approximately 1CT4 errors/bp/duplication, with frameshift errors occurring at 
a frequency of 2 x 10'5 errors/bp/duplication (Tindall & Kunkel, 1988). These 
values vary depending on a range of factors, including template, nucleotide and 
Mg2+ concentration, reaction buffer and annealing temperature, as well as the 
assessment method (Bloch, 1991). In recent years, new thermostable DNA
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polymerases with improved fidelity have been introduced. Vent® DNA 
polymerase, for example, has 3’ - 5’ proof-reading exonuclease activity resulting 
in levels of fidelity at least three times those of Taq DNA polymerase (Keohavong 
et a/., 1993).
When amplifying the DHLipDH gene from pNAT82, products from more 
than one reaction were used in subcloning and both Taq and Vent® DNA 
polymerases were tried.
The problems initially encountered with amplifying the DHLipDH gene 
were unexpected since the primers were matched to the known sequence and 
the template was a plasmid. The high melting temperature of 96°C that was 
found to be required can be explained by the high G+C content of the gene 
(69%). When using a 96°C hot-start and 3 cycles of melting at 95°C, followed by 
cycles melting at 94°C, an 800 bp band was seen on the gel. It is not clear what 
this product was, but as it seems that the template was not fully melting, it is likely 
to be an artefact due to incomplete replication of the template. Melting at 96°C 
over all cycles resolved this problem and the gene was successfully amplified.
3.7.2 The suitability of E. coli for expression of halophilic proteins
The lack of success in expressing halophilic DHLipDH in E. coli as an unmodified 
protein suggests the possibility that the internal environment is incompatible with 
either its translation or its stability. If the protein was being translated in E. coli 
but not folding correctly, two possibilities present themselves: either the protein 
forms an insoluble aggregation, or it is rapidly degraded by intracellular 
proteases. Since there was no evidence of any expressed protein in the 
insoluble component of the cell extract when run on SDS-PAGE, one should 
consider the possibility that the protein was rapidly degraded after translation. If
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this was indeed the case, attempts to modify the internal environment, such as 
raising the osmolarity of the cytoplasm, might have lead to the protein taking up 
its native conformation upon translation.
It was for this reason that attempts were made to grow E. coli in elevated 
salt concentrations. As was shown, only very slow growth was achieved in 0.75 
M NaCI and there was no significant growth in 1 M. Growth in concentrations of 
salt greater than this would be desirable, but even if it was possible, the sacrifice 
of growth rate would reduce the advantages of expressing in E. coli, as fast 
growth was seen as one of its major benefits. The use of betaine as a 
compatible solute to balance the external osmotic pressure failed to enhance 
growth rates significantly. It is possible that induced osmotolerance is strain 
specific and use of other compatible solutes may have given improved results. It 
was felt though that this was an area requiring too much optimisation with only a 
small chance of ultimate success. For this reason, no further attempts at 
inducing osmotolerance were made.
One can not exclude the possibility that the protein was not translated in 
the first place. Great care was exercised, however, when designing the 
experiments for cloning into pMEX8 and pKK223-3, that the start codon was 
optimally placed relative to the ribosomal binding site. Both these vectors have 
been successfully used in our lab for the expression of foreign proteins, so the 
reasons for the failure in this case are unknown. The possibility exists that a 
mutation introduced during PCR amplification created a stop codon shortly after 
the initiation site. I feel this is unlikely to be the cause of the problem though, as 
the reaction was repeated using both Taq and Vent® DNA polymerase, and 
unless the mutation occurred early in the sequence a truncated product would be 
expected to be visible by SDS-PAGE. Short of sequencing the entire gene one
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can not completely rule out the possibility. This option was not adopted due to 
the prohibitive length of time that it would likely have taken.
It must be acknowledged that E. coli has been successfully used to 
express halophilic proteins in the past. Malate dehydrogenase from Haloarcula 
marismortui was expressed in large amounts in a soluble but inactive form. 
Activation of the enzyme was achieved by increasing the salt concentration of the 
extract to 3 M NaCI (Cendrin et al., 1993). Dihydrofolate reductase from H. 
volcanii was also expressed, this time in an insoluble form. Activation was 
achieved by dissolving the aggregates in 6 M guanidine hydrochloride followed 
by dilution into salt solutions (Blecher et al., 1993). Both these proteins were 
expressed in pET11 vectors (Studier et al., 1990), in which cloned genes are 
transcribed from the T7 promoter by T7 polymerase, whose gene resides in the 
chromosome of the E. coli strain BL21 (DE3).
HMG-CoA reductase from H. volcanii was expressed using pT7-7, a 
plasmid also containing the T7 promoter, in E. coli BL21 (DE3) (Bischoff & 
Rodwell, 1996). Activity was detected after extracts were exposed to 3 M KCI.
The disadvantage of these plasmids is that expression can only be done 
in strains containing the T7 polymerase gene. In order to express in other 
strains, such as the DHLipDH - minus mutant JRG1342, the cell needs to be 
infected with a bacteriophage containing the polymerase gene. This may well 
have been detrimental to the growth of an already slow-growing mutant strain. It 
was for this reason that a similar plasmid was not tried for the expression of 
halophilic DHLipDH.
3.7.3 GST-DHLipDH fusion proteins
Expression was obtained by use of the pGEX-KG vector to create a GST- 
DHLipDH fusion protein. By being part of a fusion, the expressed DHLipDH was
78
probably stabilised and folded into a soluble form in the low salt environment. 
Unfortunately several problems were encountered. Firstly, there was the lack of 
binding of the fusion protein to glutathione agarose. Binding of GST fusion 
proteins diminishes with increasing molecular mass, and 86 kD is at the upper 
limit of what would be expected to bind (Frangioni & Neel, 1993). The second 
problem was the internal cleavage of the DHLipDH part of the fusion with 
thrombin. This was not predicted, although the possibility had not been 
discounted, due to the fact that the recognition site for thrombin is somewhat 
vague, namely Arg-Gly peptide bonds in specific sequences only. Since the 
thrombin-cleavage site between the components of the fusion was specifically 
designed and engineered as such, it was expected that cleavage would occur 
there preferentially.
3.7.4 Concluding remarks
The overall lack of success in expressing halophilic DHLipDH in E. coli was 
disappointing but it was felt by this stage that it was time to abandon further 
attempts and concentrate on expression in the native organism. Work towards 
this end had been conducted in parallel with the E. coli expression studies and 
sufficient progress had been made to suggest that this path would ultimately 
prove successful.
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4. Over-expression in H. volcanii
4.1 Introduction
Expression of proteins in the native organism has potential advantages over 
expression in E. coli. While the latter may grow considerably quicker, the 
significant differences in the osmotic environments of the cytoplasms of the 
respective species can lead to problems with protein folding and stability.
It was for this reason that work was initiated to express halophilic 
DHLipDH back in H. volcanii. A small number of shuttle vectors have been 
developed over the last few years that are able to replicate in both E. coli and H. 
volcanii (Lam & Doolittle, 1989; Holmes et al., 1991; Holmes et al., 1994). This 
ability is due to the inclusion of origins of replication for both species. Similarly, 
the vectors are selectable in each host by display of two types of antibiotic 
resistance.
4.2 Subcloning DHLipDH gene into the pMDS20 shuttle vector
pMDS20 is a shuttle vector containing the E. coli ColE1 plasmid ori region and 
the ampicillin-resistance-conferring (3-lactamase gene. It also contains the 
Haloferax pHK2 replicon region and novobiocin-resistance-encoding gyrB gene 
(Holmes et al., 1994) (Figure 4.1). The vector is hence able to be maintained 
and selected for in both hosts. pMDS20 has a copy number of 7-8 copies per 
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Figure 4.1: The pMDS20 shuttle vector
As with subcloning into the E. coli expression vectors, new restriction sites 
needed to be introduced at either end of the coding region of the DHLipDH gene 
in order to ligate it into pMDS20. This was again achieved by PCR. A PCR 
primer, KAJ-1, was designed to bind to a region upstream and including the 5’ 
end of the putative Box A promoter in pNAT82. This primer had mismatches to 
introduce a BamHI site. Primer KAJ-2, which was used in the amplifications for 
cloning into the E. coli expression vectors, introduced a H/ndlll site at the 3’ end 
of the coding region (Figure 4.2).
KAJ-1 : 5’ agggcgtcggatcccgaaccgcgtgaagg 3’ 29-mer
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Figure 4.2: Binding positions of PCR primers KAJ-1 and KAJ-2 on pNAT82. 
Mismatches are represented by asterisks.
The same PCR conditions were used as those optimised in Chapter 3, namely 
the following program: 96°C for 5 min followed by addition of 2.5 units Taq DNA 
polymerase, then 30 cycles of 96°C for 75 s, 60°C for 90 s, 72°C for 2 min. A 
final extension step of 72°C for 10 min was included.
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M 1
Figure 4.3: PCR amplification of DHLipDH gene from pNAT82. Key: (M) 
Ps1\K (1) Primers KAJ-1 + KAJ-2
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The PCR product was gel-purified using Sephadex G-50 recovery, cut with 
BamHI and H/ndlll and gel-purified again. This was ligated into similarly-cut and 
gel-purified pMDS20. The resulting construct, pMDS21, was transformed into E. 
coli in order to prepare enough DNA for transformation into H. volcanii. A 
miniprep was done by the alkaline lysis method and the purified piasmid used to 
transform H. volcanii WFD11. [NB: The actual ligation of the purified PCR 
product and transformation were done at the University of Melbourne, Australia 
by Dr. M. Dyall-Smith and Dr. M.J. Danson].
Cells transformed with pMDS21 were harvested and assayed for 
DHLipDH activity. No increase in activity above levels found in control cells 
transformed with pMDS20 (no insert) was detected. The cell-free extracts, as 
well as solubilised whole cells, were analysed by SDS-PAGE. No differences 
were observed between pMDS21-transformed cells and the controls. 
Additionally, a mutant strain of H. volcanii, BAS5005, lacking a functional 
DHLipDH gene, whose construction is described in Chapter 6, was transformed 
with pMDS21. No activity was detected.
The lack of expression suggests that the putative Box A region may not 
represent an active promoter. In order to overexpress the protein, introduction of 
a strong promoter to the gene was considered desirable.
4.3 Introduction of a rRNA promoter
The promoter that was chosen to overexpress the DHLipDH gene was the strong 
P2 promoter from the rRNA operon of Halobacterium cutimbrum (Brown et al., 
1989;.
The promoter was synthesised as follows. Two overlapping oligos 
(WGW-1 and 2) were designed to bind to the consensus region of the promoter, 
as well as to all of the region downstream to 2 bases past the indicated
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transcription starting point. The forward oligo had half an EcoRV site, and the 
reverse contained a BamHI site. The oligos were annealed, extended with T4 
DNA polymerase and the resultant reaction run on a 10% polyacrylamide gel. 
The band was excised and purified, cut with BamHI and initially cloned into the 
EcoRV and BamHI sites of pUK21 (Vieira & Messing, 1991). The resultant 
construct was designated pMDS65. The promoter was cut out of pMDS65 with 
EcoRV and BamHI and annealed to the BamHI end of the DHLipDH PCR 
product amplified with KAJ-1 and KAJ-2. The resultant construct was ligated into 
pWL102 (Lam & Doolittle, 1989), at the Kpn\ and Xba\ sites, to create pMDS24 
(Figure 4.4).
WGW-1: 5’ atcgatgcccttaagtacaacagggtacttcgg 3’ 33-mer
WGW-2: 5’ gcggatccgttcgcattccaccgaagtaccctgtt 3’ 35-mer
[NB: The pMDS24 overexpression plasmid was created by W. Woods and Dr. M. 
Dyall-Smith (University of Melbourne, Australia) as part of an active collaboration 
(Jolley et al.t 1996)].
pMDS24 was introduced in to H. volcanii WFD11, following passage 
through E. coli to produce enough DNA for transformation. Mevinolin-resistant 
transformants were selected and cell extracts produced, as described in the 
Materials and Methods.
The transformants had a DHLipDH activity of 0.38 ± 0.03 units/mg (95% 
confidence level) at 30°C, compared to a wild type activity of 0.03 units/mg. This 
corresponds to an average 13-fold over-expression of enzyme activity.
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Figure 4.4: Construction of the pMDS24 shuttle I expression vector
4.4 Change of antibiotic resistance marker
In order to over-express the enzyme in the DHLipDH - minus strain of H. volcanii, 
described in Chapter 6, the antibiotic resistance marker needed to be changed. 
This was because the mutant strain was constructed by inserting the mevinolin 
resistance gene into the chromosomal DHLipDH gene by homologous 
recombination. Consequently, the mutant strain was mevinolin resistant and 
pMDS24 was not selectable.
Primers were designed to PCR-amplify the novobiocin resistance marker 
from pMDS20, introducing Sph\ and Kpnl sites at the ends so it could be 
exchanged with the mevinolin resistance marker of pMDS24.
Kpnl
5’ /— ^ — \ 3’KAJ-6 c9 caggtaccca gtcccgcgtt aagtactc
I I  I I * * l  I I I I I I I I I I I I I I I I I I I I I I I
5081 tcctgatgcg catctaccca gtcccgcgtt aagtactcac cggcagcgga 
5131 gtgaaagtga actcggggcg ttgacgcgct tcgaggggcg ttcgcgccgg 




7471 acgagtaacg gctccccgcg agactttttt cgcggactcc cgccggagag 
7521 ccgcggctcc gaccgtcgct ccccgaagac atttatctcg gccggaggtc 
7571 ctaccggtat gagcgtgcga ccgcggtcga gaatcgtcgg cgtctcggcg 
7621 ctcgcgttcg tcgtcgtcct cggcggcctg accgcgcttc gggcgtggaa
I I I I I I I I I I I 1111*11*11
, c tggcgcgaag cccgtacgtt
7671 cctcgaaccg ggatcctcta
I I I I I I I I I P
ggagcttgg KAJ-7 
5
Figure 4.5: Binding positions of primers KAJ-6 and KAJ-7 to the novobiocin 
resistance determinant of pMDS20. Mismatches are represented by 
asterisks.
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KAJ-6 : 5’ cgcaggtacccagtcccgcgttaagtactc 3’ 30-mer 
KAJ-7 : 5’ ggttcgaggttgcatgcccgaagcgcggtc 3’ 30-mer
A PCR reaction was set up containing 10 ng pMDS20 template DNA and 50 
pmol primers KAJ-6 and KAJ-7. The buffer was as detailed in the Materials and 
Methods for amplification with Vent® DNA polymerase. Mg2+ concentration was 
varied over the range of 2 mM to 6 mM. After a hot-start of 96°C for 5 min, Vent® 
DNA polymerase was added and the following program run over 30 cycles: 96°C 
for 75 s, 60°C for 60 s and 72°C for 3 min. A final extension step of 10 min at 
72°C was included. See Figure 4.6.
The presence of extra bands in the reaction meant that optimisation of the 
conditions was required. Using the same concentration of reactants, the 
annealing temperature was raised to 72°C, in effect producing a two-step PCR 
reaction. 30 cycles of the following program were used: 96°C for 75 s, 72°C for 
4 min. The same range of Mg2+ concentrations was used. See Figure 4.7.
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M 1 2 3
<  2.6
Figure 4.6: PCR amplification of the novobiocin resistance determinant 
from pMDS20. Key: (M) Psfl Xmarkers, (1) 2 mM Mg2*, (2) 4 mM Mg2*, (3) 6 
mM Mg2*.
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M 1 2 3
Figure 4.7: Optimised PCR amplification of the novobiocin resistance 
determinant from pMDS20. Key: (M) PsfR markers, (1) 2 mM Mg2+, (2) 4 mM 
Mg2+, (3) 6 mM Mg2+.
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The product from lane 3 (6 mM Mg2+) was gel-purified, cut with Kpn\ and Sph\ 
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Figure 4.8: pBAP5003 shuttle vector for over-expression of DHLipDH in H. 
volcanii
When pBAP5003 was transformed into the DHLipDH - minus strain of H. volcanii, 
BAS5005, the development of which is detailed in Chapter 6, DHLipDH activity 
was 0.84 ±0.14 units/mg (95% confidence level) at 30°C. This corresponds to 
an average 28-fold over-expression of enzyme activity, compared to wild type.
SDS-PAGE analysis of novobiocin-resistant transformed cells shows a 
clear band at an apparent molecular weight of 66 kD which is absent in the 
BAS5005 cell extract (Figure 4.9). One of the extracts tested had no activity, and 
in this the 66 kD band was shown to be absent on SDS-PAGE.
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Figure 4.9: SDS-PAGE of whole cell extracts from H. volcanii BAS5005 cells 
transformed with pBAP5003. Key: (M) low molecular weight markers, (1) 
BAS5005 extract, (2-6) extracts from novobiocin-resistant colonies. No 
DHLipDH activity was detected in the extract from lane 4.
4.5 Concluding remarks
The lack of success in expressing active halophilic DHLipDH in E. coli 
necessitated the investigation of other systems to attain sufficient quantities of 
the enzyme for further studies. The only reported cases of heterologous 
expression of halophilic enzymes, malate dehydrogenase from Haloarcula 
marismortui (Cendrin et a/., 1993), dihydrofolate reductase from H. volcanii 
(Blecher et al., 1993) and Hmg-CoA reductase from H. volcanii (Bischoff & 
Rodwell, 1996) produced inactive enzymes which required refolding or salt- 
activation treatments. Homologous expression of halophilic enzymes, however, 
allows the translated product to take up its natural conformation in a native 
environment and ensures that correct post-translational modifications will be 
carried out.
The level of expression achieved for halophilic DHLipDH is sufficient for 
convenient purification and structural studies. Additionally, use of the developed 
vector systems, using the halophilic rRNA promoter, should provide a suitable 
means of expression for any cloned halophilic gene.
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5. Purification and characterisation of recombinant 
halophilic DHLipDH
5.1 Introduction
DHLipDH has previously been purified from several sources, including the 
halophiles Halobacterium halobium (Danson et al., 1986; Sundquist & Fahey, 
1988) and H. volcanii (Vettakkorumakankav et al., 1992). The procedures 
utilised have included heat treatment, hydroxylapatite chromatography, 
immobilised-metal-ion chromatography, ion exchange and gel filtration. Many of 
these techniques can utilise buffers containing high salt concentrations, generally 
preferable for the purification of halophilic enzymes, although not essential in this 
case as halophilic DHLipDH is not irreversibly denatured in the absence of salt 
(Danson et al., 1986).
Overexpression of the enzyme, described in Chapter 4, has enabled 
much greater levels of enzyme to be purified from a relatively small volume of 
cells, as well as reducing the number of steps required in the purification scheme.
5.2 Development of the purification protocol
5.2.1 Heat treatment
Due to the extreme thermostability of DHLipDH from all sources studied, a heat 
step was included as the first stage of the purification procedure. Danson et al. 
(1984) showed that the enzyme from a number of halophilic sources maintained 
full activity following incubation at 95°C for 15 minutes in the presence of 4 M 




Cell extracts from H. volcanii transformed with the overexpressing 
plasmid pBAP5003 (see Chapter 4) were subjected to temperatures ranging 
from 50°C to 95°C for 10 min. No appreciable decrease in activity was detected 
following any of these treatments (84% activity was remaining following 
incubation at 95°C for 10 min). The greatest increase in specific activity was 
achieved by incubation at 95°C.
To determine the optimum incubation period, cell extracts were heated to 
95°C for times up to 10 min. They were then cooled on ice, centrifuged at full 
speed in a microfuge for 10 min to remove any precipitated protein and assayed 
for DHLipDH activity. As shown in Figure 5.1, protein was precipitated over the 
first 4-5 min with a concomitant increase in the specific activity of DHLipDH. 






— B—  Relative specific activity 






Figure 5.1: Plot showing relative specific activity of DHLipDH and the 
proportion of protein remaining following incubation of cell-free extracts at 
95°C for varying lengths of time. Values are expressed relative to those at 
time = 0 min. [Data provided by E. Rapaport (University of Bath)].
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Based on these data, a heat step of 95°C for 6 min was chosen, the specific 
activity increasing approximately 3-fold from this step.
5.2.2 Hydroxylapatite chromatography
Hydroxylapatite chromatography has been used previously in DHLipDH 
purification protocols (Danson et al., 1986). A 2.2 cm x 20 cm column of 
hydroxylapatite Bio-Gel HT was prepared as described in the Materials and 
Methods. Heat-treated sample was applied to the column in equilibration buffer 
(50 mM phosphate buffer, pH 7.0, 1 M NaCI) and was shown to bind as 
evidenced by the lack of activity in the wash (100 ml equilibration buffer at 30 
ml/h).
The enzyme was eluted early in a phosphate gradient (50 - 500 mM 
phosphate buffer, pH 7.0, 1 M NaCI). A significant increase (approximately 7- 
fold) in specific activity was achieved from this step, as can be visualised by 
SDS-PAGE (Figure 5.2)
5.2.3 Mono-Q ion exchange
Active fractions from the hydroxylapatite step were pooled and dialysed against 
20 mM Tris-HCI, pH 7.5 at 4°C to remove the NaCI. As previously mentioned, 
halophilic DHLipDH while largely inactive in the absence of salt will regain full 
activity following its reintroduction. The sample was loaded onto a Mono-Q anion 
exchange column on a Pharmacia FPLC system. Protein was eluted with a 
linear gradient of 0-2 M NaCI. It was found that most protein eluted in a single 
major peak with no resultant increase in specific activity. Consequently this step 
was not used in the final protocol.
[Data provided by E. Rapaport, University of Bath].
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Figure 5.2: SDS-PAGE showing level of purification following heat-step and 
hydroxylapatite chromatography. Key: (M) low-range molecular weight 
markers, (1) cell-free extract, (2) heat-step, (3) hydroxylapatite.
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5.2.4 Gel filtration
Active fractions pooled from the hydroxylapatite step were concentrated to a 
volume of 1 ml using a Centricon 30 concentrator and loaded onto an FPLC 
Superdex 200 gel filtration column. The sample was eluted in 50 mM phosphate 
buffer, pH 7.0, containing 1 M NaCI at 1 ml/min and 1 ml fractions were collected. 
The specific activity of DHLipDH was not significantly increased from this step 
and it was consequently not used in the final purification procedure. SDS-PAGE 
of active fractions clearly shows the presence of a major contaminating band at 
about 48 kD (Figure 5.3).
5.2.5 Cu2+ chelate chromatography
A Pharmacia Hi-Trap chelating column was used as detailed in the Materials and 
Methods. The active fractions from the hydroxylapatite step were pooled and 
applied to the Cu2+-primed column in 50 mM phosphate buffer (pH 7.0) 
containing 1 M NaCI. The sample was eluted using a 0-100 mM imidazole 
gradient. This step resulted in an approximate 2-fold increase in purity, but SDS- 
PAGE revealed the presence of a small number of contaminating proteins, albeit 
in low quantities (Figure 5.4).
Following stripping and re-priming with Cu2+, the column was re­
equilibrated with 50 mM phosphate buffer (pH 7.0) containing 1.23 M (NH4)2S04. 
The active fractions eluted from the first run were pooled and diluted 4-fold in 
equilibration buffer to lower the concentration of imidazole which would otherwise 
inhibit binding. The sample was loaded and eluted as before, but this time in 
buffer containing 1.23 M (NH4)2S04 rather than NaCI. A different elution profile 
was obtained and a further 15% increase in purity was achieved with only a small 
loss of total activity.
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Figure 5.4: SDS-PAGE of adjacent fractions eluted from the Cu2+-chelate 
column. The sample was run in buffer containing 1 M NaCI.
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5.2.6 The final protocol
It was originally decided to utilise a heat-step as the first stage of the purification 
protocol. One of the mutants described in Chapter 7, however, was found to be 
susceptible to irreversible thermal denaturation and consequently the step was 
dropped. This was done also for the purification of wild-type enzyme in order that 
there would be no differences in the methods of purification and hence direct 
comparisons of properties could be made.
The final purification procedure consisted of hydroxylapatite 
chromatography, followed by 2 runs of Cu2+-chelate chromatography in buffers 
containing NaCI and (NH4)2S 04 respectively. The product obtained following 
these steps was deemed to be over 99% pure by SDS-PAGE (Figure 5.5). The 







Protein Specific activity 
(units/mg)
Cell-extract 21.5 488 100 344 1.42
Hydroxylapatite 0.76 435 89.3 38.0 11.5
Cu2+-chelate (NaCI) 5.25 248 50.8 10.5 23.6
Cu2*-chelate [(NH4)2S04] 1.86 203 41.6 7.44 27.3
Table 5-1: Purification table for recombinant wild-type DHLipDH. Samples 
were assayed in 10 mM Tris (pH 8), 1 mM EDTA, 2 M KCI at30°C. 1 unit=1 
pmol NADH/min.
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Figure 5.5: SDS-PAGE showing each stage of the purification procedure. 
Key: (M) low-range molecular weight markers, (1) cell-free extract, (2) 
hydroxylapatite, (3) Cu2+-chelate (NaCI), (4) Cu2+-chelate [(NH4)2S04].
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5.3 Characterisation of the purified enzyme
5.3.1 Kinetic properties o f the enzyme
The recombinant enzyme was shown to follow Michaelis-Menten kinetics, with a 
Km (DHLip) of 27 ± 15 pM, Km (NAD+) of 156 ± 43 jiM and a Vmax of 19.1 ± 1.9 
units/mg (Figures 5.6, 5.7). Samples were assayed in 50 mM potassium 
phosphate buffer (pH 7) containing 1 M KCI at 30°C. The data were analysed by 
the direct linear plot of Eisenthal and Cornish-Bowden (1974). These data are 
similar to those previously published for the native enzyme (Vettakkorumakankav 
et al., 1992); Km (NAD+) of 80 ± 5 pM and a Vmax of 11.3 ± 0.1 units/mg measured 
at 25°C in 50 mM potassium phosphate (pH 7.2) containing 1 M NaCI.
10
-100 50 100 150 200 250 300-50 0
DHLip concentration (pM)
Figure 5.6: Hanes-Woolf plot showing S/Vmaxapp against dihydrolipoamide 
concentrations for recombinant halophilic DHLipDH. The points were 
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Figure 5.7: Hanes-Woolf plot showing S/Vmaxapp against NAD+ 
concentrations for recombinant halophilic DHLipDH. The points were 
calculated from direct linear plots using five concentrations of DHLip at five 
concentrations of NAD*.
5.3.2 Salt optima
The enzyme was assayed over a range of salt concentrations in 50 mM 
phosphate buffer (pH 7) at 30°C. The activities in both NaCI (Figure 5.8) and KCI 
(Figure 5.10) were determined. NaCI was used in order to be able to make direct 
comparisons between the recombinant enzyme with previously published data 
for the native enzyme. KCI was used because activity in this salt is more relevant 






Figure 5.8: Sait activity profile of recombinant halophilic DHLipDH (NaCI)
The optimum concentration of NaCI at pH 7 was shown to be approximately 1.5 
M for the recombinant enzyme. Previously published data for the wild-type 
enzyme has an optimum concentration of 1 M, under similar conditions, with a 
significantly greater reduction of activity in the higher concentrations of salt 
(Vettakkorumakankav et al., 1992). In order to determine whether this was a 
genuine difference between the native and the recombinant enzyme, the NaCI 
activity profile was repeated using wild-type whole-cell extract (Figure 5.9). The 















Figure 5.10: Salt activity profile of recombinant halophilic DHLipDH (KCI)
105
The optimum concentration of KCI at pH 7 was found to be approximately 1.5 M, 
the same as for NaCI. Above this concentration, activity remains near maximum 
with only a slight loss as KCI levels increase.
5.3.3 pH optimum
The enzyme was assayed over the range of pH 4-10 (Figure 5.11). The buffers 
used were 50 mM acetate (pH 4-6), 50 mM phosphate (pH 6-8) and 50 mM Tris 
(pH 8-10), each containing 1 M KCI. The enzyme exhibited slightly different 
specific activities in each buffer at equivalent pH, with the activity in phosphate 
1.39 times that of the activity in acetate; the activity in Tris was 1.02 times the 
activity in phosphate. Consequently, the profile was normalised to activity in 
phosphate buffer, chosen because this was the buffer used for pH 7 which is the 
physiological condition. For this reason, phosphate buffer was used for the other 
characterisation assays, allowing direct comparison of results across the assays. 
Optimal activity was found between pH 8.5 and 9, consistent with data for the 




Figure 5.11: Normalised pH profile of recombinant DHLipDH
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5.3.4 UV-visible absorption spectrum
A UV-visible absorption spectrum of purified recombinant DHLipDH confirmed 
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Figure 5.12: UV-visible absorption spectra of oxidised recombinant 
DHLipDH and FAD. The peaks at approximately 375, 460 and 485 nm are 
characteristic of a flavin cofactor.
5.4 Crystallisation trials
Crystallisation trials of the purified recombinant enzyme were carried out using 
the hanging drop vapour diffusion procedure (McPherson, 1990) outlined in the 
Materials and Methods section. Crystal Screen™ (Hampton Research) reagents 
were used as the precipitating solutions (Table 5-2). Trials were conducted with 
the enzyme in 50 mM potassium phosphate buffer (pH 7) and either 1 M KCI or 
10% (v/v) glycerol. The trials were left at room temperature for a few weeks.
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Tube Salt Buffer Precipitant
1 0.02M CaCI2 0.1 MNa acetate pH 4.6 30% 2-methyl-2,4-pentanediol
2 None None 0.4M K, Na tartrate
3 None None 0.4M Ammonium dihydrogen 
phosphate
4 None 0.1 M Tris-HCI pH 8.5 2.0M Ammonium sulphate
5 0.2M tri-sodium citrate 0.1 MNa Hepes pH 7.5 30% 2-methyl-2,4-pentanediol
6 0.2M MgCI2 0.1 M Tris-HCI pH 8.5 30% PEG 4000
7 None 0.1 M Na cacodylate pH 6.5 1,4M Na acetate
8 0.2M tri-sodium citrate 0.1 M Na cacodylate pH 6.5 30% 2-propanol
9 0.2M Ammonium acetate 0.1 M Na citrate pH 5.6 30% PEG 4000
10 0.2M Ammonium acetate 0.1 M Na acetate pH 4.6 30% PEG 4000
11 None 0.1 M Na citrate pH 5.6 1,0M Ammonium dihydrogen 
phosphate
12 0.2M MgCI2 0.1 MNa Hepes pH 7.5 30% 2-propanol
13 0.2M tri-sodium citrate 0.1 M Tris-HCI pH 8.5 30% PEG 400
14 0.2M CaCI2 0.1 M Na Hepes pH 7.5 28% PEG 400
15 0.2M Ammonium sulphate 0.1 M Na cacodylate pH 6.5 30% PEG 8000
16 None 0.1 MNa Hepes pH 7.5 1.5M Lithium sulphate
17 0.2M Lithium sulphate 0.1 M Tris-HCI, pH 8.5 30% PEG 4000
18 0.2M Mg acetate 0.1 M Na cacodylate pH 6.5 20% PEG 8000
19 0.2M Ammonium acetate 0.1 M Tris-HCI, pH 8.5 30% 2-propanol
20 0.2M Ammonium sulphate 0.1 M Na acetate pH 4.6 25% PEG 4000
21 0.2M Mg acetate 0.1 M Na cacodylate pH 6.5 30% 2-methyl-2,4-pentanediol
22 0.2M Na acetate 0.1 M Tris-HCI pH 8.5 30% PEG 4000
23 0.2M MgCI2 0.1 M Na Hepes pH 7.5 30% PEG 400
24 0.2M CaCI2 0.1 M Na acetate pH 4.6 20% 2-propanol
25 None 0.1 M Imidazole pH 6.5 1 0M Na acetate
26 0.2M Ammonium acetate 0.1 M Na citrate 30% 2-methyl-2,4-pentanediol
27 0.2M tri-sodium citrate 0.1 MNa Hepes pH 7.5 20% 2-propanol
28 0.2M Na acetate 0.1 M Na cacodylate pH 6.5 30% PEG 8000
29 None 0.1 MNa Hepes pH 7.5 0.8M K, Na tartrate
30 0.2M Ammonium sulphate None 30% PEG 8000
31 0.2M Ammonium sulphate None 30% PEG 4000
32 None None 2.0M Ammonium sulphate
33 None None 4.0M Na formate
34 None 0.1 M Na acetate pH 4.6 2.0M Na formate
35 None 0.1 M Na Hepes pH 7.5 0.8M Na phosphate, 0.8M K 
phosphate
36 None 0.1 M Tris-HCI pH 8.5 8% PEG 8000
37 None 0.1 M Na acetate pH 4.6 8% PEG 4000
38 None 0.1 MNa Hepes pH 7.5 1 4M Na citrate
39 None 0.1 M Na Hepes pH 7.5 2% PEG 400 & 2.0M Ammonium 
sulphate
40 None 0.1 M Na citrate pH 5.6 20% 2-propanol & 20% PEG 4000
41 None 0.1 M Na Hepes pH 7.5 10% 2-propanol & 20% PEG 4000
42 0.05M K phosphate 
monobasic
None 20% PEG 8000
43 None None 30% PEG 1500
44 None None 0.2M Mg formate
45 0.2M Zn acetate 0.1 M Na cacodylate pH 6.5 18% PEG 8000
46 0.2M Ca acetate 0.1 M Na cacodylate pH 6.5 18% PEG 8000
47 None 0.1 M Na acetate pH 4.6 2.0M Ammonium sulphate
48 None 0.1 M Tris-HCI pH 8.5 2.0M Ammonium dihydrogen 
phosphate
49 1.0M Lithium sulphate None 2% PEG 8000
50 0.5M Lithium sulphate None 15% PEG 8000
Table 5-2: The Crystal Screen™ reagents used in the initial trials (Hampton
Research)
In the absence of salt many of the trials produced a precipitate, but in a number 
of these small irregular crystals could be seen. One of the best examples of
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these was in trial 45. A larger irregular crystal, along with a smaller more regular 
crystal, was seen in trial 23, also in the absence of salt. In the presence of salt, 
trial 16 produced hundreds of micro-crystals, and trial 23 produced a number of 
larger, more regular, crystals. These can be seen in Figure 5.13. Using the 
conditions in this trial as a starting point, a future project will hopefully yield 
crystals suitable for X-ray diffraction. Time constraints prevented further 
optimisation.
5.5 Concluding remarks
The purification scheme detailed in this chapter provides a suitable means of 
isolating overexpressed DHLipDH from halophilic sources. The absence of a 
heat-step in the protocol means that heat-labile mutants can be purified without 
modification of the procedure. The characterisation of the recombinant DHLipDH 
demonstrates that its properties are indistinguishable from those of the non­
recombinant enzyme.
I gratefully acknowledge the significant contribution made by Elizabeth 
Rapaport, whose undergraduate final year project was involved with the 
purification of halophilic DHLipDH (Rapaport, 1995). I am also thankful for the 
help received from Dr. Rupert Russell (University of Bath) in the setting up of the 
crystallisation trials.
109
Trial 45 (glycerol) Trial 16 (KCI)
Trial 23 (glycerol) Trial 23 (KCI)
Figure 5.13: Crystals of halophilic DHLipDH
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6. Creation of a DHLipDH - minus strain of H. volcanii
6.1 Introduction
6
In order to express mutant DHLipDH within H. volcanii without host background 
enzyme activity, a strain needed to be developed with the gene inactivated. 
Creation of the strain was done by Dr. M. Dyall-Smith (University of Melbourne, 
Australia) as part of a collaboration and sent to Bath for assay and confirmation 
of gene disruption (Jolley et al. 1996).
6.2 Insertional inactivation of the DHLipDH gene
To create a strain with an inactive DHLipDH gene, a plasmid was constructed 
which carried a mevinolin-resistance marker (MevR) inserted into the unique Xho\ 
site within the coding region (nt 593-598 of the published sequence). This was 
introduced into H. volcanii cells and allowed to recombine at the DHLipDH locus. 
The plasmid was constructed as detailed in Figure 6.1 and its legend. Mevinolin- 
resistant transformants were selected. Recombination at the HmgCoA reductase 
locus was also possible and would lead to mevinolin-resistant colonies, but it 
would destroy an Mlu\ site in the wild-type HmgCoA reductase gene. Presence 
of an intact wild-type HmgCoA reductase locus was confirmed by digesting 
chromosomal DNA with Mlu\ and probing with a MevR gene. Transformants 
lacking DHLipDH activity were designated strain BAS5005.
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Figure 6.1: Insertional inactivation 
of the DHLipDH gene. The 4.3 kb 
insert from plasmid pNAT82 was 
excised with H/ndlll and Xbal and 
ligated to H/ndlll-Xbal-cut pUC18 
(A). Plasmid pMDS51 (B), 
containing a mevinolin resistance 
marker, was cut with Xhol and 
ligated to the Xhol-cut pUC18 clone, 
thus inserting pMDS51 into the 
open reading frame of the DHLipDH 
gene. The E. coli plasmid 
component of the inserted pMDS51 
was removed by Spel digestion, 
thus leaving only the mevinolin 
resistance marker (C). The 
resulting plasmid was linearised at 
the H/ndlll site and introduced into 
H. volcanii cells (D).
6.3 Confirmation of DHLipDH gene disruption
Correct construction of the mutant strain was confirmed by PCR. PCR primers 
were designed to bind approximately 200 bp either side of the Xhol insertion site 
within the DHLipDH gene.
KAJ-8 (nt 381-399): 5’ tcgagaagctctgtaaggc 3’ (19-mer)
KAJ-9 (nt 786-768): 5’ atgtcgatgccgagctctt 3’ (19-mer)
Genomic DNA from both wild-type and the mutant strain was prepared as 
detailed in the Materials and Methods and the following PCR program run with 
primers KAJ-8 and KAJ-9: 96°C for 5 min followed by addition of Vent® DNA 
polymerase, then 30 cycles of 96°C for 75 s, 37°C for 90 s, 72°C for 5 min. A 
final extension step of 72°C for 10 min was included.
With wild-type gDNA, a band of 400 bp was obtained consistent with an 
intact DHLipDH gene. With gDNA from the mutant strain, however, a band of 
approximately 2.3 kb was obtained consistent with disruption of the DHLipDH 
gene with the mevinolin resistance marker (Figure 6.2). The 2.3 kb band was of 
a lower intensity than the 400 bp band due to less efficient amplification of longer 
sequences.
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Figure 6.2: PCR analysis of BAS5005 (DHLipDH - minus strain of H. 
vo lea nil). Key: (M) 1 kb ladder, (1) wild-type gDNA, (2) BAS5005 gDNA, (3) 
wild-type gDNA
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6.4 Enzyme assays of the DHLipDH - minus strain
The mevinolin-resistant cells were assayed for DHLipDH activity. As a control, 
the citrate synthase activities were also determined to show that a reduction in 
the level of DHLipDH activity was not accompanied by a large overall reduction in 
protein synthesis. Out of four transformants tested, two had completely lost 
DHLipDH activity (Figure 6.3).
■  DHLipDH activity 
□  CS activity
Transformant number
Figure 6.3: DHLipDH and citrate synthase activities of four mevinolin- 
resistant transformants.
All the transformants tested had levels of citrate synthase activity approximately 
80% of those of wild-type. Transformants #3 and #6 had no detectable DHLipDH 
activity, while #8 had approximately 28% wild-type activity. Interestingly, 
transformant #12 had a DHLipDH activity of 157% of wild-type levels. The levels 
of expression seen in transformants #8 and #12 may be the result of 
modifications in the spacing of control elements due to recombination events 
upstream of the DHLipDH coding region. Transformant #3 was designated strain 
BAS5005.
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An alternative, although highly unlikely, explanation for the loss of 
DHLipDH activity in transformants #3 and #6 is the activation of an inhibitor of 
DHLipDH or the switching on of a dehydrogenase that rapidly uses up any 
available NAD+. If such a scenario was occurring, one would expect a significant 
reduction in the DHLipDH activity in the cell-free extract of transformant #12 
when mixed with the extract of #3 or #6. This was not observed, effectively ruling 
out such a conclusion.
The DHLipDH - minus strain (BAS5005) was transformed to DHLipDH - 
plus by introduction of plasmid pBAP5003 (see Chapter 4), which contains the 
DHLipDH gene under control of a rRNA promoter. Transformation of the strain 
with pMDS21, which contains the DHLipDH gene with no additional promoter, 
yielded no enzyme activity. This confirms that the DHLipDH gene is not 
expressed from the putative Box A promoter, unless additional enhancer 
elements are required.
6.5 Concluding remarks
Creation of a H. volcanii strain lacking a functional DHLipDH gene enables the 
homologous expression of mutant DHLipDH proteins, without the masking 
presence of wild-type activity. A potential problem is that as the DHLipDH gene 
has been interrupted, but not deleted, the possibility exists for an incoming 
plasmid containing a DHLipDH gene to recombine at the chromosomal 
sequence. In practice this was found not to be a problem.
Ideally, it would be preferable to delete the chromosomal DHLipDH gene 
entirely. The difficulty with achieving this is that the gene is right at one end of the 
original pNAT82 clone, meaning that there is very little flanking DNA to allow 
recombination back with the chromosomal locus.
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The presence of the MevR marker within the DHLipDH gene has the 
advantage of maintaining strain selection. This does mean, of course, that to 
select plasmids within the strain another antibiotic marker must be used. The 
novobiocin resistance gene (NovR), used in the creation of the overexpressing 
plasmid pBAP50G3, is a suitable candidate.
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7. Site-directed mutagenesis of halophilic DHLipDH
7.1 Introduction
With the creation of a plasmid for homologous overexpression and a strain of H. 
volcanii lacking DHLipDH activity, the tools are in place for the production of 
mutants of the enzyme.
The molecular model of halophilic DHLipDH, described in the Introduction 
(Dr. R.J.M. Russell, University of Bath, unpublished) was used to identify features 
that may play a role in conferring halophilicity to the protein. As with other 
halophilic proteins a large negative surface charge, that would be shielded at 
elevated salt concentrations, was the predominant characteristic. Since 
mutagenesis of a significant proportion of these surface residues would be a 
monumental task, other features that are at variance with the non-halophilic 
structures were sought.
7.2 A putative K+-binding site and design of mutants
Using the program GRID (Molecular Discovery Ltd.), a search was made of the 
structure for K+-binding sites. GRID determines energetically-favourable binding 
sites for a small probe on a target molecule of known three-dimensional structure 
(Goodford, 1985). The strongest potential site was found at the dimer interface, 
and had a predicted binding energy of -88 kcal/mol, compared to -57 kcal/mol in 
the P. fluorescens structure. The site consists of four coordinated glutamate 
residues, two from each monomer (Figure 7.1). The nearest catalytic cysteine is 
17A away (measured between the a-carbons). Figure 7.2 shows a 
representation of the molecule, with the position of the putative K+-binding site 
and the catalytic residues.
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Figure 7.1: The putative K* binding site, consisting of four coordinated 
glutamate residues.
Figure 7.2: Molecular model of H. volcanii DHLipDH, based on the structure 
from Pseudomonas fluorescens. The catalytic cysteines and histidines are 
coloured yellow and pale blue respectively. The binding sites of the FAD 
cofactor adenine are coloured magenta and the putative K* binding site is 
coloured red.
One of the glutamate residues, E426, is conserved throughout most of the
sequences available, and in the two cases where it is not it is replaced by the 
similarly-charged aspartate. The other glutamate, E423 however, is only present 
in the H. volcanii structure (Figure 7.3).
423 426
Haloferax volcanii SGFVLGAQIV GPEASELIAE LAFAIEMGAT 
Pseudomonas fluorescens TDRVLGVHVI GPSAAELVQQ GAIGMEFGTS 
Azotobacter vinelandii TDRVLGVHVI GPSAAELVQQ GAIAMEFGTS 
Bacillus stearothermophilus DGVIIGAQII GPNASDMIAE LGLAIEAGMT 
Bacillus subtilis DGLVIGAQIA GASASDMISE LSLA1EGGMT 
Escherichia coli SHRVIGGAIV GTNGGELLGE IGLAIEMGCD 
Garden Pea TDKILGVHIM APNAGELIHE AAIALQYDAS 
Human TDRVLGAHIL GPGAGEMVNE AALALEYGAS 
Pig TDRVLGAHII GPGAGEMINE AALALEYGAS 
Pseudomonas putida 1 NHLILGWQAV GVAVSELSTA FAQSLEMGAC 
Pseudomonas putida 2 TDRVLGVHVI GPSAAELVQQ GAIAMEFGTS 
Pseudomonas putida 3 TDEVLGVHLV GPSVSEMIGE FCVAMEFSAS 
Saccharomyces cerevisiae TERILGAHII GPNAGEMIAE AGLALEYGAS 
Trypanasoma brucei brucei TDRILGVHIV CSAAGELIAG ALLAMEYGAS
Figure 7.3: Alignment of available DHLipDH sequences, showing the
putative K* binding site residues, E423 and E426. Residues appearing in
half or more of the sequences are shaded.
It was decided to mutate residue E423 in order to investigate the role of the site 
in conferring halophilicity and stability to the enzyme. Four mutations were 
chosen:
E423S - serine is the residue present in the P. fluorescens structure on which the 
model was based.
E423Q - glutamine is similarly-sized to glutamate but without a negative charge. 
E423D - aspartate has the same charge as glutamate but is smaller.
E423A - alanine is a small aliphatic residue.
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GRID analysis of the energy minimised mutant structures predicted the following 
binding energies at the K+-binding site: E423S: -80 kcal/mol, E423Q: -83 
kcal/mol, E423D: -82 kcal/mol, E423A: -80 kcal/mol, compared with -88 kcal/mol 
for the wild-type.
7.3 Mutagenesis
7.3.1 The Altered Sites9 II in vitro mutagenesis system
The Altered Sites® II mutagenesis system (Promega) uses antibiotic selection as 
a means to obtain a high frequency of mutants (Figure 7.4). The gene to be 
mutated is cloned into the pALTER-1 vector, which contains tetracycline and 
ampicillin resistance genes. The ampicillin resistance gene, though, is inactive 
due to a frame-shift mutation. An ampicillin resistance repair oligonucleotide, 
which is annealed to the single-stranded, or denatured double-stranded, template 
at the same time as a mutagenic oligonucleotide restores ampicillin resistance 
and enables selection. Following synthesis of the second strand with T4 DNA 
polymerase and T4 DNA ligase, the plasmid is transformed into E. coli cells. The 
mutagenic oligonucleotide is present in greater quantities than the repair 
oligonucleotide in the reaction, so providing both anneal with similar affinity, a 
large proportion of the transformants resistant to ampicillin should contain mutant 
genes.
Initially, the mutagenesis reaction is transformed into a repair-minus strain 
of E. coli (ES1301 mutS) to avoid selection against the mutation. Strain transfer 
into JM109 cells subsequently ensures proper segregation of mutant and wild- 
type plasmids.
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1. Clone insert into pALTER-1 vector
2. Isolate dsDNA
insert
3. Alkaline denature and anneal 
mutagenic and ampicillin 
 ^^  repair oligonucleotides.
Mutagenic oligo
4. Synthesise mutant strand with 
T4 DNA polymerase and 
T4 DNA ligase
Amp repair oligo
Figure 7.4: The Altered Sites® II in vitro mutagenesis procedure (Promega)
123
7.3.2 Cloning of halophilic DHLipDH into pALTER-1
A maxiprep of pALTER-1 was prepared from JM109 cells transformed with the 
plasmid. This was restricted with BamHI and Kpnl. The DHLipDH insert was 
excised from the overexpressing plasmid pMDS24 with the same enzymes. 
Following gel purification of both fragments, the DHLipDH insert was ligated into 
the vector and the resultant construct transformed into JM109 cells. 
Recombinant colonies were selected by plating on LB plates containing 12.5 pg 
tetracycline/ml, 0.5 mM IPTG and 40 pg X-Gal/ml. White colonies were picked 
and plasmids prepared from them. These were linearised with BamHI to check 
for the presence of the insert (Figure 7.5). The pALTER-1 vector with the 
DHLipDH insert was designated pBAP5004.
7.3.3 Mutagenesis reactions
Four mutagenic oligonucleotides were designed to change residue E423. In the 
list below, the mutant codon is in bold.
KAJ-12 (E423Q): 5’ tcggaggcctgggggccgac 3’ 20-mer
KAJ-13 (E423S): 5’ gagttcggaggccgaggggccgacgatt 3’ 28-mer 
KAJ-14 (E423D): 5’ ttcggaggcgtcggggccgac 3’ 21-mer
KAJ-15 (E423A): 5’ tcggaggccgcggggccgac 3’ 20-mer
The mutagenesis reactions were carried out as detailed in the kit manufacturer’s 
instructions, but two modifications were required before the procedure worked.
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M 1 2 3 4
< 7.3 kb 
*  5.7 kb
Figure 7.5: Cloning of DHLipDH into pALTER-1. Key: (M) 1 kb ladder, (1) 
pALTER-1 uncut, (2) pALTER-1 cut with BamHI, (3) pBAP5004 uncut, (4) 
pBAP5004 cut with BamHI
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The first step of the procedure requires alkali-denaturation of the double-stranded 
target DNA. The denaturation conditions were changed from 5 min at room 
temperature to 20 min at 37°C. Prior to changing this, no ampicillin resistant 
colonies were obtained.
The second problem with the procedure was the level of competence of 
the E. coli ES1301 mutS strain. Use of the RbCI / CaCI2 (recommended by 
Promega), CaCI2) or TSS transformation methods, outlined in the Materials and 
Methods, failed to produce competent cells. Another repair-minus strain of E. 
coli, BMH 71-18 mutS, was tried and was successfully made competent using 
the TSS method.
Following the mutagenesis reaction, transformation into BMH 71-18 mutS, 
and strain transfer to JM109 cells, plasmid DNA was prepared and manually 
sequenced. Only one of the reactions resulted in a mutant gene, KAJ-13 
(E423S), while the rest resulted in wild-type. After a number of unsuccessful 
attempts at producing the remaining mutants, new oligonucleotides were 
designed based on KAJ-13. The oligonucleotides also contained a silent 
mutation that would introduce an Apa\ restriction site. This enabled mutants to 
be screened by restriction, rather than by sequencing.
Apa\
KAJ-17 (E423Q): 5’ gagttcggaggcctgggggcccacgatttgcg 3’ 32-mer
KAJ-18 (E423D): 5’ gagttcggaggcgtcggggcccacgatttgcg 3’ 32-mer
KAJ-19 (E423A): 5’ gagttcggaggccgcggggcccacgatttgcg 3’ 32-mer
Using these new oligonucleotides, the remaining mutants were obtained. These 
were confirmed by restriction screening and manual sequencing (Figure 7.6).
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Wild type 
G A T C
Figure 7.6: Sequencing reactions of the wild-type and mutant genes. The mutant codon is in bold.
7.4 Homologous expression of mutants
All the mutant genes were cut out of the mutagenesis vector with BamHI and 
Kpnl. They were then gel-purified. The wild-type overexpressing plasmid, 
pBAP5003, was similarly cut, purified and the mutant genes ligated in, using a 2 
hour, room temperature incubation. The new constructs were transformed into 
competent E. coli JM109 cells in order to produce enough DNA for 
transformation into H. volcanii. The constructs were designated pBAP5005 
(E423S), pBAP5006 (E423Q), pBAP5007 (E423D) and pBAP5008 (E423A).
Minipreps from the transformed JM109 cells were restriction-digested to 
check the size and the presence of the insert. Plasmids were cut with Kpnl, 
H/ndlll and EcoRI. In all cases, the Kpnl and EcoRI digestions produced bands 
of the same size as with pBAP5003, consistent with the successful ligation of the 
insert into the vector. There was, however, a discrepancy with the H/ndlll 
digestion. pBAP5003, the original expression plasmid, produced three bands on 
a gel when cut with H/ndlll, the mutant plasmids all produced a doublet (Figure 
7.7). From looking at the pBAP5003 plasmid map (Figure 4.8), it appeared that 
the H/ndlll site upstream of the promoter was missing. The explanation for this 
came from studying Lam’s original paper (Lam & Doolittle, 1989) which details 
construction of pWL102, the precursor to pMDS24 and hence to pBAP5003. A 
BamHI site was present just upstream of the H/ndlll site near the promoter. This 
site had been overlooked and omitted from the restriction map. The effect of this 
was that cutting out the wild-type DHLipDH gene from pBAP5003 with BamHI 
and Kpnl, resulted in removal of the promoter. Not surprisingly, when 
transformed into H. volcanii BAS50005 (DHLipDH - minus), none of the mutant 
constructs resulted in expression of active enzyme.









Figure 7.7: Restriction digests of pBAP5005 and pBAP5003. Key: (M) 1kb 
ladder, (1) uncut pBAP5005, (2) uncut pBAP5003, (3-4) Kpnl cut pBAP5005 
and pBAP5003, (5-6) H/ndlll cut pBAP5005, producing a doublet (visible 
under transillumination but appearing as a single band in the photograph), 
and pBAP5003, (7-8) EcoRI cut pBAP5005 and pBAP5003. The other mutant 
























Figure 7.8: Revised restriction map of pBAP5003, showing a previously 
overlooked BamHI site upstream of the promoter. Note also the presence 
of a unique Nco\ site next to the BamHI site.
In order to get expression of the mutants two possibilities presented themselves. 
Either the BamHI site upstream of the promoter in pBAP5003 needed to be 
removed, or the mutated region of the DHLipDH gene could be exchanged with 
the wild-type part using a unique site within the gene, upstream of the mutated 
site, and Kpnl. No such site was present, however, leaving removal of the 
BamHI site the only option. Removal of this site also has the advantage that, in 
the future, other halophilic genes could easily be cloned into the vector for 
expression.
There is a unique A/col site overlapping the BamHI site. This was highly 
advantageous as it facilitated a theoretically-simple means of removing the 
BamHI site, as outlined in Figure 7.9.
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BamHI cuts at GGATCC 




cr cT A T G G
C C T A G |G
BamHI
T A C jC
Ncol
Cut with A/col
G G A T C  C A T G G
C C T A G G T A C  C
Blunt-end with mung bean nuclease
G G A T C  G
C C T A G C
Ligate
G G A T C G 
C C T A G C
Figure 7.9: Removal of BamHI site from pBAP5003. The BamHI site 
overlaps with a unique NcoI site. The vector is cut with Ncol and blunt- 
ended with mung bean nuclease, removing the terminal nucleotide from the 
BamHI recognition site. The blunt ends are then re-ligated, destroying both 
the Nco I and BamHI sites. The vector is incubated with Nco\ prior to 
transformation to linearise any plasmid still retaining the site.
In theory, this procedure should have been relatively straightforward. In practice, 
however, optimisation was required. In the first attempt, mung bean nuclease 
was used at a concentration of 1 unit/pg DNA and incubated for 30 min at 30°C, 
as recommended by the supplier. After transformation, plasmids from 12 
colonies were checked for the presence of the A/col site by restriction screening; 
none had lost it.
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The nuclease incubation time was increased to 1 hour, and increased 
concentrations of A/col and incubation time were used to ensure complete 
digestion. This time, out of twelve colonies checked, nine still had the site. Out 
of the three that had lost the site, however, two of the plasmids were significantly 
smaller than expected; up to 3 kb of the plasmid having been digested by the 
nuclease (Figure 7.10). The other preparation, though, was the correct size. The 
presence of the intact promoter was inferred by cutting with H/ndlll and observing 
three bands when run on a gel. This showed that the H/ndlll site between the 
promoter and the lost A/col site was still there, and hence so would be the 
promoter.
The plasmid cured of the BamHI site was designated pBAP5009. This 
plasmid was cut with BamHI and Kpnl and the mutant genes cloned in. The 
mutant constructs were then transformed into E. coli JM109 cells and plasmid 
DNA purified. Apal screening and manual sequencing confirmed the mutations. 
The new constructs were designated pBAP5010 (E423S), pBAP5011 (E423Q), 
pBAP5012 (E423D) and pBAP5013 (E423A).
H. volcanii BAS5005 (DHLipDH - minus) was transformed with the mutant 
constructs. Transformants were selected by growth in top agar containing 4 pg 
mevinolin/ml (selective for strain) and 0.3 pg novobiocin/ml (selective for 
plasmid).
Preliminary assays on cell-free extracts of the transformants indicated 
expression of active DHLipDH.
132
Figure 7.10: Restriction screening of plasmids following attempted removal 
of BamHI and Nco\ sites. Plasmids were cut with Kpnl and Nco\, which 
cuts out the DHLipDH insert in plasmids containing the Nco\ site. This 
results in a 1.7 kb band as seen in most lanes. The plasmids in lanes 5,6 
and 9 have lost the Nco I and BamHI sites, but only the plasmid in lane 6 is 
the right size.
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7.5 Purification of the mutant enzymes
The mutant enzymes were purified from 1 litre of culture in the same manner as 
the wild-type enzyme, as detailed in Chapter 5. Preliminary investigation of the 
thermostability of the mutants showed that E423D was significantly less stable 
than wild-type, necessitating removal of the heat-step in the original purification 
scheme. Figure 7.11 shows SDS-PAGE gels of each stage of the purification.












cell-free extract 21.96 16 146 100 351 0.42
Hydroxylapatite 3.39 13.32 115 78.7 45.2 2.55
Cu2+ (NaCI) 5.20 5.5 90 61.2 28.6 3.13
Cu2+ [(NH4)2S04] 2.52 3.0 71 48.5 7.56 9.38
E423Q
cell-free extract 24.43 16 180 100 391 0.46
Hydroxylapatite 3.90 13.32 140 77.5 51.9 2.69
Cuz+ (NaCI) 0.59 18.0 102 56.4 10.6 9.58
Cu2+ f(NH4)2S04] 3.02 3.0 85 47.3 9.06 9.41
E423D
cell-free extract 24.64 16 369 100 394 0.94
Hydroxylapatite 2.34 40 284 76.9 93.6 3.04
Cuz+ (NaCI) 9.30 2.5 143 38.8 23.3 6.17
Cuz+ f(NH4)2S04] 1.94 3.0 153 41.4 5.82 26.3
E423A
cell-free extract 22.52 16 136 100 360 0.38
Hydroxylapatite 1.17 23.3 70 51.3 27.3 2.56
Cuz+ (NaCI) 4.57 2.0 44 32.3 9.14 4.82
Cu2* I(NH4)2S04] 1.52 3.0 48 35.5 4.56 10.6
Wild-type
cell-free extract 21.47 16 488 100 344 1.42
Hydroxylapatite 0.76 50 435 89.3 38.0 11.5
Cuz+ (NaCI) 5.26 2.0 248 50.8 10.5 23.6
Cu2+T(NH4)2S04] 1.86 4.0 203 41.6 7.44 27.3
Table 7-1: Purification table for mutant and recombinant wild-type
halophilic DHLipDH. Samples were assayed in 10 mM Tris (pH 8), 1 mM 
EDTA, 2 M KCI at 30°C.
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Figure 7.11: SDS-PAGE gels showing the purification of the mutants. Key: 
(M) low-range molecular weight markers, (1) cell-free extract, (2) 
hydroxylapatite, (3) Cu2‘ -chelate (NaCI), (4) Cu2*-chelate [(NH4)2S04]
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7.6 Characterisation of mutants
7.6.1 Kinetic parameters
Kinetic parameters were determined in 50 mM potassium phosphate buffer, pH 
7.0, containing 1 M KCI. Assays were at 30°C. All measurements were done in 
triplicate and the direct linear plot of Eisenthal and Cornish-Bowden (1974) was 
used to determine Km and Vmax values, shown in Table 7-2 below.
Km (DHLip) Km (NAD+) V niax
Wild type 26.9 ±14.6 pM 156 ±43 pM 19.1 ±1.9 U/mg
E423S 23.0 ± 3.3 uM 211 ±54 pM 5.8 ± 0.4 U/mg
E423Q 22.8 ±5.4 pM 203 ± 73 pM 6.4 ± 0.8 U/mg
E423D 26.6 ± 5.4 uM 199 ±28 pM 16.2 ±0.8 U/mg
E423A 10.7 ±4.8 pM 215 ±47 pM 6.2 ±0.4 U/mg
Table 7-2: Kinetic parameters of recombinant wild-type and mutant
halophilic DHLipDH
The mutants, with the exception of E423D, were significantly less active than 
wild-type, whereas Km differences are not significant in most cases. One 
exception is the E423A mutant, which has an increased affinity for 
dihydrolipoamide.
7.6.2 Salt optima
Salt profiles of the mutants were determined in 50 mM potassium phosphate 
buffer, pH 7.0. Assays in both NaCI (Figure 7.12) and KCI (Figure 7.13) were 










Figure 7.12: Salt activity profiles for wild-type and mutant halophilic 










Figure 7.13: Salt activity profiles for wild-type and mutant halophilic 
DHLipDH (KCI). Error bars show the 95% confidence limits.
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The activity profiles were similar in NaCI and KCI. Interestingly, the 
profiles show little difference in the activity of mutants E423S/Q/A upon increase 
of salt concentration. This is a significant loss of the* activating effect of salt. The 
E423D mutant has practically no activity in the absence of salt, but is activated to 
levels approaching those of wild-type on its addition..
The optimum salt concentration (either salt;) for E423D was found to be
1.5 M, the same as the wild-type enzyme.
7.6.3 pH optima
The pH profiles for the mutants were characterise^ over a pH range of 4 to 10 
(Figure 7.14). Three buffer systems were used to attain this range; acetate (pH 
4-6), phosphate (pH 6-8) and Tris (pH 8-10), all at 50 mM and containing 1 M 
KCI. Profiles were normalised to activity in phosphate buffer.
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-o - Wild type
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E423Q
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Figure 7.14: Normalised pH profiles of mutaintand recombinant wild-type 
DHLipDH. Error bars show the 95% confide nee limits.
The mutants all have a pH optimum of 8.5, unchanged from that of wild-type, 
which would suggest no difference in the electrostatic potential around the 
catalytically-important residues.
7.6.4 Thermal stability
Thermal stability studies were done both in the presence and absence of salt. 
Tubes containing 5 pg of protein in a volume of 100 pi were heated in thin-walled 
PCR reaction tubes in a heating block, for times up to 1 hour. Heat transfer was 
found to be equivalent to using glass tubes in a PEG bath. The temperature in a 
control tube was monitored constantly, and when it reached within 1°C of the 
required temperature the t=0 tube was removed and the timing started. The time 
required to reach temperature was under 2 minutes. Following removal from the 
heating block, the tubes were cooled rapidly on ice.
The tubes were briefly centrifuged before assaying at 30°C in triplicate. 
Activity values were expressed as a percentage of the t=0 value. Logarithmic 
plots of the inactivations were used to determine the first-order rate constants of 
inactivation, which were used to display the data on an Arrhenius plot.
7.6.4.1 Stability in the presence of salt
Heat inactivations were done in 50 mM potassium phosphate buffer, pH 7.0, 
containing 2 M KCI (Figure 7.15).
The thermal stability properties of the enzyme are comparable in mutants 
E423S/Q/A to those of wild-type, although if anything they appear to be slightly 
more stable. Mutant E423D, however, is inactivated at temperatures around 





































Figure 7.15: Logarithmic plots of heat-inactivations of mutant and 











Figure 7.16: Arrhenius plot for the thermal inactivation of wild-type and 
mutant halophilic DHLipDH in the presence of 2 M KCI. For clarity, linear 
regressions are shown only for wild-type and E423D.
7.6.4.2 Stability in the absence of salt
Heat inactivations were also carried out in 50 mM potassium phosphate buffer, 
pH 7.0, containing no salt (Figure 7.17).
As was the case in the presence of salt, the thermal stability properties of 
mutants E423S/Q/A are comparable to those of wild-type, while mutant E423D is 
inactivated at temperatures just over 20°C lower. Again, it appears that the 
mutants E423S/Q/A may be slightly more thermostable than the wild-type 
enzyme. This can be see in the Arrhenius plot in Figure 7.18.
The mutants and the wild-type are less thermostable in the absence of 
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Figure 7.17: Logarithmic plots of heat-inactivations of mutant and 
recombinant wild-type halophilic DHLipDH in the absence of salt
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Figure 7.18: Arrhenius plot for the thermal inactivation of wild-type and 
mutant halophilic DHLipDH in the absence of salt. For clarity, linear 
regressions are shown only for wild-type and E423D.
7.7 Discussion
7.7.1 Mutagenesis reactions
The initial problems encountered with the mutagenesis reactions highlight the 
potential problems of oligonucleotide design for G+C rich sequences. The 
original primers that failed to bind specifically, 20- or 21-mers, were clearly too 
short even though they only introduced one mismatch. The one oligonucleotide 
that worked first time, KAJ-13, was a 28-mer, a longer sequence being used as it 
introduced two mismatches. In order to increase specificity, one should either 
utilise regions containing a higher than average proportion of A and T, a lesson 
utilised in designing the primers for upstream sequencing described in the next 
chapter, or increase the overall length.
The second set of oligonucleotides designed for mutagenesis 
incorporated a silent Apal restriction site. This enabled rapid screening of
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potential mutants by restriction analysis, and saved the need for time-consuming 
and expensive sequencing. Potential mutants detected by Apa\ screening were, 
of course, confirmed by sequencing. Inclusion of such a site was not done 
originally, as it meant creating another mismatch which would affect binding 
affinity. Also, the kit manufacturer claimed a consistent mutant success rate of 
over 90%. If this had been the case in practice, restriction screening would have 
been unnecessary.
The difficulties encountered in making the ES1301 mutS strain competent 
have since been recognised by Promega. They now sell ready-competent cells 
for use with this procedure.
7.7.2 Mutant enzyme properties
Energy minimisation of the mutant structures predicted no gross change in 
structure, but one should be cautious since the minimisation was carried out on 
an already-minimised structure, i.e. the residue was changed in the structure file 
of the wild-type enzyme in its native conformation and was then re-minimised. As 
the mutant residues were not larger than the wild-type residue and did not 
introduce new charges, energy minimisation would not be expected to show any 
large structural changes. The possibility still exists of a conformational change 
that could affect the active site.
All the mutants are less active than wild-type under optimal conditions, 
although E423D is only slightly so. The kinetic data show no significant change 
in the Km of NAD+, suggesting that NAD+ binding is unaffected. A similar case is 
found for the Km of dihydrolipoamide, except in E423A where the affinity is 
increased slightly. E423A is the least conservative of the mutations and may 
affect the conformation of the dihydrolipoamide binding region around the 
catalytic cysteines and histidine. The pH optima of all the mutants are
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unchanged from that of wild-type, suggesting that there is no difference in the 
electrostatic potential around the catalytically-important residues.
At physiological salt concentrations, the activity in mutants E423S/Q/A is 
approximately 25% that of wild-type. At lower concentrations of salt, however, 
the wild-type enzyme rapidly loses activity, whereas mutants E423S/Q/A do not, 
to the point that in the total absence of salt the activities are similar. In the 
absence of salt, the putative K+-binding site would be unoccupied, resulting in the 
wild-type enzyme having four unshielded opposing glutamate residues at the 
dimer interface which would have a destabilising effect on the structure. Under 
the same conditions, E423S/Q/A would only have two unshielded glutamate 
residues (E426 from each chain) and so the destabilising effect should be lower 
than in the wild-type enzyme.
E423D is the most conservative mutant, maintaining the negative charge, 
and the binding site would be expected to maintain a high affinity for K+. Perhaps 
the most significant property of this mutant is its lack of activity in the absence of 
salt. Interestingly, although the residue is smaller than the glutamate present in 
the wild-type, the carboxy- oxygens of the two aspartate residues are nearer to 
each other at their closest point than those of the wild t^ype glutamates (3.60A 
and 4.15A respectively). The corresponding a-carbons are also closer (8.35A 
compared to 8.59A in the wild-type), although it must be remembered that these 
measurements are based on a model structure. This may mean that in the 
absence of salt, the backbone is displaced more in this mutant than in the wild- 
type, affecting the active site conformation and hence activity. As the salt 
concentration increases, however, occupancy of the K+ binding site could result 
in stabilisation that results in the backbone near the active site taking up a 
conformation similar to wild-type. This would explain the activation with
increasing salt concentration, seen in both this mutant and the wild-type. In the 
wild-type enzyme, there is a hydrogen bond between the backbone oxygen of 
E423 and the nitrogen of E426, on the same chain. This hydrogen bond is 
predicted to be missing in mutant E423D in the absence of salt, further evidence 
of reduced stability around this site, although again caution must be exercised 
with this hypothesis due to the calculations being derived from a model.
The thermal stability data show that mutants E423S/Q/A are as similarly 
resistant to heat denaturation as wild-type. It is E423D that denatures at 
temperatures around 20°C lower, again showing that this mutant is less stable 
both in the presence and absence of salt.
What could be the role of a K+-binding site at the dimer interface? One 
possibility is that it helps maintain the integrity of the core, especially the spacing 
of groups around the active site, as the salt concentration increases. It is known 
that increasing salt concentrations tend to lead to a compacting of protein 
structure, and such a site may strengthen the core under these conditions.
I would like to thank Dr. Rupert Russell for running the GRID analyses and 
energy minimisations.
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8. The physiological role of halophilic DHLipDH 8
8.1 Introduction l _ _
Although DHLipDH has been found in a number of archaeal species in the 
apparent absence of 2-oxo acid dehydrogenase multienzyme complexes 
(Danson et a/., 1984; Smith et a/., 1987), its physiological role remains 
undetermined. In order to investigate its possible function in these organisms, 
two approaches can be followed. Firstly, sequencing upstream of the DHLipDH 
coding region could determine the identity of nearby genes that might be 
associated with the enzyme. Secondly, experiments comparing the growth 
properties of wild-type and BAS5005 (DHLipDH - minus) H. volcanii on different 
substrates may provide clues to the metabolic defect of the mutant strain. Both 
these approaches have been undertaken.
8.2 Sequencing of upstream region of pNAT82
pNAT82 is the pBluescript vector containing a 4.3 kb genomic fragment including 
the DHLipDH coding region at the 3’ end (Vettakkorumakankav & Stevenson,
1992). The remaining 2.7 kb upstream of the DHLipDH gene of this insert has 
not previously been sequenced, but the 76 bases of the published sequence 
upstream of the DHLipDH start codon appear to be homologous to an E2 
component of a 2-oxo acid dehydrogenase complex (Prof. K.J. Stevenson, 
University of Calgary, Canada, unpublished observation).
A short sequence of approximately 140 bases was obtained from the 5’ 
end, using a universal sequencing primer (Dr. M. Dyall-Smith, University of 
Melbourne, Australia). Using this sequence, a primer, KAJ-21, was designed to
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sequence the forward strand. Another primer, KAJ-20, was designed using the 
published DHLipDH sequence to start sequencing the reverse strand.
pNAT82 DNA was prepared using a Qiagen Tip-20 column. Individual 
reactions were sent for automated sequencing on an ABI Prism™ 377 DNA 
sequencer. Sequence obtained was used to design new primers until both 
strands of the entire 2.7 kb region had been completed. In all, 14 primers were 
required and these are listed below.
KAJ-20 : 5’ gagcagttccttcacgcggttc 3’ 22-mer
KAJ-21 : 5’ gagcgagatgttcaaccacgcatac 3’ 25-mer
KAJ-24 : 5’ atctcgtcggcgagttcgagcatcc 3’ 25-mer
KAJ-25 : 5’ agattcagttctccggcttcat 3’ 22-mer
KAJ-26 : 5’ ggttcactcgccgcgtcgaccgt 3’ 23-mer
KAJ-27 : 5’ cgtggacatccgaaccatct 3’ 20-mer
KAJ-28 : 5’ cgaacgtcgccttcggtcac 3’ 20-mer
KAJ-29 : 5’ cgaactcgtaacgtggcacgtc 3’ 22-mer
KAJ-30 : 5’ agcacctggtcttcggttacct 3’ 22-mer
KAJ-31 : 5’ gtgaccgaaggcgacgttcg 3’ 20-mer
KAJ-32 : 5’ ttctcgacggcctccagcgtc 3’ 21-mer
KAJ-33 : 5’ cgcgacggcgaggcgttcgt 3’ 20-mer
KAJ-34 : 5’ ccatgtggctcacgatttgg 3’ 20-mer
KAJ-35 : 5’ ctacatgccgttcgtgatga 3’ 20-mer
Sequences were aligned and edited using the GCG package. The full sequence 
of the pNAT82 insert is shown in Figure 8.1, including the published DHLipDH 




























GACGACGAGG GCGTCGAGGC CATCGAAGAA GACGTGAAAG GGCGGGTCGC
GGACGCCATC GAGGCGGCCG AGTCCGACCC GCGGCCGGAC C C GAGCGAGA
KAJ-21
TGTTCAACCA CGCATA<*GCC GAGCGAACCC CGGAGATTCA AGCGCAGTAC
GAGGAGTTCG AGGCGCTCCG CGAGAAGTTC GGCGACGAAG GATTCCTCAG
AGAATGAGCA GTCAGAACCT CACCATCGTG CAGGCGGTAC GGGACGGTCT
CTACACCGAG ATGAACCTCG ACGACGAGGT GCTCGTCATG GGCGAAGACG
TCGGCAAGAA CGGCGGCGTC TTCCGGGCTA CGGAGGGCCT CTGGGACGAG
TTCGGAGACG ACCGCGTCAT CGACACGCCG CTGGCCGAAT CGGGCATCGT
CGGCACGGCC ATCGGCATGG CCGCGATGGG ACTGAAGCCG GTCCCCGAGA
KAJ-25 v 
TTCAGTTCTC CGGCTTCATG TACCCCGGAT TCGA<£CAAAT CGTGAGCCAC
KAJ-34
ATGGGGCGGT TCCGCAACCG CACCCGCGGC CGCTACACGC TCCCCATGGT
GCTTCGTGCG CCCTACGGCG GCGGCATCCG CGCCCCCGAG TCGCACTCGG
AGTCCAAGGA GATGTTCTAC GCGCACGAGG CCGGCCTGAA GGTCGTCATC
CCCTCGACGC CGTACGACAC GAAGGGACTG CTCATCTCCG CCATCCGCGA
CCCCGACCCG GTCATCTTCA TGGAGCCGAA GCTCATCTAC CGGGCGTTCC
GCGGCGAAGT CCCGGAAGAC GACTACACGG TCCCCATCGG CGAGGCCGCG
GTTCGCCGCG AGGGCACGGA CGTGTCCGTG TTCACCTTCG GCGCGATGAC
GCGCCC£ACG CTGGAGGCCG TCGAGAACCT CGAAGAAGAG GGTATCGACG
KAJ-32 KAJ-27
CCGAGGTCGT GGACATCCGA ACCATCTCGC CGCTCGACCG C GAG AC CATC
GTGGAGTCGT TCAAGAAGAC CGGCCGCGCG GTGGTCGTCC ACGAGGCCCC
GAAGAACGGC GGCCTCGGAG CCGAAATCAC GGCGACGGTT CAGGAGGAGG
CGCTGCTCTA TCAGGAAGCG CCGGTCAAGC GCGTCGCGGG CTACGACGTG
CCGTACCCGC TGTACGCGCT GGAGGACTAC TACCTCCCGT CGGTCGCCCG
CGTCGAAGAA GGTATTCGTG AGGCGGTGAA CTTCTGAACG ATGGCGCTCA
AGGAATTCAA ACTCCCCGAC GTCGGTGAAG GCGTCGCGGA AGGCGAACTC
KAJ-29 ---------^
GTAACGTGGC ACGTCGCGCC GGGCGACGAG GTAACCGAAG ACCAGGTGCT< “
KAJ-30






























ACGGGACGGT GAAGGAACTC CTCGCCGAGG AGGGCGAGGT CGTCCCCGTC
GGCGACGTCA TCATCACCAT TCAGGAGGAT GGCGACGACG AGGAGGCCGC
CGAGGCCGCC GACGCGGACG CCGAAGCGGC CGGGTCTGAG TCGGCCGAGG
GCGACGACGG CGCTAGCGAC GACGAGTCGG GTTCCGGCGG GCGCGTGTTC




GGCAGCGGCC CGAGCGGCCG C^TGACCGAA GGCGACGTTC
KAJ-28
GCGCCGCCGC GGACGACGAC GGCGACGAGG ACGACGAGCC CAGCGGCCCG
CGGACCGTCC AGACCAACGG GAAGTCCGCG ACCGCGAAGC GCGACGAGGG
AACGTCCGCG TCCGCCTCCT CGTCCGCGCC GACCGAGAGC GCCGACCGCG
AGCAGACGCT CGCCGCGCCC GCGACCCGCG CGCTGGCCAA AGAGGAGGGC
KAJ-33
GTCGACATCG ACGCGGTCCC CGCGACGGAG ATGCGCGACG GCGAGGCGTT
CG^CTCGCCC GAGGCCGTCC AGGAGTACGC CCAAGCACAG CGCGAGGCGC
AGGCCGCGGA CGCCGAGGCG GTGTCCGCCG AGGCCGACGC CGGAACCGCG
ACCGCCGAGG CG£CGGTCGA CGCGGCGAGT GAACCCGCAC CGCCCGAGGCV ri
KAJ-26
CGGCCCCGGT GCCGGCGAGC GCGTCCCCTA CAAGGGCGTC CGCAAGGCCA
TCGGCGACCA GATGCAGCGG TCGAAGTACA CCGCGCCGCA CGTCACCCAC
CACGACGAGG TGGACGTGAC GGAGCTCGTC GAACTGCGCG AACAGCTCAA
KAJ-35
GCCCGTCGCC GAGGAGCGCG GCTCGCGGCT GACCTACATG CCGTTCGTGA
TG&AGGCCGT CGTCGCGGCG CTGAAGGGCT TCCCGTACCT CAACTCGCAG
CTCGACGAGG AAAACGAGGA AATCGTCCTG CGCGACGAGT ACAACATCGG
CGTCGCGGCC GCGACCGACG CCGGTCTGCT CGTCCCCGTC GTCCACGACG
CGGACCGCAA GG£GATGCTC GAACTCGCCG ACGAGAT G AA CGAGAAGGTC
KAJ-24
GAGAAGGCCC GCAACCGCAA AATCGCGCCC GAGGAGATGC GCGGCGGCAC
CTTCACCATC ACCAACGTCG GCGGCATCGG CGGCGAGTAC GCGACGCCGA
TTATCAACTA CCCCGAGGTG GCGATTCTCG CGCTCGGAGC CATCAAAGAA
AAGCCCCGGG TCGTCGACGG TGAGGTCGTG CCGCGAAACG TCCTCACCCT
CTCGCTGTCG TTCGACCACC GCGTCGTCGA CGGCGCGCAG GGCGCTCGGT
































GAATAATGGT CGTCGGAGAC ATCGCAACCG GAACCGAACT GCTCGTCATC
GGCGCGGGAC CCGGCGGCTA CGTCGCCGCC ATCCGCGCCG CACAGAACGG
CATCGACACG ACGCTGGTCG AGAAGGACGC CTACGGGGGC ACCTGCCTCA
ACTACGGCTG TATCCCATCG AAGGCGCTCA TCACGGGGGC GAACCTCGCC
CACGAGGCGG GCAACGCCGA GGAGATGGGC ATCCACGCCG ACCCCGTCGT
GGACATGTCG CAACTGCGCG ACTGGAAGAG CGGCGTCGTG GACCAACTCA
CCGGCGGCGT CGAGAAGCTC TGTAAGGCGA ACGGCGTCAA CCTCGTCGAG
GGAACCGCCC GCTTCAAGGA CGAGAACGCC GTCCGCATCG CCCACGGCGG
CGAGGGGCAG GGCTCGGAGA CCATCGAGTT CGAGCACTGC ATCATCGCCA
CCGGCTCGCG CGTCATCCAG ATTCCCGGTT TCGACTTCGG CGACGAGCCG
GTGTGGTCGT CGCGCGACGC CCTCGAGGCC GACACCGTCC CGGAGCGACT
GGTCGTCGTC GGCGGCGGCT ACATCGGGAT GGAGCTGTCC ACGACGTTCG
CCAAGCTCGG CGCGGACGTG ACCGTCGTCG AGATGCTCGA CGACATCCTG
CCGGGCTACG AGTCCGACGT GGCCCGCGTC GTCCGCAAGC GCGCCGAAGA
GCTCGGCATC GACATGCACC TCGGTGAGGG CGCGACGGGC TGGCGCGAGG
AGGACGACGG CATCATGGTG ACGACCGAGA CCGAAGACGG CGAGGAAAAC
GAGTACCGCG CCGACAAGGT GCTCGTCGCC GTCGGGCGCT CGCCCGTCAC
CGACACGATG GACATCGAGA ACGCCGGCCT CGAAGCCGAC GACCGCGGCT
TCCTCTCGGT CGACGACCGC CGCCGCACCG ACGTGGAGCA CATCTACGCC
GTCGGCGACG TGGTCGAGGA CACGCCGATG CTCGCCCACG TCGCCTCGAA
GGAGGGCATC GTCGCCGCCG AGCACGTCGC CGGCGAACCG GTCGCCTTCG
ACAGTCAGGC CGTCCCCGCC GCGGTGTTCA CCGACCCCGA AATCGGCACG
GTCGGCATGA CCGAGGCCGA CGCCGAGGAG GCCGGCTTCA CGCCCGTCGT
CGGGCAGATG CCCTTCCGGG CGTCCGGCCG CGCGCTGACG ACGAACCACG
CCGACGGCTT CGTCCGCGTC GTCGCCGACG AGGAGTCCGG CTTCGTCCTC
GGGGCGCAAA TCGTCGGCCC CGAGGCCTCC GAACTCATCG CCGAACTCGC
GTTCGCCATC GAGATGGGCG CGACGCTCGA AGACGTGGCC TCGACCATCC
ACACCCACCC GACGCTCGCG GAAGCGGTCA TGGAGGCCGC CGAGAACGCG
CTCGGACAGG CGATTCACAC CCTGAATCGG TGAGGAGCGT CCGAAAAACG
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4201 GCGAGCTGAT TTTTTAAGCG GTCAGGTCGG CATCGAGTTC CGGGCTGAAG
4251 AGATC
Figure 8.1: The complete nucleotide sequence of pNAT82
Figure 8.2, below, shows the direction and extent of the sequencing reactions
<------------
1000 2000 3000 4000 5000
Figure 8.2: The sequencing strategy. The direction and length of the 
arrows indicate the direction and extent of the individual sequencing 
reactions. The dotted arrow represents the published sequence of the 
DHLipDH gene.
8.3 Sequence analysis
8.3.1 Positions o f open reading frames
Translation of the upstream sequence showed the presence of three open 
reading frames. These were found to be homologous to the C-terminus end of 
E1a, and complete Eip and E2 components of 2-oxo acid dehydrogenase 
multienzyme complexes. Figure 8.3 shows the position of these open reading 
frames.
E1a E1p E2 E3
□
0 1000 2000 3000 4000 5000
Figure 8.3: Positions of the three open reading frames upstream of the 
DHLipDH (E3) gene.
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The E1a and E1p coding regions overlap by two nucleotides, with the ATG start 
codon of E ip sharing bases with the TGA stop codon of E1a. E1p and E2 are in 
frame with each other, separated by three bases. E2 and E3 share a single 
nucleotide, with the TAA stop codon of E2 overlapping with the ATG start codon 
of E3. The close spacing of these genes suggests that they are regulated as an 
operon.
8.3.2 Homology scores
8.3.2.1 The E2 gene
The E2 gene consists of 1566 bases which translate to 521 amino acids. It has a 
G+C content of 70.3%. The closest homology match is to the dihydrolipoamide 
acetyltransferase component (E2) of the pyruvate dehydrogenase complex of 
Bacillus stearothermophilus, with 37.8% identity in a 405 amino acid overlap. A 
dendrogram of the ten best matches is shown in Figure 8.4.
 bovine BCDHC E2
  human BCDHC E2
--------------------------------------------------  A. vinelandii PDHC E2
-------------------------------------------------- E. coli PDHC E2
----------------------B. stearothermophilus PDHC E2
---------------------- B. subtilis PDHC E2
---------------------------------------------------------- H . v o l c a n i i E2
------------------------------------------------------------------  A. laidlawii PDHC E2
--------------------------------------------------------------------- P. putida BCDHC E2
----------------------------------------------------------------------- B. subtilis BCDHC E2
-----------------------------------------------------------------------H. influenza OGDHC E2
Figure 8.4: Dendrogram showing relatedness of the ten best matches to the 
H. volcanii E2 sequence. Produced using PILEUP (GCG).
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The ten best matches are aligned in Figure 8.5 below. Shaded residues are 
ones identical to those in the H. volcanii protein.
H. volcanii E2 ........................................................
B. stearothermophilus PDHC E2 
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
H. volcanii E2
B. stearothermophilus PDHC E2 
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2
B. influenza OGDHC E2 
B. subtilis BCDHC E2
SEIIRVPDIG GDG.EVIELL VKTGDLIEVE QGLWLESAK ASMEVPSPKA 4 9
AIEIKVPDIG ADEVEITEIL VKVGDKVEAE QSLITVEGDK ASMEVPSPQA 50
GWKSVSVKL GDKLKEGDAI IELEPAAGAA AAPAEAAAVP AAPTQAVDEA 99
GIVKEIKVSV GDKTQTGALI MIEDSADGAA D........ AAPAQAEEKK 91
H. volcanii E2
B. stearothermophilus PDHC E2 
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. Influenza OGDHC E2
B. subtilis BCDHC E2
........ M YEFKFADIGE GIHEGTVLQW NFKVGDKVKE GETLVIVETD 41
EAPSPGASAT PAPAAASQEV RVPDIGSAGK ARVIEVLVKA GDQVQAEQSL 14 9
EAAPAAAPA. ...AAAAKDV NVPDIGS.DE VEVTEILVKV GDKVEAEQSL 136
H. volcanii E2
B. stearothermophilus PDHC E2 
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
KVNAELPSPV DGTIVSLGAK EGEEIHVGQI IVTIDDGTGT PAAAPAPAQV 91
IVLESDKASM EIPSPASGW ESVAIQLNAE VGTGDLILTL RTTGAQAQPT 199
....... MA AALVLRTWSR AAGQLICVRY FQTCGNVHVL KPKYVCFFGY 42
....... MA AVRMLRTWSR NAGKLICVRY FQTCGNVHVL KPNYVCFFGY 42
ITVEGDKASM EVPAPFAGTV KEIKVNVGDK VSTGSLIMVF EVAG.EAGAA 185
H. volcanii E2
B. stearothermophilus PDHC E2 
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
.................... M ALKEFKLPDV GEGVAEGELV TWHVAPGDEV 31
 AF.EFKLPD: GEGIHEGEIV KWrVKPGDEV 29
 1 f . H | i » i n | l | |  KWFVK*>NfieV 29
SAPTPAPAAA PQVAAPAASG DIYl|j|tFA§I |MlHf)§TIL (|jNFKVpJKV 141
.................. M  GTHV'aMlI tt&I&QVjBp' EtFfKV^II 31
APAAAAAASP APAPLAPAAA GPQi\fv®I IsA.GKARVI EVlfto®0| 248 
PPFKYSHPYQ WLKTTAALQG OIV^ft^T j&§IR|VTVK EfY|KE®Tl 92 
PSFKYSHPHH FLKTTAALRG QW<j§§ah 1®IR|VTVK E§Y|KiS t| 92 
APAAKQEAAP AAAP. .APAA GVfpNVgil i.j|. d|v|VT EVNfKVfpKg 231
.................. ,gf jglEIL.V§§L E®Ifg§fDATVA 30
.................. M  &IEQMTMPQL GE5&TEGTIS 31
H. volcanii E2
B. stearothermophilus PDHC E2 
fl. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
AEEGEWPVG DVIITIQEDG 81
VP|§TfAIi§ QTl|PfLDAPf 7 9 
vfpT^rATpl QTil|FDA£# 79 
ETWMGQlS 191 
GQF<i$£yMA$i SElfRlEV?j| 81 
VQLNAE|gT| PqE'lf LRVAp 298 
YNLDDTAYfB KPLVMBE. - - 139 
YNLDDIAYVG KPLVEf-E. . . 139 
VNVpDKVK'OI SlfjMIFEVE$ 281 
QA^feTfvSK QLLGKlSTAQ 80
d m o T L d B  em$ckS 771AEVPS
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H. volcanii E2
B. stearothermophilus PDHC E2 
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
DDE.........................EAAEA ADADAEAAGS ESAEGDDGAS 109
YENMTFKG.Q EQEEAKKE....... JJKTET VSKEEKVDAV APNAPAA. . . 118
YEDLQFKGSD ESDDAKTEAQ VQSTA&AGQD VAKEEQAQEP AKATGAGQQD 129
.ATL EQAQAPKAEA PVSEPKKGAG WGEIEVSDD IIGGSEEVHV 234
SGN HV DVPQAKPAEV PAAPVAAKPE PQKDVKPAAY QASASHEAAP 126
AA............... PSG PRAR.GSPGQ AAAAPGAAPA PAPVGAP... 329
 TE ALKDSEEOW ETPAVSHDEH 161
 TE AI.KDSEEDW ETPAVSHDEH 161
AA............... PAA APAKQE3VAAP APAAKAEAPA AAPAAKAEGK 316
EGD...................... VSSfTL KATNEPTPSD RQNAAIENSH 109
ETE...................... GANPAE QKQEQPAASE AAENPVAKSA 106
H. volcanii E2
B. stearothermophilus PDHC E2 
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
DDE SGSGGKV FAPPSVRKLA RELGVDLDAV
FAEAGPNRRV ! AMPSVRKYA REKGVDIRUV 
QAJ&VDPNKRV i AMPSVRKYA REKGVDIRKV 
VATTO -.KV IjASPVARKLA SDLGVRtATI 
IVPRQPBDKP IASPAVRKRA LDACIELRYV 
. . .SRNGAKV HAOPAVRQLA REFGVF.LAAI 
THQEINSQKT lA'.'PAVRRLA MENNIKfcSEV 
THQEIK$RKT LATPAVRRLA MENNIKLSEV 
SEFAENDAYV KATpLrRRLA REWVNLAKV
NHNADQ   SpViRRL:. AEHDLQABQI
G.AADQPNKK RYSPAVLRLA GEHGI.DLDQV
DGSGPSGKVT EGDVRAAADD 159
QGTGKNGRVL KEfil  162
TGSGNNGRW KEDI..... 17 3
KGSGEQGRVM KD§VQ  27 6
HGSGPAGRIL HEDL..... 170
NSTGPRGRIL KEDVQAYVK. 375 
LGBGKDGRIL KE$ILNYLEK 211 
V6&3KDGRIL KeI iLNY LEK 211 
kgtgrk'g r:;. rebvqayvk. 365 
ogsgvjgrlt redierei . . 151 
TGTfeAGGRlt RhUlQRLI.. 153
H. volcanii E2
B. stearothermophilus PDHC E2 
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
DGDEDDEPSG PRTVQTNGKS ATAKRDEGTS ASASSSAPTE SADREQTLAA 209
H. volcanii E2
B. stearothermophilus PDHC E2
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
PATRALAKEE GVDIDAVPAT EMRDGEAFVS PEAVQEYAQA QREAQAADAE 259
......................... GfcFL................... AGG 169
......................... DS$*V................... NGG 180
.............................................. NSKAPA 282
....... A 376
. . . T0?U LP 218 
...TG&ILP 218




B. stearothermophilus PDHC E2
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
H. volcanii E2
B. stearothermophilus PDHC E2
B. subtilis PDHC E2
A. laidlawii PDHC E2 
P. putida BCDHC E2
A. vinelandii PDHC E2 
bovine BCDHC E2 
human BCDHC E2
E. coli PDHC E2 
H. influenza OGDHC E2
B. subtilis BCDHC E2
AVSAEADAGT ATAEATVDAA SEPAPPEAGP
AKPAP A AAEgKAAPAA AKEftTTE .GE
AQEAAPQETA AP^TAAKPA AAPA.PE.GE 
EAQAPVQQTQ APAQAAASVA PSFAAAGKPQ
. .   D AFMSKPQSftft GQTPNGYARR
MMQKAKEAPA AOAASGAGIP PIPPVDF^KY 
PSPKAEIMPP PPKPKDRTIP IPISKfPVFI 
PSPKVEIMPP PPKPKDMTVP ILVSKPPVFT 
AIKRAF.AAPA AtGGGIPGML PWfKVDFSKF
. KRQAQ QVKQEAATEQ NTISTVAYSA
NPEELKTAAP APKSASKPEP KEETSYPASA
RSKYTAPHVT HHDEVDVTEL VELREQLKP. 
HSKHTAPHVT LMOEADVTKL VAHRKKFKA. 
NSKHTAPHVT IMDEVDVTNL VAHAKQFKQ. 
RSKSI rPETV LMDEINVDAL vnfrneakg. 
DAftRRVAHFS YVKE I.DVTAL F.ALRQQLNS . 
RSWLNVPHVT QFESAElTEi, EAF&VAQKAV 
AA.LKIPHFG YCDEVDETEL VKLREELKPI 
AA. LKTPHFG YGDEUDhTEL VKLREELKPI 
RNWVM PPHVT HFDKTDlTEL EAF$K§QNEE 
KAltNSTAMUT TFNEVDMQPI MTIRKTYGEK 
RSiCTF. IPHAW TMMEVDVTNM VAYRNSIRDS
GAGERVPYKG VRKAIGDQMQ 309
FPETREKMS0 IRRAlAKAMV 214 
FPETREKMS6 IRKAIAKAMY 228 
GDVEWKITR IRKAVSNAMT 332 
TDSEQVPVIG URRKttAQRHQ 211 
GEIEF.VPMTR LMQIGATNLH 426 
GKDRTEPVKG FHKAMVKTMS 268 
GKDKTEPIKG FQKAMVKTM5 268 
GELEEVELGR IQftlSSANLS 416 
RSEKRVPMTR 1AKRIAERLL 197 
AGDKF.IPVTG VRKAIASNMK 211
VAEER.GSRL TYMPFVMKAV 357
iAAEK.GIKl T1LPYWKAL 262 
VAADQ.GIKt TYhPYVVKAL 27 6 
LAESK.GIK| TYMAFIAKAV 380 
KHGDS.RGK| fl.l.PFI.VR^ !, 259 
AE. .KAGVK|i TVLpLI.lAAC 47 4 
AFAR. .GIKL S E ^ F iM a 315 
AFAR. .GIKli SEMPEflIIAA 315 
A|KRKLDVKI .TPWFIRSKAV 4 66 
FEKQH.SVRti GE®S§Y IKAV 24 6 
FKKTE .GFHJj TFFAFFVKAV 260
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H. volcanii E2 VAALKGFPYL NSQLDEENEE IVLRDEYNIG VAAATDAGLL VPWHDADRK 407
B. stearothermophilus PDHC E2 VSALREYPVL NTSTDDETEE IIQKHYYNIG IAADTDRGLL VPVIKHADRK 312
S. subtilis PDHC E2 TGALKKFPVL NTSIODKTDE VIQKHYFNIG LAADTEKGLL VPWKNADRK 326
A. laidlawii PDHC E2 IIALKEFPMF NASFNHDTDE VYIKKFlNLG MAVDTS’RGLI VPNIKNADRL 4 30
P. putida BCDHC E2 WALRDFPQI NATYDDEAQI ITRHGAVHVG LATQGDNGtM VPVLRHAEAG 309
A. vinelandii PDHC E2 AYLLKELPDF NSSLAPSGQA LIRKKYVHJG FAVDTPIGLL VPVIRNVDQK 524
bovine BCDHC E2 SLGLLQFPIL HASVDENCQN ITYKASHNIG IAMDTEQGLI VPNVKNVQIR 365
human BCDHC E2 SLGiLQpPlt NASVDENCQN ITYKASHNIG IAMDTEQGLI VPNVKNVQIC 365
E. coli PDHC E2 AAALF.QMPRF NSSLSEDGQR LTLKKYINIG VAVDTPNGLV VPVFKDVNKK 516
H. influenza OGDHC E2 VEALKKYPEV NASIDG..DD WYHNYFDIS IAVSTPRGLV TPVLRDCDKL 294
B. subtilis BCDHC E2 AQALKF.FPQM NSMWAG..DK IIQKKD1NIS IAVATF.DSLF VPV1KNADEK 308
H. volcanii E2 GMLELADEMN EKVEKARNRK IAPEEMRGGT FTITNVGGIG GEYATPIINY 457
B. stearothermophilus PDHC E2 P!FALAQEIN ELAEKARDGK LTPGEHKGAS CTITNIGSAG GQWFfpviNH 362
B. subtilis PDHC E2 SVFEISDE IN GLATKAREGK 1APAEMKGAS CTITNIGSAG GQWFTPVTNH 376
A. laidlawii PDHC E2 SVFELASQVR SLADDTIARK ISMDQQTGGT FTITNFGSAS IAFGTPVINY 480
P. putida BCDHC E2 SLWAUAGSEIS RLANAARNNK ASREEI.SGST ITLTSIGALG GIVSTPVVNT 359
A. vinelandii PDHC E2 SL&2LAAEAA ELAEKARSKK LGADAMQGAC FTISSI.GHIG GTAFTPIVNA 574
bovine BCDHC E2 SIFEIATELN RLQKLGSAGQ LSTNDLIGGT FTLSNIGSJG GTYAKP'/IhP 415
human BCDHC E2 SIFDlATElU RLQKLGSVGQ LSTTDLTGGT FTI.SNIGSIG GTFAKPVIMP 415
E. coli PDHC E2 Gi IELSREIW TISKKARDGK LTAGEMQGGC FTISSIGGLG TTHFAPJVNA 566
H. influenza OGDHC E2 SMAEIEKQIK ALAEKGRDGK I.TVEDLTGGN FTITNGGVF^ SLMST.PIINP 34 4
B. subtilis BCDHC E2 TIKGlAKDIT GLAKKVRDGK LTADDMQGGT FTVNNTGSlG SVQSMGIINY 358
H. volcanii E2 PEVAILALGA IKEKPRWD. GEWPRNVLT LSLSFDHKW DGAQGARFTN 506
B. stearothermophilus PDHC E2 PEVAILGIGR IAEKPIVRD. GEIVAAPMLA LSLSFDHRMI DGATAQKALN 411
B. subtilis PDHC E2 PEVAILGiGR IAEKAIVRD. GEIVAAPVLA LSLSFDHRMI DGATAQNAIN 425
A. laidlawii PDHC E2 PEIAILGISK IDRKPWWG. NEIKIAHTLP LSLAVDHRII DGA!X3GRF.\M 529
P. putida BCDHC E2 PEVAIVGVNR MVERPWlD. GQEWRKMMN LSSSFDHRW DGMDAALFIQ 408
A. vinelandii PDHC E2 PEVAILGVSK ASMQp.Vv&G KAFQPRLMLP LSLSYDHRVI NGAAAARFTK 623
bovine BCDHC E2 PEVAIGALGT IRALPRFNEK OKCKAQIMN VSWSADHRII |gfATVSRFSN 4 65
human BCDHC E2 PEVAI'iALGS IKAIPRFNQK GEVYKAQIMN VSWSADHRVI DGATMSttFlIN 4 65
E. coli PDHC E2 PEVAILGVSK SAMEp.VWNG KEFVPRLMLP ISLSFDHRVI D6ADGARFIT 615
H. influenza OGDHC E2 PQSAILGMHA IKERPiAL.N GC>WI.RPMMY LAtSYDHRI.I DGRESVGFI.V 393
B. subtilis BCDHC E2 PQAAILQVES IVKRPWMDN GMIAVRDMVN LCLSLDHRVL DGLVCG#LG 408
H. volcanii E2 KVKELLE... DPKLLVLE.. 521
B. stearothermophilus PDHC E2 HIRRLLS. . . DPELLLMgA. 427
B. subtilis PDHC E2 HIKRLLN. . . DPQLILMIEa. 441
A. laidlawii PDHC E2 RVKELLT... MPTLLLLS.. 544
P. putida BCDHC E2 • • QPACliFVE. . 423
A. vinelandii PDHC E2 RLGDLLA. . . DIRAILL. . . 637
bovine BCDHC E2 LV*Sy|3§. . . MPAFMLLDLK 482
human BCDHC E2 LVflCSYfE. . . NfjpAFMLLDLK 482
E. coli PDHC E2 IINNTLS. . . DIRRLVM. . . 629
H. influenza OGDHC E2 TIRELLE... DPTRLLLE;. 4 09
B. subtilis BCDHC E2 RVKQILlsiD EKTSVY  424
Figure 8.5: Alignment o f H. volcanii E2 with the ten closest matching 
sequences.
The H. volcanii E2 gene groups with the E2 of pyruvate dehydrogenase 
multienzyme complexes of Gram-positive bacteria. Perhaps the most interesting 
observation from the sequence alignments is that the H. volcanii gene is 
predicted to translate an extra hundred amino acids within the middle of the 
sequence (amino acid residues 155-256), not present in any of the other 
sequences.
There are at least five possible explanations for these extra residues. 
Firstly, it is possible that they have a role forming a large loop within the protein 
structure, but such a large extra structure seems unlikely. Secondly, they may be
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due to the presence of an intron, but these have never been found within 
archaeal structural genes. Thirdly, they may represent a fragment of protein that 
is spliced out of the final product, i.e. an intein (Colston & Davis, 1994). The 
inteins so far discovered have conserved junctions; these are not present in the 
H. volcanii E2 sequence making the intein explanation unlikely. By far the most 
likely explanations though, are that the extra sequence is due to either a 
transposition or a duplication event.
Evidence that either a transposon has interrupted the gene or that a 
duplication event has occurred is the presence of a ten nucleotide direct repeat 
at either end of the extra sequence. Such a repeat is often observed upon 
introduction of a transposable element. There are, however, no terminal inverted 
repeats. These are normally seen with transposons but are not absolutely 
essential as there are at least two cases in the literature of halobacterial 
transposons that lack them (Schnabel etal., 1984; Pfeifer ef a/., 1984).
To test whether a transposition or a duplication event is the most likely 
explanation, the extra sequence was translated in all six reading frames and 
compared with the SwissProt database. The greatest homology was to a 
hypothetical protein of a transposable element from Streptomyces fradiae, with 
an identity of 34% over 106 amino acids. This was in a different reading frame 
from the E2 gene. The extra sequence is G+C rich and will consequently give 
translations with high arginine and proline (R+P) content in most non-coding 
open reading frames. These will align with R+P rich proteins in the database, of 
which the transposon protein is one. This casts doubt on the significance of the 
alignment.
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More convincing evidence exists for a duplication event, however. The 
extra translated sequence aligns partially with an upstream region of E2 (Figure
8 .6).
Insert LAAPATRALAKEEGVDIDAV
A P R LA E GVD DAV 
H. volcanii E2 FAPPSVRRLARELGVDLDAV 139
Figure 8.6: Partial alignment of the E2 insert sequence against an upstream 
region of the translated sequence.
The possible duplication does not seem to correspond to a domain, since it 
interrupts the peripheral subunit-binding region, as evidenced by the identified 
position of this region on the aligned sequences. This region is approximately 35 
residues in length, whereas the extra sequence is over a hundred amino acids. 
This would suggest that the duplication is not a functional domain rearrangement.
With the extra sequence removed, the homology scores were
recalculated and are shown in Table 8-1.
Organism/protein % Identity (amino acid overlap)
B. stearothermophilus PDHC E2 47.8% (425 aa)
B. subtilis PDHC E2 43.0% (386 aa)
A. laidlawii PDHC E2 41.5% (429aa)
E. coli PDHC E2 38.8% (428 aa)
B. subtilis BCDHC E2 37.8% (421 aa)
A. vinelandii PDHC E2 36.7% (417 aa)
bovine BCDHC E2 35.5% (425 aa)
P. putida BCDHC E2 34.4% (425 aa)
human BCDHC E2 34.4% (425 aa)
E. coli OGDHC E2 34.1% (419 aa)
Table 8-1: Homology scores for the H. volcanii E2 protein.
8.3.2.2 The E ip  gene
The E1 p gene consists of 984 bases, which translate to 327 amino acids. It has 
a G+C content of 66.2%. The closest homology match is to the pyruvate
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dehydrogenase E1p component of B. stearothermophilus, with 56.3% identity in 
a 323 amino acid overlap. A dendrogram of the ten best matches is shown in 
Figure 8.7.
  bovine BCDHC E1p
 ^  _____human BCDHC Eip
------------------ rat BCDHC E1p
--------------------------------------------------------- A. laidlawii PDHC Eip
---------------------------------------------------------M genitalium PDHC Eip
---------------B. stearothermophilus PDHC Eip
-------------- B. subtilis PDHC Eip
-----------------------------------------------------------  H. volcanii E1 p
-----------------------------------------------------------------  B. subtilis BCDHC E1p
------------------------------------------------------------------------  P. putida BCDHC Eip
---------------------------------------------------------------------------------  A. eutrophus acetoin
oxidoreductase p subunit
Figure 8.7: Dendrogram showing relatedness of the ten best matches to the 
H. volcanii E1 p sequence. Produced using PILEUP (GCG).
The ten best matches are aligned in Figure 8.8 below. Shaded residues are 
ones identical to those in the H. volcanii protein.
H. volcanii Eip
B. stearothermophilus PDHC EiP
B. subtilis PDHC Eip
A. laidlawii PDHC Eip
B. subtilis BCDHC Eip 
P. putida BCDHC Eip
M. genitalium PDHC Eip 
human BCDHC Eip
A. eutrophus Acetoin ox/red P 
bovine BCDHC Eip 
rat BCDHC Eip
MAWAAAAGW LLRLRAAGAE GHWRRLPGAG LARGFLHPAA TVEDAAQRRQ 50
MAAVAAFAGW LLRLRAAGAD GPWRRLCGAG LSRGFLQSAS AYGAAAQRRQ 50 
............... CNSAD WP..... AA LVQGFLQPA. .VDDASQKRR 21
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H. volcanii Eip
B. stearothermophilus PDHC Eip
B. subtilis PDHC Eip
A. laidlawii PDHC Eip
B. subtilis BCDHC Eip 
P. putida BCDHC Eip
M. genitalium PDHC Eip 
human BCDHC Eip
A. eutrophus Acetoin ox/red p 






















































B. stearothermophilus PDHC Eip
B. subtilis PDHC Eip
A. laidlawii PDHC Eip
B. subtilis BCDHC Eip 
P. putida BCDHC Eip
M. genitalium PDHC Eip 
human BCDHC Eip
A. eutrophus Acetoin ox/red P 
bovine BCDHC Eip 
rat BCDHC Eip
....... GK NGGVFRATEG LWDEFGDDKV IDTPLAESGI VGTAIGMAAM 75
....... GV NGGVFRATEG LQAEFGKDRV IDTPLAESGI GGLAIGIALQ 7 2
....... GV NGGVFRATEG LQKEFGEDRV FDfPLAESGI GGIALGI.GLN 72
....... GK EGGVFRVTAG LQKKY0ETRV rDTPIAESAi VGSAVGMAIN 73
 GR KGGVFKATAG LYEQFGEERV MDTPLAESAI ^VGIGAAMY 73
 GY IGGVFRCTEG tQTKYGKSRV FDAPISESGI VGTAVGWGAY 75
....... GF FGGVRRATKG LQQKYGSF.RV WDCPIAENSM aGiGVGAAIG 75
........... GGVFRCTVG LRDKYGKDRV FNTPLOEQGI VGFGIGIAVT 139
GAGADGEKDA WGGVLGVTKG LYAKHG.RRL LDTPLSESAY VGAAIGAAAC 82
........... GGVFRCTVG LRDKYGKDRV FNTPLCEQGl VGFGIGIAVT 139
...........GGASDVLLA YETNMEKTEC LTPpLOEQGI VGFGIGIAVT 116
H. volcanii Eip GLKPVPEIQF SGFMYPGFDQ IVSHMGRFRN RTRGRYT.LP MVLRAPYGGG 124
B. stearothermophilus PDHC Eip GFRPVPEIQF IGFVYEVMDS ICGQHARIRY RTGGRYH.MP ITIRSPFGGG 121
B. subtilis PDHC Eip GKRPVMEIQF FGFVYEVMDS VSGQMARMRY R5>(5GRWT. SP VT rRSpFGGG 121
A. laidlawii PDHC Eip GLKPIAEIQF dGFIFPGYTD LVTHAARMRN RSRGQFT.VP MVLRI.PHGGG 122
B. subtilis BCDHC Eip GMRPIAEMQF ADFIMPAVNQ ITSEAAKIRy RSNNDWS.CP IVVRAPYGGG 122
P. putida BCDHC Eip GLRPWEIQF ADYFYPASpQ IVSEMARLRY RSAGF.FI .AP L7LRMPCGGG 124
M. genitalium PDHC Eip GLKP.' VEIQF SGFSFPAMFQ IFVHAARIRN RSRGVYT . AP LVVRMPMGGG 124
human BCDHC Eip GATAIAEIQF ADYIFPAFDQ IVNEAAKYRY RSGDLFNCGS LTIRSPWGCV 189
A. eutrophus Acetoin ox/red P GMRflA^l^ff- ! DEWGVCFDQ IFNQAAKFRY MFGSKAE.TP WIRAMVGAG 131
bovine BCDHC Eip ijATAIAlilQf ADYIFPAFDQ IVNEAAKYRY RSGDLFNCGS LTl|a|l^CV 189
rat BCDHC Eip GATAIAEIQF ADYIFPAFDQ IVNEAAKYRY RSGDLFNCGS LTlRAPWGCV 166
H. volcanii Eip IRAPESHSES KEMFYAHEAG LKWIPSTPY DTKGLLISAI RDPDPVIFME 174
B. stearothermophilus PDHC Eip VHTPELHSDS UgGLVRQQPG LKWIPSTPY DAKGLLISAI RDNDPVIFLE 171
B. subtilis PDHC Eip VHTPELHADS LEGLVAQQPG IKWIPSTPY DAKGLLISAI RDNDPWFIF 171
A. laidlawii PDHC Eip IRALEHHSEA lJ|VLFGSIPG LKWTPSTPY DAKGLLIARI NpPDPVvTIF 172
B. subtilis BCDHC Eip VHGALYHSQS vRa IFANQPG LKIVMPSTPY DAKGLLKAAV RDEPPVLFIE 172
P. putida BCDHC Eip |YGGQtRsQ6 p|aMFTQVCG |rTVMPSNPY DAKGLLIASt ECD^pVlFLE 174
M. genitalium PDHC Eip IKAIJCHHSET L^AlYAQIAG LKTVMPSNPY DTKGLKIAA? E.SPDPVIFrt 174
human BCDHC Eip GHGALYHSQS PEApFAHCPG IKWIPRSPF QAKGLLLSCI EDKNPCIFr'E 239
A. eutrophus Acetoin ox/red P IRAAAQHSQM LTPLFTRIPG LKVVCPSTPY DTKGLLIQAI RDMDPVIFCE 181
bovine BCDHC Eip GHGALYHSQS PEAFFAHCPG IKWVPRSPF QAKGLLLSCp EDKNPCIFFE 239
rat BCDHC Eip GHGALYHSQS PRaFFRHCPG IKWIPRSPF QAKGLLI^cS F.DKNPCIF'f’E 216
H. volcanii Eip
B. stearothermophilus PDHC Eip
B. subtilis PDHC Eip
A. laidlawii PDHC Eip
B. subtilis BCDHC Eip 
P. putida BCDHC Eip
M. genitalium PDHC Eip 
human BCDHC Eip
A. eutrophus Acetoin ox/red P 
bovine BCDHC Eip 
rat BCDHC Eip
PKLIY...................RAFRGEVPE DDYTVPIGEA AVRREGTDVS 208
HLKLl................. RSFRQEVPE GF.YTlPIGKA DIKREGKDIT 205
HMKLf................. RSFRQEVPE F.F.YT IEIjGKA DVKRESTDLS 205
PKRIY................. RAGKQEVPA EMYEIPIGKA KWKQGTDMT 206
I KRAY................. RLIKGEVPA DDYVI.PIGKA DVKREGDDIT 206
PKRLYNGPFD GHHDRPVTPW SKHPHSAVPD GYYTVPLDKA AITRl’GMDVS 224
PKKLY................. RAFRQEIPS DYYTVPIGEA NLIf3BG5JF.LT 208
PKILY................. RAaAEEVPI EPYNIPLSQA F.VlQEGSDVT 273
hRnlY.................. GLEGEVPE GAYAI P'rGEA N1VRDGKDVS 214
PKILY RAAVKQVPV EP^NIpLSQA EVIQEGSDV7 273
PKILY RAAVEqVPV EpYr IPLSQA KVIQBG5IDVT 250
H. volcanii Eip VFTFGAMTRP TLE.AVENLE EEGIDAEWD IRTISPLDRE TIVESFKKTG 257
B. stearothermophilus PDHC Eip IIAYGAMVHE S||K.AAAELE KEGISAEWD IJRTVQPLDlg :J|jlGSVEKTG 254
B. subtilis PDHC Eip II^ Py|s\MVHE SLK.AADELE KQGISAEWD LRTVSPLDID T|lA$VF.KTG 254
A. laidlawii PDHC Eip VVAV^SIVRE VEK.RvklVE AEGlSVgllD IATISPl}3EE ;jiLNSVKRTG 255
B. subtilis BCDHC Eip VITYGLCVHF AfcQ.AAERLE KUGlSAHWD LRTVYPLDKE AI1EAA3KTG 255
P. putida BCDHC Eip Vi|y|tTVYV AQV.'RA. . .E ESGVRAEVlip LRSLWPljDLD .TIVESVl^ S  270
M. genitalium PDHC Eip IVSY^PTMFD LIN.LVYSg| LKDKGIIlID LRTISPV®KQ |vFN|vl^0 257
human BCDHC Eip LVAw|tQVHV IR|vRSMAk| KlfiVScgVlD IRTIipWpVD fiCKSVIKTG 323
A. eutrophus Acetoin ox/red P IV*YY|l|lVHR ALE.AAATtA KEGIFAEIVD lRTLSPLDMD TVLr|vENM 263
bovine BCDHC Eip LVAW|TQVHV Ir|vDAMAQE KL^VScfeVlD LRTlLpV^VD jvCK&VI«B| 323
rat BCDHC Eip LVAV^TQVHV IRfeVASMAQE KLGVScfeviD LTTIVRWijVD IvCkSviK^ 300
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H. volcanii Eip
B. stearothermophilus PDHC Eip
B. subtilis PDHC Eip
A. laidlawii PDHC Eip
B. subtilis BCDHC Eip 
P. putida BCDHC Eip 
M. genitalium PDHC Eip 
human BCDHC Eip
A. eutrophus Acetoin ox/red P 
bovine BCDHC Eip 
rat BCDHC Eip
H. volcanii Eip
B. stearothermophilus PDHC Eip
B. subtilis PDHC Eip
A. laidlawii PDHC Eip
B. subtilis BCDHC Eip 
P. putida BCDHC Eip 
M. genitalium PDHC Eip 
human BCDHC Eip 
A. eutrophus Acetoin ox/red P 
bovine BCDHC Eip 
rat BCDHC Eip
Figure 8.8: Alignment of H. volcanii E13 with the ten closest matching 
sequences.
The homology scores are shown in Table 8-2 below.
RAVWHEAPK NGGLGAEITA TVQEEALLYQ EAPVKKVAGY DVP.YPLYA. 305
RAIWQEAOK QAGrlAANVVA EINERAIiSL EAPVLRVAAP Dt v .y pf aq. 302
WI^QEAQK QAGIAANVVR EINDRAltSL EAPVI.RVAAP DTV. Ff FSQ. 302
KFMVVTEAVK SYGPAAELIT MVNEKAEFHL EAAPVRFTGF pIT.VPLARr, 304
kvll|t|dtk egsimsEvaa I1SEHCLEDL DAPIKRLA^P DlPAf-tPYAPT 305
RCVWHEATK TCGr’GAELVS LVQEHCFHHL EAPIERVTGW S t ...§YPHA 317
|l l w t e a v k SFTTSAEIIT SVTEELFTf L KKAPQRVTGF ■|lV.V&ARG 306
I'LLISMEAPL TGGEA3EISS TVQEECFLNL EAP I SRVCGfY DT...fFPHI 370
BLVWDEASP RCNIATDiSA QVAQQAFGAL KRiGIEMVCPP HTP. VTPF'SPT 312
RLLVSHEftPL T MFA^I sS TVQEECFLNL EAP ISRVCGY DT...pFPHI 370
fii.Ll GHEAPi. TGGFASEISS TVQEECFLNL EAP13RVCGY DT...fFPHI 347
LEDYYLPSVA RVEEGIREAV HF. . . 328
AESVWLopNFK DWIETAKKVM NF. . . 324
AESVWLPNHK dVletarkvl EF. . . 324
.ehyhfIqpe K1AAY1ERKIA KARP. 327
MEK^FMVNPD KVEAAMRELA e|. .. 327
fjewAyreops gfGAALKKVM EV. . . 339
.EKfQFEINA RVIDAVNQLL K___ 326
FEPFYlfDKW KCYDAiaKMI SY. . . 392
LED GYLPSAA QIAAAA&KTM KGGKH 337
FEPFifrtDKW KCYDALltKMI Ire. • • 392
FBPEtlfDKW kcydaiJ kmi *Y... 369
Organism/protein % Identity (amino acid overlap)
B. stearothermophilus PDHC E1J3 56.3% (323 aa)
B. subtilis PDHC E1 p 54.2 % (323 aa)
A. laidlawii PDHC E13 50.8% (317 aa)
P. putida BCDHC E1p 48.0% (342 aa)
B. subtilis BCDHC E1(3 46.9% (324 aa)
M. genitalium PDHC E1(3 46.0% (326 aa)
A. eutrophus Acetoin ox/red 3 subunit 44.2% (335 aa)
human BCDHC E13 42.2% (327 aa)
bovine BCDHC E13 41.8% (328 aa)
rat BCDHC E13 37.6% (327 aa)
Table 8-2: Homology scores for the H. volcanii E1(3 protein.
8.3.2.3 The E1 a gene
Only 207 nucleotides of the 3’ terminus of an E1a was sequenced from pNAT82. 
These translate to 68 amino acid residues. Homologies to any known 
sequences were low but the greatest was to the PDHC E1a component from A. 
laidlawii (36.5% identity over 52 amino acids).
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8.3.3 Evidence o f regulatory regions
A search was made of the entire pNAT82 sequence for possible promoters and 
other regulatory regions. A putative Box A element was identified by 
Vettakkorumakankav & Stevenson (1992) in their paper describing the cloning 
and sequencing of the DHLipDH gene. This sequence, TGAAGGAA, appears 
35 nucleotides upstream of the DHLipDH start codon (nt 2713-2720 in the full 
sequence), but is not consistent with the halobacterial Box A consensus of 
(T/C)T(T/A)(A/T)A (Palmer & Daniels, 1995). The sequence was not found to be 
sufficient for expression as the region was included in the DHLipDH insert in our 
first homologous expression experiment, which did not result in protein 
production. Vettakkorumakankav & Stevenson (1992) claim, however, that 
Northern blot analysis revealed that the DHLipDH gene was transcribed from its 
own promoters.
The only region that identified with the consensus Box A sequence in the 
entire pNAT82 clone was nt 4212-4216. This is at the 3’ end of the DHLipDH 
coding region and is thought to be part of the stem-loop termination sequence.
Box B sequences contain the transcription start site. They have only 
weak consensus and consist of two nucleotides, (T/C)(G/A) (Hain et al., 1992). It 
was pointless searching for such a motif as it would appear too frequently 
throughout the sequence.
The motif AAGTTA is considered important in the binding of RNA 
polymerase (Dennis, 1985). The sequence was not found within pNAT82.
If the genes are transcribed as an operon, one would expect to find the 
control regions upstream of the E1a gene, which has yet to be sequenced.
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8.3.4 Structural motifs of the E2 gene
E2 polypeptide chains consist of N-terminal lipoyl domains followed by a 
peripheral subunit-binding domain and the C-terminal acyltransferase (inner- 
core) domain (Figure 8.9). The number of lipoyl domains depends on the 












Lipoyl domains Acyltransferase 
and inner-core 
domain
\  Lipoyl-lysine residue 
/ V \ /  Interdomain segment
Figure 8.9: The segmented structure of the E2 polypeptide chain. The N-
terminal lipoyl domains (approximately 80 residues) are followed by the 
peripheral subunit-binding domain (approximately 35 residues) and the C- 
terminal acyltransferase domain. The domains are connected by flexible 
but extended linker regions (approximately 25-30 residues). The number of 
lipoyl domains varies with the origin of the E2 chain. Taken from Perham 
(1996).
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8.3.4.1 The lipoyl domain
Lipoyl domains consist of approximately 80 residues arranged in two (3-sheets 
forming a flattened (3-barrel, with a core of hydrophobic residues (Green et al., 
1995). The lipoyl domain of the E2 from H. volcanii, extending from residues 1 to 
84, is evident by the conserved DKA motif around the lipoyl lysine, K44 (Dardel et 
al., 1993), as well as high homology throughout the region. There is also a large 
proportion of hydrophobic residues in this area. The structure is similar to the B. 
stearothermophilus PDHC E2 in having a single lipoyl domain.
8.3.4.2 The peripheral subunit-binding domain
Peripheral subunit-binding domains of E2 chains consist of approximately 35 
residues and form two parallel a-helices, separated by a short strand, a helix-like 
turn and an irregular loop, with a hydrophobic core (Robien et al., 1992; Kalia et 
al., 1993). From the sequence alignments, the domain in H. volcanii consists of 
residues 119-260, interrupted by the putative duplication sequence. It has been 
suggested that an aspartate and a threonine residue in the B. stearothermophilus 
PDHC E2 form a hydrogen bond crucial to the domain stability (Kalia et al.,
1993). The aspartate is conserved throughout all known E2 sequences, 
including the H. volcanii E2 (D152), whereas the threonine is replaced by a serine 
in many structures. In H. volcanii E2 it appears as S142. Since the two residues 
are similar in structure, it is predicted that the stabilising hydrogen bond is present 
in the H. volcanii structure.
Many of the hydrophobic residues in this region are also conserved, 
whereas others are exchanged for different hydrophobic groups.
Most of the residues involved in binding the E3 dimer are conserved 
between the H. volcanii and B. stearothermophilus structures (detailed in Mande
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et al., 1996). S124, R126, R130, R147 are all conserved, whereas R127 is 
exchanged with a similarly-charged lysine residue in the B. stearothermophilus 
structure. P123 is also conserved and acts as a helix promoter.
G141 is conserved throughout most E2 sequences aligned and has been 
implicated in the binding of E1 (Kalia et al., 1993). E150, however, is not
conserved in the H. volcanii structure. In most other sequences it is either a 
lysine or an arginine and has been implicated in electrostatic interactions with E1.
8.3A.3 The catalytic domain
The catalytic domain, from residues 264-521 approximately, is highly conserved, 
especially around the active site histidine, H493.
8.4 The remaining E1 a  sequence
In order to obtain the remaining E1a sequence not included in the pNAT82 clone, 
a H. volcanii cosmid library was probed. The library is located at the University of 
Alicante in Spain and was created by Consuelo Ferrer by the methodology of 
Charlebois et al. (1989). The probe was created by PCR amplifying pNAT82 
using primers KAJ-26 and KAJ-27 with Vent® DNA polymerase. The PCR 
program used was as follows: 96°C for 4 minutes, followed by 30 cycles of 96°C 
for 75 s, 50°C for 90 s and 72°C for 2 minutes. The product of this reaction was 
approximately 1 kb in length. This was sent to Spain and was found to hybridise 
to a single cosmid (126) in the library, which was sent back.
The cosmid was purified using a Qiagen Tip 20 column. Attempts were 
made to sequence the E1a coding region directly from the cosmid using primer 
KAJ-36.
KAJ-36: 5’ tgcgtggttgaacatctcgctcgg 3’ 24-mer
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No success at sequencing was achieved, due to a high noise to signal ratio. This 
is a common problem with attempts to sequence large DNA molecules, the 
cosmid being 40 kb in length.
In order to obtain the remaining sequence, it is envisaged that the cosmid 
DNA will be size-restricted and subcloned into a more convenient sequencing 
vector. Time constraints prevented this approach being followed in this project.
8.5 Growth experiments
Experiments comparing growth properties of wild-type and BAS5005 (DHLipDH - 
minus) H. volcanii were conducted in an attempt to identify the metabolic defect 
of the mutant. Cells were grown on minimal medium agar containing a range of 
compounds as sole carbon sources at concentrations of 0.2% to 0.5% (w/v). 
This work was conducted mainly by Dr. M.J. Danson (University of Bath) and Dr. 
M. Dyall-Smith (University of Melbourne, Australia). Table 8-3 summarises the 
results of these experiments. No differences in growth were observed between 
wild-type and BAS5005.
Analysis of the first sequencing reactions, prior to completion of pNAT82, 
suggested homology to an acetoin dehydrogenase complex. To test if such a 
complex was present in H. volcanii, wild-type, BAS5005 cells and BAS5005 
transformed with the DHLipDH overexpressing plasmid pBAP5003 were grown 
on minimal media plates with acetoin as the sole carbon source. Similar low 
levels of growth were observed for all strains on 0.5% acetoin, suggesting that 
DHLipDH plays no essential role in acetoin metabolism.
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Table 8-3: Growth properties of wild-type and BAS5005 (DHLipDH - minus) 
strains of H. volcanii. Key: -, no growth; w, weak growth; +, ++, or +++, 
positive growth (Jolley et al., 1996).
8.6 Discussion
The identification of two E1 genes in H. volcanii places its putative 2-oxo acid 
dehydrogenase complex nearer to the eukaryote and Gram-positive bacterial 
PDH complexes. These organisms have an a2p2 E1 heterotetramer in the 
PDHC, whereas Gram-negative bacteria usually have a homodimeric E1 protein. 
The mycoplasmas are an exception, although these group phylogenetically with 
Gram-positive bacteria. Both the H. volcanii E1(3 and E2 genes group with 
homologous components of Gram-positive PDH complexes. The E3 gene 
similarly groups with the DHLipDH gene from Gram-positive bacteria (data not 
shown).
Although no activities for any 2-oxo acid dehydrogenase multienzyme 
complex have been reported in the Archaea, the sequencing of E2 and E1 
components in H. volcanii provides evidence of their one-time presence. As the 
components group with those from PDH complexes rather than from BCDHC or
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OGDHC, it is possible that an ancestral PDHC existed. The presence of a 
putative duplication sequence within the H. volcanii E2 gene provides an 
explanation for its apparent lack of functional enzymic activity.
The similar degrees of identity of the E1J3, E2 and E3 genes of H. volcanii 
to the homologous genes of the B. stearothermophilus PDHC might suggest that 
any inactivation of the halophilic E2 gene occurred relatively recently in evolution. 
The identity scores are 49.6% for E3, 47.8% for E2 (not including the insert 
sequence) and 56.3% for the E1p. Further evidence for a recent inactivation is 
the high degree of conservation in the binding and catalytic regions of the 
putative E2 gene product. If this is the case, the question of whether DHLipDH is 
a remnant of a now inactive complex or whether it occupies another role still 
needs to be asked. If it was solely a remnant, there would be no evolutionary 
pressure selecting for its continued activity and yet the gene codes for an active 
DHLipDH and it is clearly expressed within the cell. Its role, however, remains 
unclear, especially in the light that no metabolic defect was identified in the 
DHLipDH - minus mutant strain. If the DHLipDH gene is part of an operon, as it 
appears to be, the other genes within the operon must also be expressed.
The recently-completed sequencing of the entire genome of 
Methanococcus jannaschii (Bult et al., 1996) shows the presence of a DHLipDH 
gene in the apparent absence of genes for E1 and E2 components of a 2-oxo 
acid dehydrogenase complex. This would suggest that the possible explanation 
for a lack of PDHC activity in H. volcanii is not applicable to all other Archaea and 
it seems likely that the DHLipDH in H. volcanii occupies a role other than as a 
remnant of a PDH complex. DHLipDH is also found in the thermophilic archaeon 
Thermoplasma acidophilum in the apparent absence of a PDHC (Smith et al., 
1987).
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Dihydrolipoamide is known to possess antioxidant properties (Suzuki et 
al., 1994) and it has been implicated in the repair of membrane thiol groups in 
mitochondria (Zimmer et al., 1991). The role of DHLipDH in H. volcanii and other 
Archaea may, therefore, be in repair mechanisms. Such a role would not be 





Heterologous expression of foreign proteins in bacteria such as E. coli is a 
compromise. The advantages of such a system often outweigh potential 
disadvantages. These advantages include high cell densities, rapid growth and 
detailed knowledge of the surrogate genetic system. Transformation and other 
manipulative techniques are routine, abrogating the requirements of 
development and optimisation of such protocols in the natural host. There is a 
considerable choice of commercial expression vectors available, offering a range 
of inducible promoters that provide high levels of control over expression. This 
inducibility allows cells to reach high cell densities rapidly before their translation 
machinery is subverted to the production of the foreign protein.
Clearly there are difficulties in using a eubacterial system for expressing 
proteins whose native environment is highly saline. Although success has been 
achieved in the past, this project has demonstrated that such expression is not 
necessarily facile. The advantages of using a homologous expression system, 
therefore, are obvious. Any protein translated in its native environment would be 
expected to adopt its correct conformation and to undergo any necessary post- 
translational modifications. The disadvantages, though, are slow growth, a lack 
of inducible promoter systems and an incomplete understanding of the 
intracellular biochemistry of these organisms. Another consideration comes 
when considering a scale-up of expression using large-scale fermenters. The 
saline growth medium required of halophilic organisms is highly corrosive to 
stainless steel, often used in such systems, which would probably need to be 
replaced with more resistant materials such as glass. For research purpose's,
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however, on a laboratory scale, homologous expression of halophilic proteins 
represents a useful system and creation of the pBAP5009 shuttle vector should 
enable the expression of any cloned halophilic gene.
9.2 The nature of halophilic proteins
It is generally accepted that the predominant characteristic of halophilic proteins 
is a high degree of negatively-charged residues on the surface. These allow the 
protein to maintain a hydration shell by competing with the bulk solvent for 
hydrated salt ions. A concomitant reduction in the surface hydrophobicity 
counteracts the tendency of proteins to precipitate under these saline conditions. 
DHLipDH from H. volcanii conforms to these observations.
The identification of a potential K+-binding site at the dimer interface, 
however, suggests that the surface charge is not the sole structural feature 
important in conferring halophilicity. Halophilic proteins need to maintain the 
spatial alignment of key residues in the catalytic and binding regions of the core, 
while under increasingly saline conditions the molecule is under pressure to 
contract from the increased surface tension at the protein-solvent interface. 
Occupancy of the K+-binding site may well increase the stability of the core, 
especially as the salt concentration increases. As more halophilic structures 
become available, it will be interesting to see if such features are common. The 
tetrameric structure of malate dehydrogenase from H. marismortui (Dym et al., 
1995), consisting of two dimers, does not however appear to have such a site 
between the monomers making up each dimer.
The hypotheses of structural features involved in conferring halophilicity, 
based on precise spatial arrangements of atoms, must be treated with a degree 
of caution when those arrangements are based on a molecular model. Clearly, 
an X-ray crystal structure is desirable, and the crystallisation trials have shown
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that halophilic DHLipDH will form crystals and have identified starting conditions 
around which future trials can be optimised. It is still valid to make predictions 
from model structures as long as one remains aware of the potential positional 
uncertainties.
9.3 Phylogenetic implications
The discovery of genes coding for putative E1 and E2 components of a 2-oxo 
acid dehydrogenase complex in the Archaea is the first indication of their possible 
existence within these organisms. The presence of a large duplicated region 
within the E2 gene that would be expected to perturb its binding of the E3 
component provides an explanation for the lack of detectable activity. Disruption 
of binding between E3 and the putative E2 gene product complements the 
discovery that in gel filtration of whole-cell extracts of halophilic Archaea, all 
DHLipDH activity is present in a single peak representing free enzyme (Danson 
et al., 1984). In these experiments, the possibility exists that in the process of 
making cell extracts, large multienzyme complex structures may have 
dissociated. Since no activity at all was detected in fractions larger than the 
DHLipDH dimer, however, it seems likely that the enzyme exists solely in an 
unassociated form in these organisms. The function of an unassociated 
DHLipDH may be in oxidative repair mechanisms (Suzuki et al., 1994; Zimmer et 
al., 1991) or in sugar transport (Richarme, 1989; Richarme & Heine, 1986), 
although the growth experiments seem to rule out the latter.
If a 2-oxo acid dehydrogenase multienzyme complex existed at one time 
in the halophilic Archaea, it would appear that the case is not universal across 
the archaeal domain. Since the putative E2 and E1 genes and the functional 
DHLipDH gene of H. volcanii have very similar percentage identities to the 
homologous components of the B. stearothermophilus PDHC, any evolutionary
172
event that resulted in a loss of function for the complex would be expected to 
have occurred relatively recently. This is consistent with the analysis of the 
sequencing of the entire genome of Methanococcus janaschii (Bult et al., 1996). 
This organism, while having a DHLipDH gene, lacks genes for either the E1 or 
E2 components, unless their coding regions are so dissimilar from their 
homologues that they are not recognisable.
One experiment that may yield conclusive insight to the former role of the 
halophilic 2-oxo acid dehydrogenase complex would be to remove the duplicated 
region of the E2 gene. It is possible that removal of this extraneous DNA would 
allow the expression of a fully active complex. Whether this would work depends 
partly on how long ago the duplication event occurred which would effect the 
degree of mutation within the gene. Once the remainder of the E1a gene 
sequence is obtained, it may be possible to express all the components of the 
multienzyme complex. It cannot be absolutely ruled out that the genes do code 
for an active complex whose expression is tightly regulated and is hence not 
detectable under normal assay conditions. Sequencing of regions upstream of 
the E1a gene may provide clues to the regulation of the operon and the 
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